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Recent advancements in accelerator technology and increasing experience with utilising
charged particle beams for medical applications have supported the growing presence
of ion beam therapy worldwide. The advantageous dosimetric properties enable high
amounts of radiation to be precisely shaped and delivered to target sites while sparing
surrounding healthy tissue. Accelerators, beam transport and delivery systems are de-
signed to optimally and safely deliver the beam according to the prescribed treatment.
This is maintained by beam instrumentation devices however limitations are seen with
conventional tools. Therefore advanced diagnostics are needed to fully exploit funda-
mental benefits, for enhanced functionality and to accommodate new developments in
particle therapy. A novel online beam monitor based on LHCb VELO detector tech-
nology is being developed, capable of providing non-interceptive, active measurements
of the beam halo and was optimised for the 60 MeV ocular proton beamline at the
Clatterbridge Cancer Centre, UK.
The facility offers a unique environment to assess the viability of the detectors how-
ever in order to integrate the system, the propagation and behaviour of the beam must
be well understood. Several computational tools were developed to precisely model
and completely characterise the facility. Simulation studies were performed using a
GEANT4 model of the treatment line to generate transverse beam distributions which
showed minimal impact of the sensors on the beam whilst revealing a dependency on
the input beam parameters. Experimental measurements were performed using EBT3
film and benchmarked with a Medipix3 detector to verify the model and also to test for
the first time, its performance and applicability in a clinical proton environment.
An alternative approach was necessary to resolve beam information upstream and
an extensive review was required to overcome facility related limitations to determine
fundamental beamline parameters. An optical lattice was defined in MAD-X and BD-
SIM, enabling the possibility of end-to-end modelling and yielding parameters (σx,y =
6.89, 2.14 mm, βx,y = 9.52, 4.59 m and Dx,y = 0.01, 0.00 m) which were used to define
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the treatment beam. This was utilised in a redeveloped TOPAS model of the CCC de-
livery system which also incorporated the progress made with multiple codes, providing
a single platform for future use. Simulations of the dose deposition, transverse beam
profiles and linear energy transfer were achieved. Measurements were also performed
with a MiniPIX-Timepix detector to experimentally verify the model for correlation with
radiobiological applications.
These methods provide a basis to reproduce the physical properties of the beam
given the present state of the Clatterbridge facility. This approach was also applied for
proof of concept measurements performed at the University of Birmingham. Several
uncertainties and improvements are discussed however the achieved results demonstrate
the possibilities of the adapted VELO sensors as a beam monitoring system. This thesis
combines computational modelling, experimental studies and accelerator concepts to
establish a framework to characterise, optimise and realistically simulate medical proton
beamlines. The application of this work supports the development and integration of
novel diagnostics as explored at existing facilities, for improvements in the delivery and
outcomes of proton therapy.
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The pursuit of a cure for cancer has long challenged the medical and scientific community.
Cancer is a universal burden and is a leading cause of death worldwide. It imposes a
costly and significant impact on communities yet rates of incidence are continuing to
rise. In recent years it was estimated that there were more than 18 million diagnosed
cases and over 9.5 million related deaths annually, contributing to 1 in 6 deaths globally
[1, 2]. In developed nations these rates are slightly higher and in the United Kingdom,
this equates to an estimate of 1 in 2 people who will be diagnosed with cancer in their
lifetime. Despite these alarming statistics, the presence of cancer does not always result
in loss of life; cancer survival rates are at approximately 50% and steadily increasing
[3]. Today, several methods are employed on their own or as a multi-modal approach to
treat cancer: surgery, chemotherapy, immunotherapy, hormonal therapy and radiation
therapy. Advancements in modern technologies and improvements in these methods
have enabled progressive steps toward this common goal of combatting cancer.
One such development is the administering of ionising radiation to cancerous sites:
radiotherapy or radiation therapy (RT). RT is one of the more economical methods of
treatment however its availability, accessibility and usage varies significantly. This is
associated with aspects of demographics, cost and income levels which are significant
factors limiting the effective nature of RT for curative and palliative applications [4].
In the UK around 40% of all cancer patients were treated with radiotherapy yet it is
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predicted that more than half of all cases could benefit from RT [3, 5]. The efficacy of
RT is well established however there is still an ongoing demand for accessible, affordable
and effective cancer care [6]. These global goals have driven further work and innovation
in the understanding and delivery of radiation for cancer care; these motivations also
provide the context of which this thesis aims to ultimately contribute toward.
1.2 Medical Applications of Radiation
Following their discovery by Röntgen in 1895 [7], X-rays were recognised foremost for
their useful application in medicine, as a diagnostic tool and then as a means of treat-
ment. The biological effects and knowledge surrounding this new method were explored,
initiating the start of radiation therapy; a field which set out to utilise these newfound
ionising capabilities to irradiate malignant tissue sites.
1.2.1 Conventional Radiotherapy
Today, the application of X-rays still form the basis of conventional external beam ra-
diation therapy (EBRT). Countless developments in technology have since transformed
rudimentary methods of X-ray production by emitting tubes to modern accelerators and
delivery systems which are found in clinics today. Primarily, this was made possible due
to improvements in the ways beams were generated and transported, as well as inno-
vations in the computational proficiencies of systems which image, shape and calculate
the resulting dose. For the former, this includes the introduction of shielding, multi-leaf
collimators and electron linear accelerators (linac). The latter describes computed to-
mography (CT), positron emission tomography (PET), magnetic resonance (MR) and
dose calculation algorithms. This led to the creation of treatment planning and the de-
velopment of conformal treatment modalities such as intensity-modulated radiotherapy
(IMRT), volumetric-modulated arc therapy, image guided radiotherapy and stereotac-
tic radiotherapy [8]. More novel delivery methods also include spatially fractionated
schemes (i.e. GRID/LATTICE) and microbeam radiation therapy [9–11].
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These techniques allow the beam to be manipulated and delivered in such a way as to
reduce the amount of radiation deposited in surrounding normal tissue; the dose is dis-
tributed and directed precisely to the tumour volume. Radiotherapy is often performed
in conjunction with surgery or chemotherapy and depending on tumour localisation or
metastasis, also presents as an effective alternative for palliative care. Given the needs
of the patient, the premise of radiotherapy is the non-invasive delivery of radiation to
a target, such that tumour cells are sufficiently irradiated whilst sparing surrounding
healthy tissue.
In order to provide the most optimal and effective treatments, significant progress
in the field of high energy physics (HEP) led to the development of advanced concepts.
New horizons were made possible by new accelerating machines (cyclotrons, synchrocy-
clotrons, synchrotrons), facilitating the application of different particle types for treat-
ment. Further improvements in the technological and radiobiological aspects alongside
growing experience have supported the emergence of the next generation of radiation
treatment: charged particle therapy (CPT).
1.2.2 Charged Particle Therapy
The rationale to use charged particles for radiotherapy was first conceived in the 1940’s
by Robert Wilson [12], based on the phenomenon of the ‘Bragg Peak ’: the increased
ionisation seen at the very end of an energy dependent range, originally observed in
alpha particles by William Bragg in 1904 [13]. The idea to use protons was explored
firstly with preclinical work at the Lawrence Berkeley National Laboratory (LBNL),
California, followed by the Gustav Werner Institute, Uppsala and the Harvard University
Cyclotron Laboratory (HCL), Massachusetts. In 1954, the first patients were treated
at the LBNL and shortly after, a clinical program was run at the HCL in collaboration
with the Massachusetts General Hospital (MGH) at the end of the 1950’s. Over the
next years with growing research interests and funding, MGH realised the potential of
proton therapy for ocular, skull-based and head-and-neck region cancers and continued
to treat thousands of patients at the HCL until its closure in 2002.
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In Europe and beyond, several programs had commenced in mostly research insti-
tutes in the early 1990’s; Paul Scherrer Institute (PSI) was the first in Switzerland, along
with centres in Nice and Orsay, France as well as Chiba, Japan [14]. Most notably, in
the United Kingdom, the Douglas cyclotron was built in Bebington, Merseyside and
commissioned in 1984 at the Clatterbridge Cancer Centre (CCC). Although initially
purposed for neutron therapy trials, it became a proton therapy service and treated the
first set of ocular patients in 1989 [15]. This marked the establishment of the world’s
first hospital based proton beam therapy facility and in the next year was joined by
the Loma Linda University Medical Center in California, United States and soon after,
more centres across America and Europe.
1.2.3 Current Status
Since these beginnings, over 190,000 patients have been treated with protons [16]. At
present there are more than 100 operating CPT facilities worldwide, almost 40 under
construction and a further 30 planned. New participation in regions without CPT mean
multiple continents will see their first centres in locations such as India, Egypt, Norway,
UAE, Singapore and Australia. In the UK, there has been a recent rapid growth in the
market for proton therapy, 4 clinics have been built and started treatments in the past
2 years and at least 3 more centres are anticipated [17].
The physical characteristics, observed biological effects and patient outcomes have
affirmed proton use as a viable option for therapy. This success suggested the possibility
of using alternative particle types in clinical beams to deliver a more precise beam with
greater radiobiological impact. As seen in Fig. 1.1, other heavier charged particles
also exhibit similar dose deposition behaviour. Thus neutrons, pions, helium, neon and
carbon ions for particle therapy were studied and further work led to another modality
of CPT: carbon-ion therapy. This was pioneered in 1994 at the National Institute of
Radiological Sciences in Chiba, Japan and was followed by centres in Germany, Austria,
Italy and China [8].
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Figure 1.1: Dose profiles in water for various particle types. Peaks of high dose followed
by a significant drop off are demonstrated for heavier particles (bottom row) [18].
These dosimetric characteristics of heavy charged particles were recognised to offer ad-
vantages over conventional photon radiotherapy. Protons are the lightest in this category
and easiest to use, hence are the most commonly used particle type for CPT and have
treated the highest number of patients. As the purview of work carried out in this
project relates specifically to protons for CPT, proton beam therapy (PBT) will be the
focus throughout this thesis.
1.3 Proton Beam Therapy
1.3.1 Rationale
The primary benefit of using protons over conventional X-ray radiation therapy relates
to the advantage of delivering a beam with a finite range. In essence, due to their mass
and charge, protons will continually undergo interactions and transfer energy along their
path. Consequently they slow down and before coming to a complete stop, there is a
culmination of dose where the majority of their remaining energy is deposited. This
is known as the aforementioned Bragg Peak (BP). Following this, there is a steep fall-
off with negligible transfer of energy and this enables the beam to be manipulated
and delivered to targeted sites for the purposes of treatment. The specifics of these
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interactions which occur between protons and matter are discussed in greater detail
later in Section 2.1.1.
Figure 1.2: Direct comparison between the depth dose distributions of a conventional
16 MV photon beam and 200 MeV proton beam [19].
In X-ray EBRT, healthy tissues are often exposed to higher amounts of radiation as
photons have a larger surface and exit dose; this can have significant and adverse effects
(Fig. 1.2). Although in PBT several proton beams are superimposed to form a ‘spread
out Bragg peak ’ (SOBP) to cover the whole tumour volume, the localised energy transfer
can offer an increased cell kill efficiency and higher biological damage. As a conservative
estimate, it is generalised that protons inflict damage by a factor of 1.1 times more than
photons. This is given the term ‘Relative Biological Effect ’ (RBE) which is a quantitative
representation of radiation quality and is used to measure the potential biological impact
of two different modalities. In practice, this translates to the application of this generic
factor to the physical doses calculated for photon plans for an equivalent proton plan
[20]. There is ongoing debate over the discrepancy of RBE as a single value despite
its dependence on numerous parameters [21] which are not discussed in this thesis. An
exception to this is the linear energy transfer (LET) which correlates to cellular damage
as a result of energy losses; this value changes across the total path length, according to
the particle type. Protons and heavier charged particles have much higher LET values
than photons, this is discussed further in Section 5.4.
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Moreover, there can be remarkable differences when comparing the dose distributions
and treatment plans between the two modalities, particularly for specific cases (Figs. 1.3
and 1.4). This is especially a concern when the tumour is in close proximity to critical
organs or deep within the body and normal tissue may be exposed to excess amounts of
radiation.
Figure 1.3: Example of treatment plans for: A) Conventional photons.
B) Intensity modulated photons. C) Spot-scanned protons and D) Intensity modulated
protons. This is a head and neck case for a paediatric patient, lower integral doses
outside the target volume can be seen for protons [22].
Figure 1.4: Comparison between treatment plans for a spine case with intensity mod-
ulated photons (left) and protons (right) [19].
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PBT is often more commonly accepted for paediatric cases to lower the risk of secondary
or future malignancies. Protons have been proven to be especially effective for paediatric
patients and against certain carcinomas. Improved clinical outcomes have also been
realised for skull based, head and neck, brain carcinomas and radiation resistant or
other challenging cases [19].
All these characteristics suggest the great potentials and opportunities for a signifi-
cant reduction in adverse effects, toxicity, recurrence rates and better local control. Even
though there are clear physical advantages offered by the Bragg peak, the option of PBT
against other treatment modalities is still uncommon: there are several considerations
and uncertainties which limit the complete clinical exploitation of protons.
1.3.2 Challenges and Motivations
Clinical studies have provided mixed evidence regarding PBT as an effective treatment
modality. In adherence to policies for medical care, several countries have national guide-
lines defining specific candidates and cases where PBT is recommended only if there are
clear advantages [19]. This holds true for ocular melanoma, which is well suited for and
has seen consistently high success rates since the inception of PBT [23]. These sites are
almost always treated with passively scattered beams where the dose is mechanically
shaped laterally and longitudinally to the tumour. In contrast, modern facilities mostly
use an active approach of pencil beam scanning (PBS), where multiple small ‘beamlets’
are magnetically directed to cover the extent of the target and shifted longitudinally by
varying the beam energy (described in Section 2.2.4). Many features of PBT have also
emulated conventional techniques, such as dosimetry, protocols, intensity modulated
(IMPT) schemes and treatment planning. Although proficiencies have been established,
PBT still suffers from complexities associated with biological and physical uncertainties,
robustness of plans, positioning and beam delivery [19]. Conversely, significant develop-
ments have improved the effectiveness of photon EBRT and maintained its prominence
as common practice. Much recent research and development have been done in the field
to keep PBT competitive however there are several areas needing improvement and are
well identified in research [24–26].
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These challenges can be related to three main themes: biology, physics and technology.
The following points are briefly explained for context:
• Biology: There are deficiencies in precisely quantifying radiobiological effects
and cellular responses which may account for sub-optimal treatment planning and
clinical outcomes. The generic RBE value doesn’t account for variations in LET
and the unknowns of mechanisms at the molecular to macroscopic scale [27–29].
• Physics: Uncertainties with heterogeneities in the beam path as well as changes
to tumour size and position, result in discrepancies identifying the depth of the
Bragg peak. Enhanced imaging is needed for in-vivo range verification, adaptive
treatment planning, delivery with moving targets, online and in-room capabilities.
The application of these with superior dose calculation methods (Monte Carlo,
algorithms, robust optimisation, biological implementations etc.) for utilisation
with treatment planning systems (TPS) [30, 31].
• Technology: There are high capital costs of building a PBT facility, accom-
modating for the large footprint required for the accelerator system, beamlines
and shielding. Further considerations are associated with the intended through-
put, delivery methods, gantry system, maximum energy and other specific beam
requirements. Reductions and better conformity of resulting dose distributions
(decreasing the beam penumbra with contouring and collimation, spot weighting
etc.), better beam control and delivery (higher uptime and shorter times required
when changing beam parameters, more efficient PBS approaches etc.) [31, 32].
The issue of cost is becoming less significant as the availability of smaller and cheaper
systems for clinical PBT is increasing. Several vendors offer complete single or multiple
room gantry systems and facilities have become well equipped to treat large numbers of
patients. Treatment costs can also be suggested as more economical due to the potential
of better quality of life with more effective therapy and therefore will have lesser long
term complications [33].
New novel accelerators and methods of beam generation (dielectric wall, laser driven
plasma [34], high-gradient linacs [35] and fixed-field alternating gradient [36]) along with
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the implementation of rapid cycling and superconducting technology may also lower
costs [37, 38]. Work in these areas provide the possibility to achieve superior delivery
and more effective treatments in the future. Nevertheless, current improvements to
PBT can be met by advancements to existing technologies and those which address the
previously listed themes [32]. As PBT evolves on a whole (also for different or mixed
particle species and better beam quality), the increased complexity of beam transport
and accuracy of treatment verification necessitate advanced beam instrumentation and
dosimetry systems.
Therefore, this thesis delves into aspects related to all three themes with a practical
focus on tools to improve beam delivery related to the accelerator and beam transport
system, as well as the capacity to accurately model and examine this computationally.
Beam diagnostics are fundamental for monitoring and ensuring effective delivery of the
beam for treatment. There are several promising developments in particle beam detector
technologies and this work centres around solid state silicon devices: specifically their
application in medical proton facilities.
A major part of this project involved the study and characterisation of these facilities,
in order to understand the behaviour of the generated beam and model this precisely
in several simulation codes. This also enabled studies into the integration of various
silicon detectors, their feasibility, performance, impact on the beam and to support
experimental measurements performed at two different proton beamlines.
Significant original contributions in this scope relate to: development of a novel online
beam (halo) monitor, first tests with instrumentation in clinical environments, developed
tools to analyse and obtain beam profiles, comprehensive studies and characterisation of
the Clatterbridge facility, development of extensive beam transport (optical lattice) and
tracking simulation models (treatment delivery system) and their use for radiobiological
applications.
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1.4 Project Objectives and Overview
The main goals of this project were to study the behaviour and propagation of the
CCC clinical proton beam, in order to contribute to the development of the LHCb
VErtex LOcator (VELO) detector as a clinical proton beam monitor [39]. The detector
operates a novel concept of measurement, by only detecting the halo of the beam distri-
bution. As a result, the extensive characterisation of relevant medical proton facilities
were necessary to investigate the feasibility of the detector. The physics surrounding
PBT, definitions, quantities, accelerators, beam transport and delivery, instrumentation
technology and an overview of relevant clinical practices are described in Chapter 2.
Simulation studies of the CCC beamline were done with GEANT4 [40] to investi-
gate the integration and impact of the VELO detector which is discussed in Chapter
3. These studies revealed that minute differences with the input parameters affect the
beam distribution, necessitating other approaches to overcome these. Measurements
were performed with EBT3 film [41] and compared with beam profiles achieved using
a Medipix3 detector [42] to validate and improve the simulation model. Alternatively,
as detailed in Chapter 4, an extensive beam dynamics study of the CCC beamline was
carried out in order to model the beam optics. An optimised optical lattice represent-
ing present day conditions was developed using the accelerator codes MAD-X [43] and
BDSIM [44] and combined with the treatment line geometry to generate an end-to-end
model (exit of cyclotron to treatment nozzle). These were used to determine the input
beam distribution and the RMS sigma sizes for integration of additional diagnostics
systems to measure beam properties along the transport line.
The verified geometry of treatment line components were combined with the optics
calculated input beam and implemented in TOPAS, another Monte Carlo simulation
code specifically for proton therapy. The code, finalised model and simulated results are
presented in Chapter 5 alongside experimental measurements using a MiniPIX-Timepix
detector [45] to verify the LET. Lastly, a measurement campaign with VELO at the
medical research beamline at the University of Birmingham is described in Chapter 6.
First test results with the upgraded detector, simulation and film results are shown and
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further prospects of clinical impact are discussed. A summary and outlook is presented
in Chapter 7.
This thesis endeavours to provide a better understanding of the beam produced,
transported and delivered at these facilities; to explore the capabilities and support
the development of several beam instrumentation systems. Comprehensive studies were
performed to characterise the beamlines for detector integration and to develop com-
putational tools to accurately model these facilities. These simulation models also aim
to facilitate further study into the current understanding of radiobiological effects from
protons. Each of these aspects contribute to the framework established in this work,
outlining a method to simulate, optimise and characterise medical proton beamlines.
This thesis combines beam optics, beam diagnostics, simulation modelling and particle
accelerator concepts in the context of radiotherapy for improvements in the delivery,
efficacy and outcomes of proton beam therapy.
Chapter 2
Clinical Proton Beams
The goal of radiotherapy is to deliver a sufficient amount of radiation to the target tu-
mour volume whilst sparing healthy tissue. Unwanted exposure to radiation can increase
the risk of second malignancies or other treatment induced, adverse late effects and these
outcomes limit the therapeutic effectiveness of EBRT. However, the treatment efficacy
can be enhanced by delivering the dose such that it is more conformal to the tumour
site or also, by increasing the concentration of dose delivered to the target site.
Although the advanced methods of conventional RT delivery allow comparable dose
distributions to PBT, this modality is limited by the nature of photon beams. Photons
readily transfer their energy through interactions which mobilise atomic electrons such
as Compton scattering, the photoelectric effect or pair production: these are stochastic,
statistical processes which occur over a continuous length [46]. Even though the dis-
tribution can be rearranged geometrically, normal tissue will always be included in the
total energy deposition [47]. In contrast, the physical advantages of protons enable the
beam and dose deposition to be shaped better than with conventional photon beams.
Advanced PBT delivery methods can deliver a highly conformal dose distribution with
a lesser number of beams and particularly for complex cases, can result in a decreased
amount of radiation to critical structures. The finite interaction range results in a re-
duction in energy transfer following the BP, also enabling a higher ratio of dose delivered
within the target [48].
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2.1 The Physics of Proton Beam Therapy
Protons lose energy with depth as a result of multiple types of interactions along their
path. These can be classified broadly as either atomic or nuclear, where primary protons
are slowed predominantly due to coulombic interactions with atomic electrons or nuclei.





where E is the mean energy loss and x is the distance. As this represents the energy
lost by the particle along its length of travel due to opposing forces, it is a function of
the kinetic energy of the incident particle and the absorbing medium. It is often more
useful to express the mass stopping power ( MeV
g cm2







The amount of energy lost is the sum of contributions from electronic, radiative and
nuclear processes. These must be considered across the range of particle energies for
CPT and also account for relativistic effects. Therefore, the total mean energy loss for
























The variables are defined as: Avogadro’s number NA; the radius re and mass of the
electron me; the atomic number Z, relative mass A and the mean excitation potential
I of the absorbing material; the charge z and velocity v of the incident particle where
β = vc , with speed of light c; the Lorentz factor γ =
1√
1−β2
; density corrections for energy
losses due to electron shielding δ as applicable at higher energies and the shell correction
C at low energies. The behaviour of the energy loss from the different interactions
for a proton in water is shown in Fig. 2.1. Electronic processes dominate across the
entire energy range and at relevant PBT energies, nuclear interactions have minimal
contributions. Water is considered equivalent to tissue in PBT as it is similar in density,
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effective Z/A and other attributes. Protons experience corresponding energy losses and
interaction processes and as such, water equivalent materials are used for phantoms and
in standard dosimetry practice [50].
Figure 2.1: Energy loss contributions of different interactions experienced by protons
in water. Within ranges for CPT, the energy loss is demonstrated by the Bethe-Bloch
formula (Eq. 2.3) [51].
Due to their mass (much greater than electrons), heavy charged particles and particularly
protons, travel mostly in a straight line where their rate of energy loss is inversely
proportional to the square of their velocities. In tissue, the proton range is almost equal
to the projected path length calculated from stopping power data [50]. Deviations are
caused by density inhomogeneities of the different biological components within the body
and effects from fluctuations in the energies of individual protons are also evident.
2.1.1 Proton Interactions
The main types of interactions which occur can be categorised as stopping, scattering
and nuclear [52]:
Stopping : Protons may collide with atomic electrons (in-elastic scattering) if suf-
ficient energy is transferred, resulting in ionisation events which generate secondary
electrons. These energy losses continuously slow or stop the protons, contributing sig-
nificantly to the achievable proton range and variations in the longitudinal profile. These
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variations caused by individual differences in the energy lost by collisions are known as
range straggling effects [46].
Scattering : Proton collisions with atomic nuclei (elastic scattering) via multiple
Coulomb scattering (MCS) result in a change of trajectory. Protons are deflected from
their original path which may also generate secondary recoil particles. The scattering
mostly observes a theoretically Gaussian distribution and causes the angular, lateral
broadening of the beam. In larger beams, this occurs only in the outer edges; protons
scatter outward from the central region but this is replaced by particles which scatter
back in. In narrow beams, there is less scatter back inside and with depth, the central
dose region decreases. For this case, the spread in the transverse plane is estimated to
be 5% of the initial range [46, 51]. These are important considerations in passive and
active delivery methods.
Nuclear : Protons with sufficient energy to overcome the Coulomb barrier and cross-
section may interact further with atomic nuclei (non-elastically). A nuclear reaction
results in the absorption of the primary proton, producing secondary protons or other
particles such as gamma rays, neutrons, deuterons, tritons, helium or other ions. A
reduction in the proton fluence occurs and is compensated by secondaries which can
also contribute up to 10% additional dose in high energy PBT treatment [50].
In terms of the energy transfer and its significance to dose, the electromagnetic (EM)
interactions dominate. The physics of these collisional events (excitation, ionisation or
MCS) which continuously slow, deflect or stop protons, is well understood. In contrast,
it is estimated that only 1% of primary protons undergo nuclear interactions and the
distributions of secondary particles produced are also more difficult to model. Although
these interactions occur less frequently, they affect both the longitudinal and lateral
beam profile. Moreover, the additional dose deposited by secondaries can have a noted
biological effect [38, 52].
Furthermore, if non-elastic scattering causes protons, nucleon clusters or neutrons to
be ejected, they will have lower energies and larger trajectory angles which deposit doses
further downstream of reaction sites. Additional secondary particles such as gamma
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rays or neutrons, produced from interactions with delivery components or the patient
also pose further risks. If irradiating biological matter, secondary fragments containing
alphas and residual nuclei may also result [50, 52]. These will have a high stopping
power and LET: this is meaningful when examining radiobiological impact and must be
accounted for as they have an increased effect in simulations.
2.1.2 The Bragg Peak
Given these interactions, protons lose their energy over a distance, leading to a build up
at the BP. This results in a deposition profile with a lower entrance dose and a minimal
exit dose as protons achieve complete energy loss. These mechanisms of energy loss
can be calculated to model the BP analytically [53, 54] or by using simulation methods
(shown in Chapter 5.3.1). As shown in Fig. 2.2, the different interaction processes
contribute in varying amounts to the total dose distribution.
Figure 2.2: Contributions of different processes to the BP and total dose deposition
profile (in water) for a 160 MeV PBT beam a) Overall dose profile. b) Primary proton
flux. c) Dose from local energy transfer. d) Dose from long range secondaries. e) Dose
from primary protons. f) MCS beam broadening [54].
The dose is concentrated at the BP as the number of protons decrease and at this point,
most of their energy and momentum has been transferred to other particles; the depth
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the BP occurs is defined by the initial beam energy. The contributions from primary
protons via Coulombic interactions are significant along the entire range whereas nuclear
interactions and secondaries only add to the entrance dose and plateau region. As such,
the range is defined as the depth in the medium at which half the protons involved in
EM interactions have stopped. Typically, this is assigned to the distal depth in water
at 80% maximum dose, after the BP [52]. The slight curve in the fall-off is due to the
energy spread and range straggling: these determine the width of the peak.





D is the physically absorbed dose (Gy or J/kg) and E is the mean imparted energy
in a medium of mass m. Given Eq. 2.2, for a beam of dN protons passing through a







× 1.602 [Gy]. (2.5)
As mentioned, when the beam propagates in water, scattering causes particles from the
middle of the beam to spread out in the transverse directions. This effectively results
in a reduction of the fluence in the central region with depth and is more pronounced
for smaller fields and pencil beams. In active delivery methods where there is magnetic
steering of a narrow (pencil) beam, i.e. proton pencil beam scanning, this is compensated
by using multiple beams or overlaying fields of dose [52]. However, this gives rise to the
‘halo effect ’, where the secondaries from nuclear interactions results in an excess of
dose which surround the primary beam. This appears as a low dose tail along the
lateral edges of the beam and cumulatively with multiple beams, can have significant
dosimetric impact on the total delivered dose and distribution. This halo effect was
originally defined by Pedroni et al. [54] as specific to PBT and in addition, an analogous
phenomenon is also a prevalent point of discussion in accelerator physics. As the VELO
detector is also often described as a ‘halo’ monitor [55], the ‘beam halo’ is a key concept
in this thesis. This is discussed for context as although these concepts are similar in
terminology, each are in fact physically different.
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2.1.3 The Beam Halo
In PBT, the halo is defined as the peripheral dose produced from nuclear fragments,
scattering inside the patient, phantom, diagnostics (ionisation chambers), components
in the beamline (nozzle, range shifter etc.) and also the accelerator. In general, it
refers to the region which surrounds the ‘core’ of the beam, made of primary protons
interacting by EM interactions. The ‘aura’ consists of neutral secondaries and loosely,
the halo is the wider region [56], as depicted in Fig. 2.3. For further explanation, it is
also studied extensively in several other works [57–62].
Figure 2.3: The dose components of a PBT beam distribution in water. The halo region
encompasses all secondaries which surround the core and aura contributions [56].
As the halo effect is less significant for larger sized beams and given that the VELO
monitor provides halo measurements in air (discussed in Section 2.3.3), the halo men-
tioned in this thesis for this case, is defined differently. The CCC facility operates a
passively scattered beam where MCS is utilised to broaden the beam to a field size
suitable for treatment (explained in Section 2.2.4). However, as the VELO modules will
always remain a certain distance apart from the beam core, the halo is determined by
the distance between the sensors: the aperture radius plus separation distance. The
part of the beam which is greater than this gap will record hits on the monitor and
regardless whether these originate from EM or nuclear interactions, is designated as the
halo region. Therefore, MCS interactions from the treatment line delivery elements and
in air would mostly contribute to the detected halo: the PBT beam at CCC can be
similarly visualised as in Fig. 2.3.
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Furthermore, although the halo in PBT is extended to include effects from the accel-
erator and other components which intercept the beam, in accelerator physics the beam
halo has another definition. It can be defined and quantified in several ways [63–67] and
is dependent on several factors which differ for the type of machine (i.e. high intensity
beams, circular accelerators). For relevance and brevity, the beam halo is broadly de-
scribed as an intrinsic property of the beam, referring to a lower density distribution of
particles surrounding the beam core [68]. The formation of the halo is due to several
mechanisms such as space charge effects, scattering with residual gas particles, beam
mismatches and particle variations in phase space. Particles oscillate around an ideal
orbit but may arrive at different angles and distances and diffuse out from the beam
core which can differ from the acceptance of beamline optics. Therefore, it is an impor-
tant consideration when designing beamlines, the optical elements (i.e. magnet aperture
size), diagnostics and optimising machine operation.
In linear machines, the halo is characterised by beam mismatching and space charge
forces: EM repulsion within particle bunches and between bunches. For circular ma-
chines it arises from asymmetric resonances, collective instabilities and unstable har-
monics which are propagated with each revolution. For all machines, the beam halo
influences the transverse beam size and most significantly, can result in beam losses. It
is also largely correlated with the beam quality: the ability of a beam to be transported
and focused into a small region of space while remaining as minimally divergent [69].
This is represented by the ‘emittance’, a term which quantifies the elliptical distribution
of particles in phase space. This corresponds to the physical size of the beam and is
determined by the beam dynamics of the accelerator, discussed later in Chapter 4.
Additionally, to avoid confusion between terms which are defined differently across










For a beam, F is the flux for N number particles over time t and I is the intensity or
commonly, beam current. The charge q for a proton is 1.6022 × 10-19 C.
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2.2 Accelerators
The most utilised types of accelerators for PBT are cyclotrons and synchrotrons. Cy-
clotrons are much more commonly found, partly due to the early development of this
concept of particle acceleration by Ernest Lawrence at LBNL [37]. They have a smaller
footprint than synchrotrons and since the introduction of superconducting magnets, the
physical size of these machines has reduced, making them cheaper to build and accom-
modate.
2.2.1 Cyclotrons
The main features of a cyclotron include its ability to generate a continuous beam at
a fixed energy and rapidly switch beam intensities. They are mostly used for other
applications, at low (10-20 MeV) to medium (∼50 MeV) energies primarily for medical
radioisotope production and up to 250 MeV for treatment [70]. For treatment with
different particle sources or for imaging capabilities where higher energies (330 MeV)
are required, a synchrotron is necessary. As the proton facilities described in later
chapters operate cyclotrons, the basic principles of the classical isochronous cyclotron
(Fig. 4.5) are outlined.
Figure 2.4: Overview of the components and working principles of a cyclotron. An
alternating voltage is applied across the two dees where a beam of protons originates
from the centre. A constant, perpendicular magnetic field forces the protons to circulate
around the vacuum vessel where they continually accelerate with each pass across the
gap until their orbit radius increases to a maximum and they are extracted [37].
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The principle of acceleration in a cyclotron is governed by the Lorentz force. A charged
particle in an electric field will experience a force perpendicular to the field, gaining
kinetic energy proportional to half its mass and the square of its velocity. This centripetal
force in combination with a uniform magnetic field (also in the perpendicular plane)





with the cyclotron frequency fc, particle mass m and charge q and magnetic field B.
This equation holds true for a non-relativistic case, corrections are necessary otherwise.
As shown in Fig. 4.5, two D-shaped ‘dee’ electrodes are positioned slightly spaced
apart laterally, between the pole faces of two large magnets which generate a constant
magnetic field in the perpendicular plane. An oscillating voltage is supplied by a ra-
diofrequency (RF) system (with a fixed ∼MHz frequency) to the electrodes: this is the
cyclotron frequency and is provided by Eq. 2.7. As the magnetic poles are grounded,
this results in a potential difference between the dees. An ion source (typically ionised
hydrogen gas) injects a beam of protons from a central point within this gap and gains
some energy when it crosses the gap. When there is a positive difference, the protons are
accelerated toward the grounded region and if negative, they accelerate towards the gap.
The electrodes keep switching polarities and with each crossing, the protons continually
gain some acceleration.
As the dees are enclosed within a vacuum vessel, the magnetic field stays constant and
the protons will keep circulating with a larger radius as their velocities increase. However,
the time it takes for each crossing remains the same. When they reach maximum kinetic
energies at the distance equivalent to the pole face radius, protons are evacuated into the
beam transport line by an extraction process. The extracted beam consists of bunches of
protons which have a distribution of energies across the specified cyclotron energy. The
generated beam parameters are dependent on the focusing properties and extraction
components of the cyclotron. The beam intensity is determined by the ion source arc
current. Several considerations are necessary to maintain orbit stability and to keep the
protons circulating; often this can be synchronised by adjusting the RF to be in phase
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[71]. The dynamics of the particle beam within the cyclotron is complex and is detailed
in [72, 73], however features relevant to CCC are discussed later in Chapter 4.
2.2.2 Synchrotrons
Synchrotrons require much more space and typically consist of several parts including
an ion source injection system, RF cavities, linear accelerators, dipole, quadrupole and
sextupole magnets and the extraction system. Typically, a linac is used to pre-accelerate
particles for injection into the synchrotron ring, consisting of a series of magnets which
maintain a fixed orbit radius. As the bend radius is constant, the magnetic fields must
vary with the increase in particle velocity; this revolution frequency must synchronise
with the RF cavity voltage, where particles acquire energy and are accelerated with
each pass. This requires an initial dead time period to ramp up the magnetic field so
that sufficient bunches of particles fill the ring until they achieve the required energy
for extraction. They are held constant at this energy and are then slowly extracted,
resulting in a pulsed beam with a specific repetition rate [71, 72, 74]. An advantage
of this acceleration method is the possibility to extract beams at variable energies and
with higher magnetic rigidities. This includes beams using other ion sources (carbon
ion, helium etc.) and also at higher energies [37]. Additionally, this reduces the need for
an energy selection system (ESS) which is used in cyclotron facilities, where absorbers
or degraders intercept the beam to lower the beam energy. This has an impact on
the quality and physical characteristics of the beam; the production of neutrons also
generate some radioactivity. Furthermore, the pulsed time structure of a synchrotron
produced beam is comparable to the respiratory cycle and this presents a challenge for
certain treatment cases with moving organs [75, 76].
2.2.3 Linacs
Linacs have also been reconsidered for PBT in recent years as new advances have led
to much improved accelerating gradients, enabling the possibility for cost and size com-
petitive accelerators. Some benefits include the generation of a beam with a smaller
emittance and fast variable energy and intensity modulation capabilities [76]. It is no-
table that there is a clinic planned for the UK which will uniquely use a purpose built
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linac for proton treatments [77–79]. The significance of this new innovation relates to
what could be the next frontier of CPT, where fundamental differences to the beam
quality, current and delivery could be achievable due to this unprecedented accelerating
technology. This development may lead to lower capital costs and also initiate the use
ultra high dose-rate (> 40 Gy/s) ‘FLASH ’ irradiation [80–82]. Current proton accelera-
tors and conventional clinical linacs (electron mode) can also be modified for these dose
rates [83, 84] however the associated challenges in this case are then related to machine
specifications, delivery and online dosimetry [85–90].
The rapid irradiation at ultra-high doses per pulse are necessary for the FLASH ef-
fect, showing enhanced treatment efficacy by increased tissue sparing. Promising results
have been reported for different RT modalities; the use of different particle types are
still being explored however the biological mechanism particularly in PBT, is not well
understood [91–94]. Nevertheless, this opens up a new realm of research into the needed
dosimetric tools in addition to the different chemical and biological responses induced.
2.2.4 Beam Delivery
Given these accelerator types, the choice is contingent on the facility goals and con-
straints including the cost, geography, throughput, treatment candidates and clinical
requirements. Different beam transport and delivery systems must also be considered.
As mentioned, the emergence of superconducting technology has effectively increased
the commercial availability of compact cyclotrons and synchrotrons. Single room systems
are now offered by leading vendors: a progression from typical multi-room treatments
where a single accelerator source produces a beam which can be delivered to multiple
beam lines. The beam is likely to pass through several optical elements, diagnostic
devices and the ESS system which comprise the beam transport system (BTS), before
reaching the gantry or delivery system in the treatment room. The goal is to optimally
transport the beam with characteristics sufficient for the prescribed treatment. Several
parameters are determined by the BTS including the beam position, size, energy, in-
tensity and overall transmission. The beam transport line is designed to accommodate
the desired beam properties for the type of accelerator and facility; more requirements
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are discussed in [46, 95, 96]. The presence of a (rotating) gantry also introduces more
challenges and optical considerations in comparison to a fixed beamline. For this case,
a fixed beam delivery avoids the complexities associated with a moving gantry such
as magnetic rigidity, momentum and energy acceptance requirements and positioning
uncertainties [97, 98].
The BTS or if no acceleration occurs, the beam transfer line (BTL), consists of a
series of quadrupole magnets which focus the beam (in one plane) and dipoles to bend
and steer the beam. Beam dynamics concepts are discussed later in Chapter 4; the
optics define the resulting beam parameters and properties. In general, a high quality
beam with maximum transmission with the applicable beam intensity (i.e. dose rate),
transverse distribution (penumbra) and modulation characteristics (range, distal fall-
off) for delivery is desired [99]. Some typical objective PBS treatment values derived
from accelerator parameters are listed in Table 2.1.
Table 2.1: Objective PBS treatment and beam parameters [100].
Parameter Accelerator Clinical Beam
Dose rate Beam current 1 Gy/L min 100 × 109 protons/min
Range (in water) Beam energy 32 cm 226.2 MeV
Penumbra in air Beam size, emittance 3.4 mm 3 mm σ
These parameters are for a 226 MeV scanned pencil beam and it is noted that the appli-
cable spot size will differ according to the beam energy. As the transverse distribution of




2σ2 ln 2 = 2 ln 2σ = 2.3548σ. (2.8)
This is demonstrated by the full width half maximum (FWHM ) of the distribution given
the particle intensity against position in the transverse plane.
Pencil Beam Scanning
PBS has become the most common method of beam delivery for PBT facilities world-
wide. Thousands of individually modulated, small (3-8 mm) beams are scanned across a
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treatment volume in both planes and generate a dose distribution (SOBPs) which covers
the volume in three dimensions (Fig. 2.5). This results in the delivery of multiple BPs
which each deliver a small amount of dose, totalling anywhere between 10,000-50,000
spots and 30-100 slices, over two or more fields. Typically one fraction takes an average
of 30 minutes, with a complete treatment course requiring 15-20 daily fractions, varying
for the size of the treatment volume and the complexity of the case [31, 101].
Figure 2.5: Active PBS delivery: scanning magnets are used to deflect the beam which
traces across a target volume, superimposed in multiple layers for a conformal 3D dose
distribution [102].
This delivery technique enables the beam position, range and intensity to be altered to
trace the entire target site and accurately deliver the dose, as prescribed by the treatment
plan. The beam itself is magnetically deflected in the transverse plane and movement can
also be performed in conjunction mechanically with adjustable collimators, or by also
moving the target. However, the time required to switch energies for each layer and the
sheer number of spots can be lengthy and rescanning may be required to compensate any
underdosage or errors caused by movement [103]. As such, there are several different
schemes which can be adopted to enhance the dose delivery and distribution. This
includes varying the weights of beamlets, optimising the field coverage and applying
biologically weighted factors. PBS is analogous to IMRT and provides a highly conformal
dose delivery with protons.
Furthermore, as the beam extracted from the accelerator source will have a small
distribution, originally, physical components were used to spread the beam in three
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dimensions. PBS overcomes these associated requirements of scattering, modulation or
patient specific devices and their limitations. For the case of shallow tumours and in
particular ocular treatment (Fig. 2.6), few facilities exist which use the scanning method
[104, 105]: these are normally delivered with passive systems.
Figure 2.6: Example of a patient being situated for ocular treatment at CCC [106].
Passive Scattering
Although there is a demand for higher energy beams which can treat a greater range
of cancers with conformal techniques and penetrate through to deeper seated tumours,
there still remains a need for dedicated ocular treatment beams [15, 107]. Uveal melanomas
have the highest incidence rate for adult ocular tumours and although treatment using
other methods are possible, proton beam therapy is considered the gold standard treat-
ment modality for these cases [23]. Clinical protocols have been well developed by early
facilities such as CCC; although these may vary across centres, the ongoing experience
and practised delivery of exploiting the sharpness of the distal edge enables a large
volume of patients to be treated effectively.
High energy, multi-room facilities require an ESS in the gantry or further upstream to
decrease proton energies to levels applicable for eye treatments. Facilities which operate
at close to the maximum machine energy are able to generate a fixed, passively scattered
beam with minimal energy or range straggling effects. This makes it possible to produce
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a beam with a steep BP fall-off whereas higher energy beams require the presence of
a degrader which also decreases transmission. Hence, consistent beam penumbrae and
distal-off characteristics can be achieved regardless of the treatment prescription; these
parameters remain until the beam is modified for patient specific conditions. Moreover
there is no time lost waiting on the ESS to switch between energies and short treatment
times are particularly important for the patient experience.
There are several different types of passive scattering systems: a range modulation
device can be used to spread the beam longitudinally and a single or double scatterer
is used to generate a field broad enough for treatment. The most simple system has a
single scatterer (Fig. 2.7a) where the beam passes through a typically high-Z material,
spreading the beam before it is collimated to restrict the delivery of only the central
region: this enables a uniform dose distribution at the target. More extensive systems
have multiple scatterers and collimators to shape the beam. Fig. 2.7b shows a double
scattering system with an occluding ring where the overlap of several Gaussian beam
distributions generate a large field with a sharp penumbra. The ring attenuates the




Figure 2.7: a) Single scattering system and b) double scattering system with ring for
passive PBT delivery, both form a uniform dose distribution [108].
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This double scattering technique is also used at CCC which has two tungsten foils, a
brass stopper and a rotating modulation wheel; this is detailed more in Section 3.1.1.
Several studies were performed to design the system to produce a beam with ideal
treatment characteristics, this mostly involved the materials, arrangements and position
of the scattering components [109–112].
However, the rigidity of this shaping technique necessitates additional beam modifi-
cation devices to modulate and conform the dose delivered for each patient treatment.
Customised brass apertures or patient collimators (Fig. 2.8a) are used for lateral shaping
while compensators, range shifters or modulation wheels adjust the beam longitudinally.
The different gradients in the wheel absorb the beam and shift the BP in depths to gen-
erate a SOBP; a modulator used at CCC is shown in Fig. 2.8b.
(a) (b)
Figure 2.8: a) Patient specific brass aperture [74] and b) range modulation wheel for
passive beam shaping and modulation at CCC.
2.3 Beam Diagnostics
Beam checks and measurements are essential during accelerator operation; for the pre-
cision required with PBT, specific instrumentation is needed across all clinical facilities.
Beam diagnostics typically refer to the devices which are placed within the BTL however
as the systems described in this thesis may be used both in the BTL or the treatment
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room, are all considered as beam diagnostics instruments. In clinical environments, the
objective of diagnostics are fundamentally for patient safety: to measure and monitor
the beam during delivery and to verify the dose distribution. These ensure that the
beam is delivered correctly within the standard codes of practice and according to the
treatment plan.
2.3.1 Quality Assurance
There are established protocols which provide guidelines for different performance fac-
tors such as the beam properties, delivery, dosimetry, treatment planning, imaging and
uncertainties. For quality assurance (QA) procedures, this covers dosimetry equipment
calibration, TPS, mechanical components, machine and patient QA. With relevance to
clinical practice, the diagnostic technologies examined in this thesis relate to machine
QA and dosimetry [113, 114]. QA checks involving these are often performed daily or at
regular intervals after commissioning in order to maintain performance and adherence
of the dose delivered to target volumes within certain margins.
Several systems are commonly used in PBT for beam measurements including the
profile, intensity, position, uniformity and current or dose. These are performed by a
range of different types of detectors; their uses and properties can be found in [38, 115–
118]. There are benefits of using certain instruments for specific tasks however their
suitability can be limited due to several operational or technological factors.
Ionisation chambers (IC) are recommended for reference dosimetry in all modali-
ties of EBRT by standard code of practice. Reference measurements are performed in
defined, specific conditions to establish the conversion between absorbed dose to wa-
ter: these involve several corrections and calibration factors [117]. This is necessary to
ensure that dosimetry methods are consistent and can be correlated to primary stan-
dards provided by national laboratories. Essentially, the ICs measure an amount of dose
delivered under reference conditions and this gives an equivalent dose ‘monitor unit ’
(MU). These are considered as absolute measurements, within precise and reproducible
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conditions. For subsequent irradiations under non-reference conditions (relative mea-
surements), the absorbed dose (Eq. 2.4) can then be expressed in MU as proportional
to the dose monitor output (i.e. dose per MU) [118, 119].
2.3.2 Dose Monitors
Conventionally, either cylindrical or parallel plane ICs are used as dose monitors and
are arranged in pairs within the treatment head on a gantry, or the delivery system in
the treatment beamline. Dose monitors are fundamental to the beam delivery as they
actively monitor the flux and also the transverse beam size and position. Furthermore,
the monitors will interrupt the delivery if beam measurements exceed clinical tolerances
[116]. Although different types of ICs are used across facilities and treatment techniques,
these detectors provide highly reliable and accurate measurements. They are also LET
and relatively energy dependent, however regular and individual calibration is needed
as each chamber varies [117].
(a) (b)
Figure 2.9: a) Multi-strip parallel plane IC for PBS systems [120] and b) parallel plane
IC used at CCC. Both types are used for online dose monitoring during delivery.
To monitor the flux, ICs contain a cavity lined by metal foils (electrodes) placed in
parallel at the windows (Fig. 2.9b) or multiple electrodes arranged in pixels or strips
(Fig. 2.9a). These chambers are sealed and often contain a gas, where a constant voltage
applied creates a potential difference. When the beam passes through, particles ionise
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the gas inside creating ion pairs which move toward the electrodes and produce a charge
proportional to the number of traversing particles and their stopping power. The applied
voltage needs to be high enough such that there is very high collection efficiency (>95%),
the measurement time needs to accommodate the ion pair drift time (even up to ∼100
µs) and the readout fast enough (∼ms), which also depends on the beam time structure
(pulses can be 1-10 µs). Additionally, the output signal response may not be linear and
can be affected by recombination effects where the ion pairs combine before collection
by the electrodes, resulting in charge and signal losses. Multi-channel, -wire or -strip
ICs are used for monitoring the beam position and size, providing measurements within
a resolution of <0.5 mm and 1 mm, respectively [115, 117].
Beam monitors must have a uniform field coverage and be able to provide dose
within a 1% tolerance or the allowable limit for the prescribed dose. For X-ray EBRT,
ICs are simple and easy to implement. CPT and the new methods of delivery present
more challenges: at high beam intensities, the occurrence of recombination increases
and their readout systems are insufficient at the currents (µA) anticipated with future
accelerators and beam delivery technologies [85]. They will also need to accommodate
the changes in the beam structure, including high flux rates, short pulses and fast
repetition rates [116]. In general, ICs have a slow response time, low sensitivity and
their performance will degrade at high dose gradients. The gas filled cavities also mean
that the properties of the active volume need to be maintained (temperature, pressure
etc.) and the electrodes protected to prevent leakage current [118]. The ideal capabilities
for a beam monitoring system include [115, 121]:
– Linear correlation between the charge collection and beam fluence
– High charge collection efficiency, signal-to-noise ratio and sensitivity
– Linear response independent of charge, temperature, energy or dose rate
– Minimal saturation and radiation hard
– Uniform response across the active volume (<1% deviation)
– Real time measurements
– Beam flux, fluence, position, energy and transverse profile measurements
– High spatial and time resolution
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– Minimal beam scattering and interference
– Minimal beam losses and energy deposition in the detector
– Stable and reliable system performance
Although ICs are the gold standard for PBT beam monitoring, a combination of dif-
ferent detectors are necessary to cover these requirements. Improved and new types of
monitors have been widely investigated; recent research and developments into silicon
based detectors have identified several benefits [122–125]. The use of silicon enables di-
rect measurements by individual particle counting, a fast response time, high sensitivity
and increased resolution. As such, the VELO detectors were investigated as an online
beam monitor to provide minimally invasive, active measurements during beam delivery.
The novelty of this system is related to its technology and design: nothing similar exists
for clinical application.
2.3.3 VELO Beam Monitor
ICs can provide several different measurements of the PBT delivery however their mode
of operation requires that they are physically interceptive of the beam. Scatter from
direct interactions with the detector itself can impact the beam quality and these ef-
fects can multiply with each additional beamlet (such as for PBS or with a SOBP).
In contrast, the VELO detector modules are considered non-interceptive and comprise
position sensitive, silicon detectors surrounding a central aperture (Fig. 2.10a).
(a) (b)
Figure 2.10: a) VELO sensor hybrid modules; semi-circular silicon sensors surround an
aperture [126] allowing b) the beam to pass without interference [127].
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Many of these modules were originally built for and used to provide precise track co-
ordinate measurements of secondary vertices originating from collisions at the LHCb
experiment at CERN, the European Organization for Nuclear Research. As such, the
detection system needed to satisfy specific criteria: high signal-to-noise ratio, an ade-
quate acquisition and readout response and micron scale spatial resolution. As VELO
is capable of assessing several beam properties in real time with high resolution, sensi-
tivity and radiation hardness, the detector system also presents as a feasible candidate
for clinical beam monitoring.
The advantageous design enables precise measurements of the beam halo (defined in
Section 2.1.3) which can provide information about the active delivery of the beam with
minimal interference (Fig. 2.10b). The repurpose and adaptation into a standalone
beam monitor began from previous work reported in [128]. Initially, the system was
aimed at optimisation for implementation into the PBT beamline at CCC however,
ongoing developments have since been made to improve several aspects of the system
and also to explore its application at other facilities [39, 129].
LHCb VELO Detector Technology
The VELO detector module consists of hybrid semi-circular, radial (R) and azimuthal
(ϕ) sided sensors with multiple silicon micro-strips enabling the full geometrical accep-
tance of interaction points. Both sides are structurally similar where a semi-circular
aperture sits centred along the central, outer edge. When opposing detector halves are
positioned together, this geometry permits the sensitive area to approach up to 8.2 mm
radially from the beam axis. Built specifically for the beam and conditions of the LHC,
the system is well matched to cover the full momentum and angular range of nearby
interactions and displaced vertices [130]. Corresponding track reconstruction algorithms
are based on a cylindrical polar coordinate system where signal readouts occur at the
bunch crossing time of 25 ns, at a frequency of 40 MHz. Due to the nature of these
requirements, a cooling system is essential in order to dissipate heat generated from the
readout electronics and maintain the sensors at temperatures below 0 ◦C.
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To withstand heavy radiation, the sensors are manufactured from enriched strips of
n-type semiconductor material. Each side contains 2048 strips which transmit AC signals
via capacitive coupling from a layer of oxidised silicon dioxide through to the readout
electronics, around the circumference of the sensors [131]. Each detector module consists
of two 300 µm thick p+ doped silicon sensor halves with an R and ϕ side each; combined
geometrically, they provide sufficient spatial information to resolve and reconstruct the
points of interactions. Approximately, both sides have an active area which covers across
a width of 84 mm, from the straight edge up to a 42 mm outer radius. The modules can
also fully retract up to 60 mm apart laterally. The architecture depicting the distinct
sides comprising a module is shown in Fig. 2.11.
Figure 2.11: Schematic of a VELO module showing the geometry of the r and φ sides,
as named on each half. Key features and sections have dimensions listed along with
partial illustration of the diode strips [131].
The R-side sensor consists of four sectors each split at 45◦ with 512 diode strips oriented
concentrically around the central aperture, through to the circumference. This half
provides positioning information relative to the origin of the beam axis. Between the
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micro-strips, the pitch increases linearly from 38 to 101.6 µm and charge sharing occurs
more asymmetrically across the thinner strips, allowing interactions to be resolved more
precisely in the inner regions [132]. The ϕ-side sensor provides angular positioning
information orthogonal to the R-sensor and the azimuthal coordinates. Similar to the
R-side, there are 2048 diode strips, however these are split into an inner and outer region,
oriented radially from the origin. The inner section comprises 683 strips and the outer
has 1365 strips, forming an active area with a marginally larger angular coverage [131].
Structurally, the VELO sensor remains largely unchanged but in order to operate the
system as a lone device, several modifications were necessary to migrate the system out
of the LHC environment. To be successfully integrated into the treatment line at CCC,
the existing technology needed specific amendment for the conditions and restrictions of
the medical facility. Moreover, it needed to operate without altering the beam whilst still
performing at full functionality. A dedicated cooling and air flow system was designed
to preserve the operation of the hybrids below 0 ◦C and without water condensation:
this is below the dew point of air. A Faraday cup (FC) was also built specifically for
beam current measurements and to match the CCC beam parameters, along with an
assembly to precisely move and position the detector locally. Several modifications were
also made to simplify the readout electronics and bypass the pre-existing scheme used
for the LHCb experiment, these are detailed in [128].
Standalone Monitoring System
Following first proof-of-principle measurements achieved in 2014 [55], the main consid-
erations for improvement were identified as related to the readout process and synchro-
nisation with the CCC facility. As the LHC has a bunch crossing frequency of 40 MHz,
the front-end electronics i.e. readout chips (Beetle chips) needed to be synchronous with
the cable delays and (TELL1 board) external triggers for data acquisition (DAQ). The
VELO monitoring system is required to match the arrival of proton bunches which are
generated by the 25.7 MHz RF frequency of the CCC cyclotron. The internal frequency
of the clocks correspond to non-interchangeable quartz crystal and therefore cannot be
changed. A solution for this was to inject an external readout trigger for universal
clock synchronisation. Improvements to the post readout process were also achieved by
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software updates which manage the signal processing and FC readout [39]. The entire
system setup with the main components labelled, is shown in Fig. 2.12.
Figure 2.12: The VELO beam monitor system with main components labelled (com-
puters for DAQ processing and storage are not shown).
These initial CCC measurements achieved outputs from the VELO sensors which demon-
strated good linearity with FC measurements of the absolute beam intensity. It is an-
ticipated that the combination of measurements obtained with the VELO detector, the
beam intensity determined by the FC and knowledge of the dose rate with the CCC
beamline, can all be correlated to provide beam and dose information during delivery.
These seek to also reduce the time demand required for quality assurance checks in the
clinical workflow.
As the VELO sensors are proton counters and register individual charges with each
hit, the relationship between the amount of charge induced within the silicon, to ab-
sorbed dose can be determined. Fundamentally, this means that fewer conversion factors
are needed to determine the MU, in contrast for ICs. The FC is the most direct way
of obtaining the beam current and by cross-correlating the total distribution with halo
measurements, offers the possibility of online dose monitoring through non-interceptive,
relative measurements. The intrinsic properties of this technology also extends its use
for potential application in future accelerators and delivery methods.
2.3.4 Radiochromic Film
Another widely used tool for relative dosimetry measurements are radiochromic films.
These are commonly used for machine quality assurance and as a visual check of beam
characteristics in EBRT. This has led to the development of an industry standard
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GAFchromicTM film where the most recent model is EBT3 [41]. The use of EBT3
film is well established in PBT and is commonly used to determine beam performance
and quality. The high spatial resolution and low energy dependence enables measure-
ments of transverse dose profiles [115]. For patient specific or machine verification, it is
essential to be able to perform checks with high accuracy and reliability, prior to deliv-
ering a course of treatment. Film dosimetry allows a visual representation of the beam
as well as an analysis of the geometrical beam characteristics (i.e. uniformity, shape and
size) and the 3D dose distribution.
Figure 2.13: Sketch of the composite layers in EBT3 film, a 28 µm active region is
surrounded by two thicker substrate layers.
EBT3 film is made of a 28 µm layer of lucite, enclosed by 125 µm of polyester substrate
on each side (Fig. 2.13). Exposure to ionising radiation results in polymerisation of free
radicals within the active layer, inducing the film to darken [133]. EBT3 self develops and
the dark colouring or optical density (OD) is proportional to the extent of irradiation,
increasing with absorbed dose. For CPT however, the use of EBT3 film is limited due to
quenching effects and saturation at points of high doses, such as the Bragg Peak [134]. It
is also noted that there are multiple considerations and sources of uncertainties involved
when using film to determine the beam distribution as a function of dose. Calibration
measurements must be performed under specific conditions. Established methods and
standard protocol have been reported in literature [134–138]; these are further discussed
in Section 3.4.1 and were applied for all the film measurements and analysis.
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2.4 Summary
The rationale of proton therapy leads from the advantageous dosimetric characteristics
of charged particles as they traverse and deposit energy along a path, accumulating
to a maximal point as represented by the BP. This enables a high amount of dose to
be precisely and suitably distributed to target sites, necessitating the consideration of
several factors which influence the properties of the beam. These include the type of
accelerator, transport line, delivery system and beam diagnostics employed. Although
these aspects differ across facilities as dependent the requirements of the clinic, they
ultimately serve the purpose of optimally delivering a beam safely to the patient, for the
specific purposes of the treatment prescribed.
Several different parameters and concepts integral to the delivered beam have been
overviewed, with a particular focus on the CCC facility. In contrast with modern fa-
cilities, CCC has a unique beamline and treatment system which offers an applicable
environment for further study and integration of beam instrumentation. Diagnostics
are necessary to provide accurate beam measurements to ensure a correct delivery and
a high quality of treatment. ICs are typically used to monitor the dose however are
interceptive devices and encounter performance limitations, particularly for enhanced
CPT beams and techniques. As such, a novel system based on LHCb VELO detector
technology was proposed. To support its development and examine the feasibility of
other tools, simulation studies, optical modelling and experimental measurements were





Clinical and research proton beams provide opportunities to study different aspects
of PBT. With advances in medical accelerator technology and further potential PBT
developments, an outcome of this thesis is to explore the capabilities of several silicon
detector systems. The VELO online beam monitor is currently being developed to
provide measurements such as the profile, current and dose whilst minimally interfering
with the beam. This is possible with the novel concept of detecting only the halo where
there is no significant impact on the delivery of treatment. However, to resolve these
beam properties, measurements must be firstly correlated using some approach which
provides knowledge of the entire beam distribution. This can be done in several ways;
commonly VELO is calibrated with other beam diagnostic instruments (i.e. an ion
chamber, Faraday cup or film). Alternatively this can also be attained by simulating
the beam to determine information for relative measurements. Simulation studies are
essential for the optimisation and application of the VELO monitor in medical beamlines.
Furthermore, it is valuable to evaluate the beam characteristics and expected detector
response before integration into any facility. Simulations allow this possibility without
the burden of beamline accessibility. Particularly for clinical facilities, there is often
high patient load and other constraints where scheduling beamtime is difficult. This
was the case for CCC, where the VELO system was originally adapted for integration
into the ocular PBT beamline. Therefore, preliminary simulations were necessary to
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investigate the beam behaviour and potential impact, feasibility and performance of
the detectors implemented in the treatment line. A model built with the Monte Carlo
toolkit, GEANT4 was used to simulate the environment at the CCC PBT beamline.
This chapter provides an overview of the Clatterbridge treatment delivery system and
the operational parameters of the beam. These are essential for characterisation of the
treatment beam and simulations in GEANT4. The simulation model and fundamental
mechanisms of the code are also summarised. Further developments to the model were
made and the outcomes of simulation studies are described. To examine the accuracy
of the model and results, experimental beam profile measurements with EBT3 film and
a Medipix3 detector were performed; these results and several observations about the
CCC beam and cyclotron are reported.
3.1 Overview
The Clatterbridge Cancer Centre is one of a few dedicated ocular proton therapy clinics
in the world. It operates a fixed horizontal treatment beamline which delivers protons
at 60 MeV at isocentre using a purpose built, double scattering system (Fig. 3.1). This
produces a conformal beam with a range of 31 mm and a sharp 0.9 mm fall-off, enabling
the targeted and precise delivery of uniform dose to tumour volumes.
Figure 3.1: CCC delivery system and chair schematic. Dimensions are in cm [15].
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Patients are always seated upright in a motorised chair capable of precise alignment
(translational in three directions) and wear a custom mask which is attached to a frame
at the top of the chair (Fig. 3.2). Each treatment typically lasts 30 seconds and depend-
ing on patient requirements, various range shifters and modulators are implemented to
adjust the beam energies. Patient collimators shape the field in the transverse plane.
Many of these developments were commissioned and are manufactured in-house; these
enable the facility to continually provide a well established proton service. As such,
high rates of local tumour control, ocular retention and preservation of visual acuity
have been achieved and patients with ocular melanoma have been successfully treated
for more than 30 years [15, 139, 140].
Figure 3.2: Treatment chair and extent of treatment beamline. The rigid frame (silver)
at the top of the chair secures the patient and mask in place.
Facility considerations, delivery approaches and beam requirements for ocular treat-
ments have been discussed in Section 2.2.4. For CCC, quality assurance procedures to
maintain typical and local treatment beam parameters are discussed in detail in [139].
A summary is provided in Table 3.1 †.
†Personal communications, A. Kacperek, 2019.
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Table 3.1: General treatment beam parameters.
Parameter Value
Dose rate 8-30 Gy/min
Set-up time 10-15 mins
Treatment time 30 s
Verification precision ± 0.2 mm
Field uniformity <1%
Field diameter <34 mm
Penetration depth 4-29.3 mm
Fall-off 0.9 mm (90-10%)
Penumbrae 1.1 mm (80-20%)
3.1.1 Treatment Delivery System
The CCC treatment beamline was built during initial neutron therapy trials to provide
a clinically useful proton beam as an additional treatment modality. A set of double
scatterers, modulation devices, several collimators and custom-built diagnostics combine
to generate a uniform beam, whilst also minimising the beam penumbra and energy
losses [111]. This is illustrated in Fig. 3.3 where significant components are grouped
and denoted with letters.
Figure 3.3: Schematic of the beam shaping components of the CCC treatment delivery
system. The proton beam originates from the accelerator bunker behind the wall and
traverses two scattering foils and beam stopper (A), an optional range shifter and
modulator (B & C), drift pipe (D), several collimators (E), two dose monitors (F),
cross-wires (G), treatment nozzle and collimator (H).
Details of the cyclotron and generated beam are described later in Section 4.2.1. From
the accelerator bunker, the beam (in vacuum) enters the treatment room and traverses
through two tungsten scattering foils which spread the beam laterally. There is a central
(brass) beam stopper attached to the second foil which significantly reduces the beam
fluence such that it attains a uniform transverse profile when it leaves the treatment
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nozzle. The beam then exits by a kapton window into air, through an aluminium box
containing the modulation devices. Range shifters or absorbers (blocks of PMMA)
can be placed here to decrease the maximum proton range and energy at isocentre. A
rotating modulator can also be inserted adjacent, to produce a SOBP. This arrangement
results in the small lateral penumbra but also increases energy losses in air [15].
An aluminium drift pipe connects the modulation box to the dosimetry box. This
section of the delivery system is an important location and is identified as the ‘Integration
Zone’ from [128]. The pipe can be easily removed to allow sufficient space to situate the
VELO monitors. Following this, two dose monitors (parallel plate ionisation chambers)
and two tungsten wires arranged in a cross, comprise the QA diagnostics. These are
used to routinely monitor the uniformity and performance of the beam. The beam
leaves through an end brass nozzle which can be fitted with a cap to secure the last
brass collimator. A range of collimators can be fitted here to limit the beam by altering
the aperture diameter as dependent on patient requirements.
3.2 Simulation Modelling
At the time of its construction, the CCC treatment beamline was designed to capitalise
on the available accelerator technologies and various advantages offered by different
delivery approaches [110–112]. As a pioneering facility, the changes to improve the beam
delivery were also often self-developed with the equipment built on premises. Several
studies were performed to simulate the treatment beamline for further development,
examine the performance of different components and for dosimetry [109, 141–143].
Specifically in [142, 143], the Monte Carlo codes MCNPX, GEANT4 and McPTRAN
were used to simulate the CCC beam and dissimilarities between the codes were due to
differences in the computation of interactions and transport of radiation. Since then,
several other codes have been assessed for application in medical physics. In particular,
GEANT4 has been benchmarked to clinical data and its capabilities for ocular PBT
modelling are well demonstrated [144, 145]. Numerous other facilities have beamline
models, the most prominent being ‘Hadrontherapy ’ [146, 147] which is available with
every build of GEANT4 as an example to assist users with developing their own models.
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At Clatterbridge, more recent simulation work of the beamline was done by [148]
however this was based on the Hadrontherapy example where the geometry was adapted
from the CATANA, Italy ocular beamline [149]. As the model was not available and
previous efforts to validate the geometry were not implemented, the development of an
accurate and reliable simulation model of the CCC treatment beamline was pursued. A
validated simulation model is essential to investigate the implementation of the VELO
detector system and its viability as a candidate for online dose monitoring. This is also
highly valuable as CCC supports a wide and diverse scope of experimental work and
can benefit the ongoing studies into facility upgrades, integration of other instrumenta-
tion and radiobiology. Therefore, an objective was to develop a finalised model and to
make the source code and documentation available for wide use as a verified, standard
simulation model for all related work performed with the beamline.
3.2.1 GEANT4
GEometry And Tracking or more commonly known as GEANT4 [40], is a software
toolkit which enables the accurate simulation of the movements and interactions of par-
ticles through matter. Originating from CERN initially for high energy physics, an
established collaboration of worldwide members provide ongoing developments and user
support to maintain and improve capabilities. GEANT4 is written in object-oriented
C++ programming language and offers an extensive range of functionalities, visuali-
sation interfaces and approaches to analyse generated results. This flexibility and the
open-source accessibility of the code has promoted the use of toolkit for a vast range
of applications including particle, detector and nuclear physics, as well as space and
accelerator science.
The code utilises Monte Carlo (MC) methods and applies physics models to describe
electromagnetic and hadronic interactions from high energies (TeV) down to sub-eV
scales. As the nature of radiation events are stochastic in nature, it is necessary to
consider particle interactions and physical processes given their probabilistic distribu-
tions. GEANT4 utilises random number generation to simulate individual particles on
an event-by-event basis, through the geometry of any material. Users can build an ap-
plication with the toolkit by specifying the particle source, detector properties, tracking
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management parameters and selecting packages which implement models of particular
physics processes. This is detailed extensively in [150, 151] and the code is fully docu-
mented online on [152].
The simulations described in this chapter were performed using a model of the CCC
treatment delivery system developed at University College London (UCL)†. GEANT4
versions 10.02.p.01 and 10.04.p.02 were used and simulations were executed on the UCL
HEP high performance computing cluster. The source code and details of the model
are also provided online on [153]. It is noted that the upgrade to the newer GEANT4
version was also accompanied by significant changes to the model, mostly to improve
the computational efficiency. Further development was necessary to perform the same
tasks as the initial model and also to add capabilities; these specific contributions to
the source code are described. As the workings of the toolkit itself are complex, only
essential features pertinent to the scope of work in this thesis are overviewed.
Structure & Processes
In principle, GEANT4 will generate a particle, transport and track it through geome-
tries of different materials and record information about physical interactions and pro-
cesses which occur. Different libraries and classes are utilised for functions to initialise,
invoke and process events, define geometry and collect data for analysis and visuali-
sation. Some key classes are: G4RunManager, G4EventManager, G4TrackingManager,
G4SteppingManager, G4GeometryManager, G4ParticleGun, G4ProcessManager and
G4VisManager. These execute the main features [154]:
• Run: A collection of events which occur under identical conditions, with the same
beam and detector implemented. The execution of a single run is typically syn-
onymous with and referred to as a simulation.
• Event : The units of a simulation where collectively, multiple events constitute a
run. An event starts with the generation of a primary particle, tracking these and
secondaries completely through the same experimental configuration.
†Developed by M. Hentz, 2017.
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• Track : Represents the movement of particles along a trajectory. It provides details
of physical quantities in the current instance and is executed independently of the
particle type or physics processes. Tracks are updated after each step.
• Step: The distance between two interactions where the process with the shortest
interaction length occurs. There are two stages; pre-step and post-step, where
particle information can be retrieved at the start, along or end of the step.
• Geometry : Objects are constructed by definition given three conceptual layers;
solid, logical and physical volume. These describe the dimensions, materials and
spatial positioning of geometrical and detector structures.
• Detector : Geometry components used to specifically retrieve and record particle
information such as the kinetic energy, momentum, time, position and energy
deposition. This is attributed at the logical volume level where detector geometries
serve as sensitive volumes.
• Hit : A physical interaction of a track which has occurred within a sensitive detec-
tor. This information can be collected and obtained as outputs.
• General Particle Source: Defines the distribution and initial properties of the
primary particles generated. This includes the shape, energy, position, spatial and
angular distribution of the input source particle.
• Physics: Describes the transport and interaction processes of each particle within
a material. Different algorithms are needed to model the physics across a wide
range of energies or for varying applications; several may be combined to accurately
represent the entire domain. These processes are constructed as physics lists which
can be user defined, in addition to the several default benchmarked lists available.
• Visualisation: Simulations can be executed interactively by graphical sessions to
visualise the geometrical and beam components. It is useful to be able to view the
model and the beam can be instantiated to generate particle tracks. Several differ-
ent graphical systems are offered as dependent on the requirements and demands
of the visualisation.
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3.3 The CCC Treatment Line Model
The model was built to simulate the delivery system and the 60 MeV PBT beam,
incorporating information from CCC and older simulations, as shown in Fig. 3.4.
Figure 3.4: Visualisation of the CCC treatment line in GEANT4. Main components
(left to right): dual scattering system, modulation box, integration zone, dose monitors,
cross-wires and nozzle. Axes (blue): x (horizontal), y (vertical), z (beam propagation).
This treatment line is placed within an ‘inner room’, a smaller box representing the
treatment room within the world volume which must contain all the components of the
simulation. The start of this beamline is positioned at -4200 mm (in the z axis) from the
centre of these volumes. Geometries are defined with dimensions as half lengths and their
points of origin are at the centre of their mother volume. This is inherent to GEANT4
which uses a hierarchical system so that structures can be defined in relative parameters,
using boolean operations and to avoid intersections at the same levels: this is often a
common error. However, this can be complicated as components have different mother
volumes and thus origin points, so calculations between multiple coordinate systems are
needed to determine the correct positions in z. For simplicity, the edge of the inner room
where the beginning of the scattering tube is situated will be referred to as the origin of
the simulation (z = 0). The particle source was rotated and translated to be placed at
this point. Beam parameters provided for this model were sourced from unconfirmed or
older documentation. Default simulation source settings:
Gaussian distribution of protons
Mono-energetic 62.5 ± 0.082 MeV beam
Beam size of σx, y = 4, 4.5 mm
Angular spread of σx, y = 2.3, 1.2 mrad
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3.3.1 Running the Simulation
The simulation is executed in GEANT4 as defined in header (.hh) and source (.cc) files
containing mandatory and optional user action classes. All parameters can be directly
programmed within these files or run using either of two ways; interactive or batch
mode. The interactive mode is executed through a visualisation session using a graphical
interface, where individual lines of command must be input to define each parameter
(i.e. /run/beamOn 1000 will generate and simulate 1000 primary protons through the
model). This is more useful for debugging or visual checks as simulating large numbers
of particles this way is computationally taxing. For batch mode, commands are listed
instead in a macro (.mac) file where the complete simulation is executed according to
these parameters. This mode also makes it easier to set or change different settings or
create a customised set of parameters for each simulation.
This CCC model was firstly made available with preset macros to run, visualise and
score, as well as with python scripts to analyse and plot simulated data. Shell (.sh)
files were also provided to submit parallel versions of the simulation (different seeds) to
a queue in the UCL Linux cluster and combine results into new created directories. A
summary of the macros and functions of each are provided for context:
• run.mac: Set detector geometry and position, activate tracking, call scorer.mac,
set physics list, cuts, initialise, set seeds, particle beam parameters, step limits,
verbosity, output analysis files, number of protons, call score dump.mac.
• scorer.mac: Create scoring mesh and define size, position, number of bins, quantity
scored, close mesh.
• score dump.mac: collect scored quantities, define file and dump data to .txt files.
• vis.mac: Open visualisation driver, draw volumes, set axis and viewer style, pa-
rameters, zoom, axes, particle trajectory colours.
A pristine BP and the lateral beam profile could be simulated using the primitive scoring
method by defining a mesh, collecting the total energy deposition within a number
of bins, dumping to a file and plotting (Appendix B.1). Running with the default
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simulation parameters achieves a BP at 30.80 mm and a wide, rounded transverse dose
profile at isocentre. The beam has diverged from the central axis in air (treatment nozzle
is only 34 mm in diameter) however it is expected that the dose deposition here should
be more homogenous. In practice, a flat beam is used for treatments such that dose
coverage across the target site is uniform. A cause for this difference could be due to a
missing collimator between the dose monitors and cross-wires.
More detailed methods were necessary to obtain further information about each par-
ticle including the type, position, direction, momentum, kinetic energy. This can be
achieved by tracking particles by accessing each step in the simulation and recording
relevant parameters at defined points. This is managed by the G4UserSteppingAction
class which checks for various conditions at the PreStepPoint and PostStepPoint loca-
tions contained in G4Step and writes this information as an output. Protons were only
tracked if they were inside the components of beamline and ignored if greater than the
widest geometries i.e. >100 mm in x or y. The tracking intervals were set given their
position in z and steps were counted only if both the pre- and post-step points crossed a
boundary. This feature is enabled in the run macro and only particles which completely
crossed were recorded. Care must be taken when considering steps and boundaries as
this can result in inconsistencies or incorrectly counted steps. These z intervals could
be defined in SteppingAction.hh (Appendix B.12) where specific information about the
beam at any arbitrary position along the treatment beamline could be retrieved.
3.3.2 Beam Study
Simulating protons from the source to isocentre enables different particle quantities
to be determined to define the characteristics of the beam. Four main properties are
considered; the transverse emittance (in x ), beam profiles (in the transverse plane and
intensity in x) and the energy spectra, which were all plotted using a python script‡
(default case in Appendix B.2). Noticeably, a mean energy of 60.15 MeV is obtained
with the model which is inconsistent with the measured clinical mean energy of 60.00
MeV. As the simulation was unvalidated, partly due to inaccessible facility information,
‡Provided by M. Hentz, 2017.
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several assumptions were made about the geometry and input particle source. The
following changes were implemented as information was verified or newly acquired‡:
Scattering foils:
- Tungsten thickness reduced from 25 µm to 20 µm
Dose monitors:
- Air separation reduced from 3.6 mm to 2 mm
- Guard ring thickness reduced from 1.6 mm to 1 mm
- PMMA layers reduced from 1 mm to 0.5 mm
These changes resulted in slightly different beam characteristics (Appendix B.3); mainly
an increase in the resulting energy to 60.25 MeV. This is expected as several layers of
material have been reduced, thus there is less attenuation. To investigate the impact
of each component and behaviour of the beam through the delivery system, the beam
was tracked at 15 z positions. This was defined in lines 35 and 51-53 in the header file
(Appendix B.12). Simulations with 100 million primaries were run using the default
input beam parameters (see Section 3.3) and the recommended QGSP BIC HP physics
list for clinical proton beams. Characterisation plots for significant positions are shown
in Figs. 3.6-3.11; the remaining are included in Appendices B.5-B.9.
At the start of the treatment line (Fig. 3.5) the beam is fairly sharp: its appearance
is indicative of the default parameters. An observation at this point is that by definition,
this beam represents the case of a clean, mono-energetic beam with a limited Gaussian
spread. The beam then passes through a small aperture (6 mm diameter) and the first
tungsten scatterer (Fig. 3.6). The collimation causes a reduction in the beam size and
penumbra, removing the surrounding tails. Combined with traversal through the foil,
there is a mean energy loss of 0.21 MeV. After passing through the second foil and
stopper, the beam distribution and emittance changes considerably (Fig. 3.7). The
brass stopper attenuates a significant proportion of the central region of the beam and
the remaining lateral protons form a ring. As indicated by the shape of the emittance
plot, there is an observable outward spread and a slight halo. The change in flux up to
this point amounts to a loss of approximately 94% of initial protons.
‡Personal communications, A. Kacperek, 2018.
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Source
Figure 3.5: Plots of the simulated transverse beam emittance, profiles and the en-
ergy spectra at the beam source. The blue line overlayed on the treatment beamline
schematic above indicates the tracked position in z.
First Scattering Foil
Figure 3.6: A sharper beam emerges from the first collimator and scattering foil with
a lower mean energy but greater energy spread.
54 Chapter 3. Clatterbridge Beamline Characterisation
Second Scattering Foil
Figure 3.7: The second scattering foil spreads the beam and energy further, the brass
stopper results in significant attenuation in the central beam axis.
Now in air, an increase to the spread in the beam profile and emittance indicates that
the beam starts to scatter (Fig. 3.8). The dip at the central axis starts to disappear
within the integration zone (Appendix B.6) and the particle flux starts to even out by
the end of pipe (Fig. 3.9). The lateral extent of the particle distribution is noted here
and the beam propagation is examined in more detail later (see Section 3.3.3). After
passing through both dose monitors, some energy is lost, the beam widens and the return
of the lateral tails are evident (Fig. 3.10). This degradation of the beam due to the
dose monitors can be prevented by the use of a non-interceptive measurement method:
a benefit of the VELO monitoring system.
After exiting the treatment nozzle, the beam has again been collimated and the
distribution is restricted to the size of last aperture (Fig. 3.11). There is a small
penumbra and the rotation of the phase space ellipse shows that the beam is diverging.
The beam transmission from the source to the end of the treatment beam line is 2.45%
with an energy loss of 2.16 MeV (3.5%). The beam also loses another 0.1 MeV in the
70 mm air before it reaches isocentre; the rest of these quantities are listed in Table 3.2.
Chapter 3. Clatterbridge Beamline Characterisation 55
Start of Modulation Box
Figure 3.8: Following its departure from the vacuum through the kapton window, the
beam starts to diverge at the the start of the box containing the removable modulation
components. The central dip also starts to decrease
End of Integration Zone
Figure 3.9: The beam shape returns to a Gaussian distribution at the end of the
designated VELO integration zone, inside the beam pipe.
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After Dose Monitors
Figure 3.10: Traversal through the dose monitors results in greater spread of the beam.
After Nozzle
Figure 3.11: After evacuating the treatment nozzle, the beam is noticeably narrow.
The collimation also results in a small energy spread
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Source 0 100.00 62.50, 0.00
After foil 1 81 23.56 62.29, 0.34
After foil 2 307 6.44 62.08, 0.67
After kapton window 357 9.28 62.01, 0.78
Start of modulation box 471 8.87 61.87, 1.01
Start of integration zone 676 8.08 61.73, 1.81
Mid of integration zone 900 7.86 61.37, 1.23
End of integration zone 1099 7.59 61.13, 2.19
After dose monitor 1 1195 7.55 61.01, 2.38
After dose monitor 2 1265 7.55 60.93, 2.51
After cross-wires 1577 7.55 60.55, 3.12
After nozzle 1759 2.45 60.34, 3.46
At isocentre 1829 2.45 60.25, 3.60
3.3.3 Integration Zone
The previous simulations and results provide an overview of the beam distribution and
transport along the treatment beamline. As the VELO system is to be implemented
specifically in the integration zone, the physical impact of the detectors on the beam
performance must firstly be assessed. In fact, the beamline at CCC presents a unique
case to test the online monitoring system and is thought to be a contributing factor to
its conception. Aside from the geographical proximity of Clatterbridge, the beamline
offers several advantages for testing and implementation. The cyclotron can produce
a beam of protons with relatively high clinical currents (>30 nA, ∼1011 protons/s)
over a range of beam sizes using customisable collimators, up to the internal 34 mm
nozzle diameter. Typically operating at maximum energy, the fixed components of the
treatment line and interchangeable modulators enable delivery of a consistent beam. As
a result, the beam should be predictable at any location within known margins. There
are minimal differences in accelerator settings for treatment as a sufficient standard at
isocentre must be achieved. Moreover, due to the passive scattering system arrangement,
the characteristics of the beam within the integration zone should also be consistent.
Therefore, evaluating the beam propagation at this location determines the expected
beam distribution and halo which would be measured by VELO.
58 Chapter 3. Clatterbridge Beamline Characterisation
Simulations were performed to obtain the transverse beam profiles and intensity maps
across 15 different positions in the integration zone (Fig. 3.12). This is relevant as the
VELO sensors are counting detectors and there are several different metrics to correlate
with the halo. In Fig. 3.12b, 5 distances are denoted as ‘VELO positions’ where the
modules were previously placed for measurements in [128].
(a)
(b)
Figure 3.12: a) Projection of intensity maps for 100 million simulated protons.
b) Positions of interest across the integration zone.
The pipe was removed in the simulation and negligible differences were found for both
simulated cases; in practice the pipe is used as a physical external barrier. The FWHM
at each z position was calculated to examine the beam divergence across the integration
zone (Fig. 3.13). There is a clear linear trend: the further upstream, the lesser transverse
spread, divergence and probability of particles being obstructed by the sensors.
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Figure 3.13: Integration zone transverse beam sizes (FWHM) are shown in mm and
VELO positions labelled (red). Linear fit (black line) equation above.
Position 0 (z = 736 mm) indicates the most upstream location and therefore the best
case to accommodate the modules with minimal interception. Given the dimensions of
the VELO modules (Fig. 2.11), a representative 0.6 mm thick silicon disc was placed
in the simulation at this position. As a small gap exists between the halves due to the
PMMA shrouds, the disc was constructed with an inner diameter of 21 mm and outer
diameter of 90.5 mm (Fig. 3.14).
Figure 3.14: Silicon disc placed in the integration zone in GEANT4.
The beam is still slightly larger than the sensor aperture here and a cut-off effect on the
beam profiles can be seen as it propagates downstream (Fig. 3.15). The notch along the
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Figure 3.15: Transverse beam profiles in x with sensor implemented (left) and without
(right) at z positions a) 766 mm, b) 886 mm and c) 1096 mm.
The impact of the sensors on the beam and energy spectra at isocentre is relatively min-
imal. A larger total number of particles are recorded and the distortion in the penumbra
suggests there may be some forward scattering of protons. There is a greater deviation
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of kinetic energies, a very small tail at ∼59 MeV and a resulting energy loss of 0.04 MeV
(0.06%) (Appendix B.4). Additional simulations with the disc placed at the other 5 po-
sitions caused higher losses, this is detailed in [39]. At these positions there is significant
collimation and the beam appears much sharper at isocentre which is impractical for
treatment. It is ideal to place the monitors as close to the exit of the modulation box as
possible to minimise interactions and changes to the beam. Furthermore, the modules
can also be translated laterally to allow the beam to pass through completely. However
there must be a balance: the detectors must be able to detect enough particles to register
the halo. A threshold for the CCC environment was not established in previous studies
and further development is necessary to optimise the VELO monitoring system. First
measurements were demonstrated in an experimental proton beamline and are described
later in Chapter 6.
3.3.4 Input Source Parameters
For all of these simulations, changes were only made to update the geometry and default
beam settings were used, resulting in an increased difference from the expected 60 MeV
energy at isocentre. The GEANT4 model continued with the input parameters previ-
ously determined in [142] which were back calculated to achieve a BP at 30.80 mm. The
differences in the models persist where slight disparities between the simulated BP com-
pared to previously attained QA data‡, are seen (Appendix B.10). As the shape of the
curves are similar, the beam energy and range was matched later, after further updates
to the model. However, given that the default parameters were not recently validated,
their significance and effect on the simulation were examined. A range of applicable
beam energy and spread values were calculated (Table B.1) and simulated to observe if
there were any substantial differences at relevant locations: the start of the integration
zone and at isocentre. Changes in the input beam energies had insignificant effects on
the beam distribution in the integration zone. As expected, a reduction in the input
energy resulted in corresponding decreases to the BP range and a larger deviation in the
mean energy. In contrast, variations in the beam distribution (sigma size, emittance)
led to significant differences and these are summarised in Table 3.3.
‡Provided by A Kacperek, 2019.
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Start of 1.0, 1.0 2.3, 1.2 23.6473 2.4048 700
integration 2.0, 2.0 2.3, 1.2 22.0441 0.8016 600
zone 4.0, 4.5 2.3, 1.2 21.2425 0 200
4.0, 4.5 5.0, 5.0 22.8457 1.6032 200
10.0, 10.0 2.3, 1.2 21.2425 0 400
Isocentre 1.0, 1.0 2.3, 1.2 39.6794 3.2065 120
2.0, 2.0 2.3, 1.2 38.0762 1.6033 120
4.0, 4.5 1.0, 1.0 36.4729 0 45
4.0, 4.5 2.3, 1.2 36.4729 0 45
4.0, 4.5 5.0, 5.0 38.0762 1.6033 45
10.0, 10.0 2.3, 1.2 36.4729 0 10
Modifications to the default input parameters (boldface font) in Table 3.3 resulted in
noticeable differences to the FWHM determined at both of the beamline locations. The
beam sigma has a direct effect on the transmission (particles at peak/s); if a geometri-
cally smaller beam is delivered then more particles are recorded. This results in a larger
FWHM at both locations but remains unchanged even with a larger input beam. Chang-
ing the emittance appears to have no influence on the transmission but a higher emit-
tance results in a larger beam spread in both directions and thus an increased FWHM.
The FWHM was calculated by using the same script to fit a Gaussian distribution to
each beam profile and although the differences equate to a few mm, this is consequential
for VELO. The variations especially at the integration zone demonstrate that the input
parameters are significant: inaccuracies at the source will propagate along the beamline
and scale with beam current. Therefore, the beamline must be characterised and each of
the input beam parameters (beam energy, spread, size and emittance) must be precisely
known in order to optimise the detectors for CCC.
Phase Space Scoring & Tracking
Subsequent major improvements to the model were implemented by the developer.
These improved the tracking capabilities and enabled more detailed particle quantities
to be retrieved with less computational demand. As mentioned in Section 3.3.1, particles
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were tracked if their spatial coordinates met certain conditions. A different approach is
required in order to track particles independent of their material and boundaries, thus
a parallel world was introduced. This world remains separate from the mass world and
they do not overlap or interact. Constructing geometry in a parallel world enables scor-
ing at any arbitrary position by placing multiple sensitive detectors along the beamline.
Particle information is recorded using the SensitiveDetector class where different quan-
tities (i.e. parentID, particleName, x, y, z, momentum in x, y, z and kinetic energy) can
be collected and the registered hits are processed by PhaseSpaceSD.cc. As this signifi-
cantly changed the way which relevant quantities were scored, several adaptations and
further improvements to the simulation were required. The following changes made to
the source code (Appendices B.13-B.15) are summarised:
Enable option to track across ‘all ’ positions at defined intervals
- Construct a ParallelContainer large enough to contain the entire beamline and
phantom.
- Place it in the parallel GhostWorld (duplicate of mass world) at z = -2340 mm
relative to the mass world, this centres it relative to the beamline.
- Parameterise it to contain thin boxes to track along 1 nm slices in z.
- Define new variables to convert the coordinate reference frame from the Ghost-
World to relative to the beamline (GPS source z = 0).
- Link this such that the position, length and slice can be defined in proton.mac.
Modify the ParallelContainer length to score within a ‘detectorvolume’,
specifically to obtain a BP
- Construct a detectorvolume component within the ParallelContainer.
- Introduce new variables to convert the coordinate reference frame from the Paral-
lelContainer to be relative to the beamline z.
- Link this so parameters can be defined in proton.mac.
Enable option to score the energy deposition in an arbitrary phantom
- Retrieve the total energy deposited as hits in PhaseSpaceSD when the start of each
step is on a boundary (G4double energy = step->GetTotalEnergyDeposit();).
- Change the layer thickness to match its mother volume.
- Link this so the dimensions can be defined in proton.mac.
- Dump eDep in each layer to a .txt file.
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Modify ParallelContainer length to score within a detectorvolume, as a thin
slice for interchangeable components
- Construct detectorvolume for components as defined in proton.mac.
- Place additional components but with z positions relative to ParallelContainer.
- Dump phase information to a file defined by beamline z position in proton.mac.
As each phase space file contains a considerable amount of data (hundreds of millions of
particles), further analysis was required and additional scripts were written to merge the
data and extract meaningful information [155]. All of these developments enable further
possibilities to study different aspects of the delivery system and facility. However, the
focus of the model for the remainder of this project was mainly to evaluate the perfor-
mance of the simulation and examine how closely it was able to predict measured beam
quantities. As such, measurements of the lateral beam profiles along the delivery system
were performed to validate the model and to support the complete characterisation of
the CCC beamline.
3.4 Experimental Measurements
Beam measurements were performed at multiple locations along the treatment line us-
ing two different methods to determine the transverse beam distribution: with EBT3
gafchromic film and a Medipix3 detector. The transverse beam profiles, beam divergence
and lateral spread indicate the accuracy of model parameters.
3.4.1 Film Irradiation
EBT3 film provides the geometrical beam distribution as a function of the dose, evalu-
ated by converting the grey value of each pixel to an OD value. The OD is dependent
on the extent of irradiation and thus each OD value results in a corresponding dose
(Gy). The dose at this location is determined by establishing a correlation with known
quantities of radiation. This is done by exposing a calibration set of film to well defined
quantities of radiation under standard conditions, with reference to the dose measured
by the ion chambers. A calibration curve can be obtained which enables dose conversion
across the full dose range, taking into account any corrections for minor deviations in
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grey values and saturation effects. This process is prone to several uncertainties dis-
cussed later. Nevertheless, as the OD is fitted to a calibration curve, net OD is used
to represent the film response to measured dose. This is expressed as the difference
between transmission intensities [136]:






where exp refers to whether the film was irradiated (unexp, unexposed) and bckg is the
zero-light transmission quantity. This is the pixel value related to the white light value
of the scanner used. I is the respective intensity value and is taken across each colour













Eight pieces of film were placed along the treatment line and irradiated under standard
conditions simultaneously (Fig. 3.16); 4 Gy at isocentre for ∼30 s with a 43 mm nozzle
collimator at ambient room temperature (24.2 ◦C) and pressure (1016.8 mbar). The
film was cut into equivalent and sufficiently large pieces to contain the complete beam
spots and labelled to ensure that the direction and orientation remained consistent.
(a)
(b)
Figure 3.16: a) CCC beamline sketch with positions of film (red).
b) Pre-irradiation photo with films 1, 3, 6, and 7 visible.
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A calibration set consisting of 12 pieces of film (2 control) were irradiated individually
at isocentre with doses ranging from 4-60 Gy (Fig. 3.17).
(a)
(b) (c)
Figure 3.17: a) Film 7 irradiated at 4 Gy at isocentre. Calibration films were also
positioned here and irradiated at b) 20 Gy and c) 60 Gy. The appearance of the beam
spots are darker with increasing dose.
3.4.2 Analysis
Following complete development (>24 hours), the irradiated film pieces were scanned
using an EPSON 750 scanner and saved as 48-bit .tif images with no colour corrections
at 150 dots per inch (dpi). All film analysis was done using the image processing software
ImageJ [156]. A circular region of interest (ROI) was selected such that it was encased
inside each beam spot and duplicated for each film. ImageJ generates a plot of the grey
values per pixel against distance which gives a simple indication of the beam profile
and a way to check the suitability of the ROI. The software measures the ROI intensity
metrics for each film, for each colour channel. The net OD values can be determined
using Eq. 3.1 and are plotted against the corresponding irradiated doses with the error
bars given by Eq. 3.2. Plots for each colour channel constitute the calibration curves and
given standard protocol, the red channel is used to generate a fitted curve to correlate
the net OD to dose (Fig. 3.18).
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Figure 3.18: Calibration curve to determine dose from net OD values.
The exponential (or double exponential function) fit is used to calculate the dose from
the net OD for each pixel value. The position along the horizontal axis for each pixel
is found by converting from dpi to mm. Therefore the transverse beam profile can be
obtained by plotting the dose against position. For comparison, a Gaussian function was
fitted to each profile with the calculated FWHM. This entire process was written into
several Matlab scripts which automate the generation of the calibration curve, fit and
beam profile plots for each film. This material has been fully documented and developed
into a package for self-directed use at CCC. The authored guide and code is included in
Appendices C.1-C.5; it can also be used for general film analysis elsewhere or for other
applications. Any settings specific to the facility (i.e. scanner dpi, zero value and pixel
range) can be easily modified within the code.
3.4.3 Results
The estimated dose for each beam spot was determined by calculating the net OD from
the mean pixel values over the total ROI area. Although each ROI is uniform, this
gives only an approximated dose as the uncertainties associated with each piece of film
are not individually corrected for. The control provides a single baseline value for the
background OD: negating the background OD doesn’t account for the more significant
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changes at higher doses due to the exponential fit. A resulting 4.59 Gy was obtained
for the film 7 beam spot which is slightly larger than the expected 4 Gy. However as
there are large associated uncertainties, the mean dose was scaled to 4 Gy and similarly
calculated for the other pieces of film to provide the dose ranges along the beamline (Fig.
3.19). This is useful to estimate the anticipated dose upstream of the ion chambers as
there are no diagnostics to obtain this otherwise.
Figure 3.19: Mean dose for each film (red) in order along beamline: 1, 2, 3, 6, 4, 8, 5
and 7. z positions differ slightly to correspond with the updated simulation model.
The beam profiles obtained for each film are shown in Fig. 3.20.
(a)
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(h)
Figure 3.20: Beam profiles for each film in order along beamline a) 1, z = 380 mm. b)
2, 449 mm. c) 3, 676 mm. d) 6, 846 mm. e) 4, 1009 mm. f) 8, 1446 mm. g) 5, 1671
mm and h) 7, 1871 mm. Corresponding scanned film images and calculated FWHM
are also shown.
There are clear non-uniformities for all the generated plots indicating a beam tilt in the
positive x direction (right, in the reference frame of the direction of beam propagation).
As this is consistent throughout, it suggests that it is correlated with the beam itself
rather than misorientation of the film. Although, film 6 (Fig. 3.20d) was free standing
and may not have been exactly perpendicular to the beam. In addition, the possibility
that the beam stopper may actually be angled slightly (left, where more of the beam is
attenuated) was mentioned in the past. Given these considerations, the FWHM between
the film and simulated beam profiles was compared quantitatively (Table 3.4). Simulated
beam profiles are included in Appendix B.11 for reference.
Table 3.4: Film and simulated FWHM comparisons.
# Film [mm] Simulation [mm] Difference [mm] Difference [%]
1 12.02 11.62 -0.40 -3.32
2 13.04 14.03 0.99 7.59
3 20.49 21.24 0.75 3.68
6 28.28 26.85 -1.43 -5.04
4 34.71 32.46 -2.25 -6.48
8 47.58 46.09 -1.49 -3.13
5 50.29 55.71 5.42 10.78
7 47.24 36.47 -10.77 -22.80
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The differences between the two cases increase with distance and significantly, the sim-
ulated FWHM is ∼11% larger than the film just before the beam exits the nozzle (film
5). This is again partly due to the absence of a (90 mm) collimator before the cross
wires in the updated simulation model. At the isocentre, the FWHM drops to much
less than the film spot size which has diverged slightly from the 43 mm (radiobiological)
nozzle collimator used for these measurements. Similarly with the effects observed in
Table 3.3, the severe collimation by the nozzle restricts the transmission and there is
also slight divergence from the 34 mm nozzle opening. These differences are reasoned
as the nozzle itself was different than in the simulation model.
It is also observed that a central dip appears in film 5 (Fig. 3.20g) which indicates
attenuation caused by traversal through the cross-wires. This almost recedes by the
time it reaches isocentre (Fig. 3.20h) however a decrease at x = 0 mm can be seen. The
dose distribution here is also not uniform which suggests limited beam uniformity and
performance on the day.
Uncertainties
The calibration and response of film is generally affected by a multitude of uncertainties
which can arise at almost every step during analysis. The errors represented within
the error bars in Fig. 3.18 indicate the overall uncertainty, accounting for variations in
the measured transmission and standard deviation of the grey pixel values. Although
these quantities are defined by the ROI and scanner used, results are largely dependent
on the post-processing protocol and its extent of reproducibility. Images of the film
were provided afterwards by the facility where attempts had been made to scan each
piece consistently (same approach, settings, orientation, position, time, environmental
conditions etc.). It was discovered later that more extensive procedures [136, 138] could
reduce the uncertainties however these were not repeated. Moreover, these appear to
be exacerbated by the spatially non-uniform beam delivered. This was unpredictable as
the beam is optimised for clinical treatments but these measurements were performed
after biological experiments during research beamtime. Several other aspects and incon-
sistencies which impacted these results were also identified.
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Firstly, due to the composition of the film (each sheet of film also differs slightly),
its physical characteristics are important. The orientation must remain the same as
the grain size and positioning can affect the polymerisation process. The beam must
pass through the film on the same side and this exposure must be done under the
same conditions and environment. The film must be adequately stored before and after
irradiation and scanned at the same time.
For the analysis, the selection of the ROI was significant. The size and shape was
found to affect the resulting transverse beam profile and therefore the FWHM. The
ROI must contain enough pixels for sufficient statistics to obtain a smooth profile with
acceptable resolution. However, if the ROI is too large then the profile gets smeared out
and the characteristics of the distribution are not obvious. A circular ROI was used for
the calibration set but as the beam spots size and shape differed too much for films 1
to 7 (Figs. 3.20a-3.20h), a rectangular ROI was used (see Appendix B.23). As a result,
it was unclear whether it was reasonable to match the simulated profiles to approach
the film profiles or if simulations should be more appropriately used as a benchmark.
One approach is if both profiles were able to resemble each other and agreement was
reached within a certain percentage of uncertainty (i.e. clinical criteria states a 2%
dose uncertainty [138]). To examine this further, measurements were performed with a
Medipix3 detector and compared with film.
3.4.4 Medipix3
The Medipix3 is a hybrid pixel detector which comprises a single quantum counting
chip and a SPIDR readout system. This technology was initially developed for particle
tracking at the LHC, evolving to radiation imaging. Medipix was firstly used for X-ray
detection however the newer generations have supported its developments specifically
for medical applications [42, 157]. The chip consists of a 500 µm silicon sensor with
an active area of 28 × 28 mm2. This collects the charge deposition of protons passing
through the sensor and registers individual hits as pixels on an event-by-event basis.
The chip is capable of detection at large flux rates however this was the first time its
performance was tested within a clinical, high proton flux environment. The objective
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of these measurements were twofold: to benchmark the film with an absolute detection
method and to investigate the applicability of Medipix3 for absolute proton therapy
dosimetry.
3.4.5 Method
The Medipix3 detector was placed at three locations throughout the treatment beamline
and irradiated under varying beam conditions (Fig. 3.21). Sections of EBT3 film were
also positioned in front of the detector and irradiated simultaneously in order to directly
compare performance. A summary of the experiment is described in [158]; for relevance
to this thesis, only the main methods, results and other supplementary observations are
discussed‡.
Figure 3.21: Experimental setup with irradiations performed at three different positions
(integration zone and after the nozzle) with the Medipix3 detector and EBT3 film.
The sensor itself was held in an aluminium cooling block and connected to the readout
system by fibre cables (Fig. 3.22a). A small assembly was designed to securely hold
a piece of film 3.5 cm in front of and parallel to the sensor and was clamped onto the
edges of the block (Fig. 3.22b).
‡All detector related hardware modifications, operation and analysis was done by N. Bal.
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(a) (b)
Figure 3.22: a) Medipix3 chip affixed within an aluminium cooling block with the
SPIDR readout system (red). b) Clamp assembly to attach film, the adjoining plastic
shield was built as protective casing for transport.
Prior to the experiment, the expected dose (Fig. 3.19) and estimated fluence was calcu-
lated to estimate the possible range of measurements and registered events. Similar to
VELO, the Medipix3 chip can withstand high amounts of radiation and hence was also
situated in the beginning of the integration zone. At this position, the beam FWHM
was expected to be smaller than the sensor sensitive area (Table 3.4) however a 20 mm
collimator was needed for the nozzle.
On the day, the lowest stable beam current of 0.012 nA was attained and then
was ramped up to 1.97 nA for the different runs. These readings were provided by an
electrometer connected to the second scattering foil as the dose monitors could not be
used with the detector in the integration zone. The foil currents have a linear relationship
with the dose monitor MU.
3.4.6 Results
Images obtained with the detector were directly compared with film using the procedure
described in Section 3.4.2. An additional set of 5 films were irradiated from 4-25 Gy
to generate a calibration curve (Appendix B.22) to convert the film to beam profiles.
The Medipix3 images were generated by integrating over all frames where some post-
processing was required mainly to normalise detector caused effects (Appendix B.23).
Small artefacts in the centre are observed from the join between the sensors as the
sensitive area combines 4 sections. Changes for the different grey pixel range and dpi
were also made.
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As the selection of the ROI is significant, total horizontal beam coverage with suf-
ficient vertical height was ensured in order to generate a smooth profile. Consistent
ROI selections were used for each film and corresponding Medipix3 image; the resulting
profiles at 9.5 cm and 30 cm after the nozzle at the same beam current are shown in
Figs. 3.23a and 3.23b.
(a)
(b)
Figure 3.23: Film and Medipix3 beam profiles at a) 9.5 cm and b) 30 cm after the
treatment nozzle.
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For these cases, correspondence between both methods was achieved, particularly at the
lateral penumbra. Slight translation (in the positive x direction) for both plots suggest
that the detector was not precisely aligned at the centre of the beam axis. Nevertheless,
a linear response was observed across the full current range and the high doses were
detected right through to the edges of the sensor. The observable differences at the
highest points of dose are likely to be related to the image analysis and also due to
fundamental differences between the detection processes.
The beam fluence recorded by Medipix3 was directly converted to dose by scaling
the pixel values to the film irradiated at the same experimental location. This preserves
the linearity of the grey values (grey pixel intensities would correspond to numbers of
hits) and also correlates the magnitude of hits to a determined quantity: dose. The
dose was not calculated from hits or the resolved beam current recorded by Medipix3
due to the uncertainties with the electrometer. These were further perturbed by beam
instabilities, particularly at the low currents during moments where there was a complete
loss of beam. This was presumed to be caused by a dropout in the RF supplied to either
one of the dees of the cyclotron, resulting in a loss of the accelerating field between the
two electrodes and therefore a disruption to the beam. It was also mentioned that it may
be related to issues with the deflector which has deteriorated with use or from changes
to the ion source (discussed later in Section 4.2.1). Furthermore, maintenance cleaning
of the cyclotron tank can also influence the beam operation, resulting in changes to the
beam characteristics.
Although the beam operated reliably at higher currents and particularly at clinical
rates, several other observations about the accelerator and general beam were realised
from the measurements with Medipix3. Recurring jitters were seen in the data where
variations in the count rate over time appeared as small amplitude waves. At a higher
time resolution and deconvolved, these seemed to comprise of sets of periodic waves at
low (few ms) and higher (order of hundreds of ms) frequencies. One set was presumed
to be related to the mains electricity however it is unclear if the second was associated
with the cyclotron or detector. This was not experienced during previous detector tests
with X-rays nor supposedly seen with any other measurements at the beamline. This
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is possibly because Medipix3 is capable of measuring the beam current by detection of
individual protons with high temporal resolution: this is not commonly achievable with
typical instruments.
The significance of these rapid oscillations may be meaningful as they demonstrate
something otherwise unforeseen which may have an impact on beam performance. When
the beam is modulated with a rotating wheel to generate a SOBP, the graduations
determine the longitudinal distribution of dose. If there are variations in the beam
currents, there could be asynchronicity with the rotational frequency of the wheel and
may cause aberrations in the dose delivered at each step.
If the oscillations are present in regular operation, these sorts of measurements may
indicate an underlying aspect of the cyclotron. An irregularity in the structure or accel-
erating process can influence the beam dynamics (orbit, stability, focusing effects from
magnetic field etc.) of the circulating protons and therefore the extracted beam quality
(energy spread, emittance, dispersion etc.). These are likely to be caused by a com-
bination of different factors including the design, changes to the ion source and aged
components. It is unknown if or how the beam is adjusted upon extraction. If there is a
collimator at the exit then some properties of the beam would be regulated, such as the
beam distribution in the transverse plane. Nonetheless, these observations suggest the
tendency of the parameters of the beam to change based on the operation and changes
to the cyclotron over time. Differences from originally documented beam parameters
would be reasoned: this is an important finding and is discussed in greater detail in
Chapter 4.
3.5 Summary
Simulation modelling is essential to investigate the implementation of the VELO detector
system; to examine the behaviour of the beam and to establish a correlation between
the entire beam distribution and halo. The CCC facility, treatment delivery system and
previous efforts to simulate the beamline are overviewed, facilitating the development
of a new and improved simulation model in GEANT4. The structure of the toolkit, its
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classes, processes and how the CCC model runs from its source and macro files have
been detailed. Default input parameters were used to characterise the beam along the
entire treatment line and examine the beam divergence within the integration zone.
These were found to significantly affect the transverse distribution and therefore the
beam must be well defined for the integration of the VELO detectors. The VELO beam
monitor has a limited impact on the resulting beam and can be a suitably accommodated
in the facility due to the arrangement of the delivery system components. Nevertheless,
several developments were needed to enable accurate measurements and simulations; the
code was modified for better modelling capabilities and analysis scripts are provided.
The GEANT4 model was assessed by quantifying differences in the FWHM between
the simulation and film obtained transverse beam profiles. Measurements with EBT3
gafchromic film required an extensive process of analysis and scripts were written to
automate the conversion from OD to dose, obtaining plots of the 3D dose distributions at
different locations throughout. To explore the accuracy of the film profiles, simultaneous
measurements were performed with a Medipix3 detector. Good agreement with the
irradiated film provided an absolute representation of the spatial spread of the beam.
Both methods contribute meaningfully to the benchmarking, development and validation




There has been a rapid emergence of clinical ion beam facilities worldwide especially
in recent years, due to significant advancements in accelerator technology. For proton
therapy, the majority of facilities in operation treat with higher energies (i.e. >160
MeV) and encompass a variety of different beam delivery methods and arrangements of
beamlines, gantries, cyclotrons, synchrotrons or synchrocyclotrons.
Modern facilities constructed by major turnkey vendors often feature the same or
related designs, systems and commissioning procedures to enable higher consistency with
day-to-day operation. Although each facility or individual machine may be different (as
mentioned in Chapter 2), minimal requirements and standards of performance must still
be met before initial or regular clinical operation. Acceptance and commissioning tests
are performed to study, verify and characterise the beam; necessary performance and
beam quality is maintained across the lifetime of the equipment. However, this can
differ across facilities, particularly for centres which were developed much earlier and
have been longer established. The extent of characterisation and study may be limited
and as for this case, they are most often unique facilities.
As described in Chapter 3, Monte Carlo codes can be used to extensively simulate
the beam delivery and particle interactions. However, in order to have a complete
understanding of the facility, it is essential to also examine the transport of the beam.
It is expected that accurate modelling of the beam dynamics are employed in the design
process for modern builds yet this is less certain for older facilities. These methods may
be studied only for relevant research and development purposes. For the implementation
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of the VELO detectors, it is crucial that the distribution and divergence of the beam
is completely and precisely known in order to correctly correlate the halo region with
the total beam. As discussed, there are several factors which affect the resulting beam
profiles and thus an alternative approach was devised: to model the CCC beam optics to
determine applicable beam input parameters for simulations. Simultaneously, this also
contributes to complete end-to-end characterisation of the CCC beamline. This serves
as a basis for future upgrades, optimisation, testing and integration of diagnostics. This
method of characterisation and modelling can also be applied for similar facilities. This
chapter covers the fundamentals of beam dynamics as relevant to study the optics of the
Clatterbridge beamline.
4.1 Transverse Beam Dynamics
Beam dynamics are fundamental to accelerator physics, representing the theory and
physical concepts to describe the movement of charged particles. As particles travel at
high velocities, their paths are affected by focusing and bending fields in an accelera-
tor. Electromagnetic fields are designed to guide and direct their trajectories along an
intended path. In practical terms, this enables the beam of particles to be defined and
also to determine certain beam properties. As the work in this chapter relates to the
geometrical implications of the beam trajectory, the specifics of fundamental derivations
are not shown. Instead, key beam dynamics concepts are summarised. A more complete
review of accelerator beam dynamics can be found in [159–161].
Co-ordinate System
The transverse motion of a single particle within an accelerator or transport line can be
visualised given a reference coordinate system, as shown in Fig. 4.1. In this transverse
plane, the particle (red circle) traverses some distance along s with deviation shown
by the tangential z -axis, with horizontal co-ordinates in the perpendicular x -axis and
vertical co-ordinates in the also perpendicular, y-axis.
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Figure 4.1: Reference frame for an ideal particle.
This represents the path of an ideal particle with ‘perfect’ conditions and is named the
reference, design orbit or closed orbit (for a storage ring). Under electromagnetic fields,
particles will follow a circular path given an angular rotation θ around the x -axis with
a local radius of curvature ρ.
Magnetic Fields
The trajectory of particles with charge q is influenced by electromagnetic forces as
governed by the Lorentz force and this radius of curvature ρ is dependent on the particle
momentum p and strength of the field B. Accordingly, magnetic elements such as dipoles
and quadrupoles are used to constrain and guide the beam of particles in an accelerator.
The sequence of these are commonly referred to as the ‘optical lattice’ and vary according
to the design and warranted beam properties of the accelerator. Dipoles are used to steer






B is the magnetic field strength and when multiplied by ρ, is known as the magnetic
beam rigidity. This represents the resistance of a particle to move along a curved path
and is an important quantity to consider when optimising and designing for the required
field strength and length of dipoles.
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Quadrupoles have four poles with zero field in the central axis (x, y = 0), resulting in
opposite effects in two different planes: focusing or defocusing. A conventionally focusing
quadrupole (Fig. 4.2) will correct particles which deviate from the horizontal axis but
defocus the beam in the vertical axis. This is the opposite for defocusing quadrupoles,
where the particles are focused in the vertical plane and defocused in the horizontal
plane.
Figure 4.2: Sketch of a conventionally focusing quadrupole (particle travelling out of the
page). The field lines (blue) are spaced closer toward the edges of the yoke indicating
a stronger field. The pole tip radius (red dotted arrow) and the direction of the (B)
fields generated by current passing through wrapped around coils, are also shown.
As the field changes along either axis, the strength of the quadrupole field is defined as a
constant quantity k where the field gradient g = ∂By∂x . This is also commonly described
as the ‘normalised gradient ’, ‘normal quadrupole strength’ or ‘normal quadrupole coeffi-
cient ’. This can be determined by using Eq. 4.1 and taking g over magnetic rigidity or












The gradient is related to the nominal current I by g = 2NIa with N number of turns of
wire about each pole face for the coils, µo is the magnetic permeability in vacuum and
a is the quadrupole pole tip radius.
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There are also higher order magnets such as sextupoles (six poles) and octupoles
(eight poles) which are used to correct optical aberrations or for further beam manipu-
lation. However, a study of non-linear optics is beyond the scope of this thesis and this
work is limited to just the linear optics.
4.1.1 Particle Motion
For these linear fields, as only an idealised particle follows the design orbit, the actual
motion of a particle can be determined by considering the deviation or oscillation from
this reference path. The sets of equations which describe this are derived from Hill’s
equations [159], where solutions provide several expressions and optical parameters.
Given that the facility has a straightforward lattice: a fixed horizontal transfer line with
a slight bend, no ESS and is without sextupoles or higher order considerations, only the
following few terms are discussed.
Equations of Motion
Given the focusing effects as particles traverse through dipole and quadrupole fields, the
equations of motion are developed into differential equations representing the deviation
from the design orbit in both the horizontal (x ) and vertical (y) planes (Eq. 4.4). The
periodic functions in Eq. 4.3 describe the focusing properties of the lattice; these are
















Considering only the linear terms and assuming several conditions, including that k and
ρ are constant, provides the equations of motion in x and y :
x′′ +Kx(s)x = 0,
y′′ +Ky(s)y = 0.
(4.4)
These illustrate that the path of a particle changes with the strength of the field as
dependent on s and in fact, exhibits motion with a periodicity as similar to a harmonic
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oscillator. The transformations and further steps are detailed in [162–164] where a
solution to Eq. 4.4 will yield the following expression for the particle’s position, for x :
x(s) =
√
εβ(s) cos(ψ(s) + ψ0). (4.5)
Where ε is the emittance related to the beam area, β is an amplitude term and ψ is
the phase component and both vary according to s. Taking the derivative of Eq. 4.5 to







sin (ψ(s) + ψ0) + α(s) cos (ψ(s) + ψ0)
)
. (4.6)
It is important to note the beta (β) term here again as it relates to the amplitude
and is an important quantity which is strongly associated with the beam envelope and
therefore the physical geometrical size of the beam. It is also known as the betatron
or beta function (βx or βy for each plane) and varies along s, as dependent on the
focusing properties of the magnetic elements in the optical lattice. Similarly, ε is another
important parameter which relates to the beam envelope and physical size of the beam.
Twiss Parameters
Ideally, the emittance should be considered as an invariant (Liouville’s theorem [159])
and is rearranged to obtain the following (Courant-Snyder) expression:
ε = γ(s)x2(s) + 2α(s)x(s)x′(s) + β(s)x′2(s), (4.7)
where ε represents the area the beam occupies in phase space (position against angle)









These are known as the Twiss parameters and describe the transverse beam phase space
at any point along s. For the horizontal plane, these can be referred to as αx, βx, γx for
x and similarly as αy, βy, γy for y.
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4.1.2 Beam Ellipse
Accordingly, in a beam of particles, several particles with the same energy will exhibit
oscillatory motion in this elliptical shape described in another co-ordinate system afore-
mentioned as phase space (x−x ′). A plot of Eq. 4.7 depicts this parametric coverage by
particles, as the beam travels along s. The ellipse will vary in shape around the origin
of the reference axis however the emittance is independent of the lattice focusing prop-
erties. The area remains constant according to the Liouville theorem for a Hamiltonian
system: the density in phase space is conserved in the absence of acceleration, collisions
or dissipative forces.
Figure 4.3: Twiss parameters and the beam ellipse in the horizontal phase space.
Each particle can be defined by the 6 phase space variables (x, x ′, y, y ′, z, z ′), giving

















88 Chapter 4. Clatterbridge Beam Dynamics
where δ is the relative momentum offset in the longitudinal plane as the z -axis is parallel
to the reference frame trajectory.
Dispersion
A beam will consist of particles with different positions (in the x and y transverse planes)
however they will all not have the same energy or momentum. This momentum spread
δ results in some deviation as the beam passes through magnetic fields. A correction for
this can be rewritten for Hill’s equations (Eq. 4.4) to determine the particle’s position
again:
x(s) = xβ(s) +Dx(s)δ, (4.10)
where D(s) is known as the dispersion, representing the position offset (in x or y) due to
the change in momentum. Particles with higher momentum will have a higher bending
rigidity and therefore bend less given the same field; this holds true for the opposite.
Similarly, particles will trace out another orbit as related to the differences in momentum,
represented by this dispersive term.
Emittance
A particle with an ideal trajectory will have no difference in momentum and zero diver-
gence from the design orbit and therefore zero emittance. In reality, a beam will contain
a spread of particles in phase space and therefore this area is a significant indicator of
accelerator performance. The emittance is important for the design and optimisation
of the beam optics as it is closely linked with the Twiss parameters and the beam size.
The emittance can be defined in several different ways depending on how the particle




〈x2〉 〈x′2〉 − 〈xx′〉2. (4.11)
As shown in Fig. 4.3, the occupied phase space is πε. The emittance εrms is usually
given in units of π mm mrad and considers the distribution of particles in an equivalent
ellipse in phase space, within one standard deviation (of x = 0). The brackets 〈 〉 indicate
an average value.
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The transverse emittance can be measured using many different methods [69, 165] as
dependent on the type of facility, properties of the beam and the extent of disturbance
on the beam. Several limitations meant that a scheme for these measurements needed to
be tailored to the specifications of Clatterbridge; this is discussed later in Section 4.4.1.
4.2 The Clatterbridge Facility
A few studies were done previously at Clatterbridge involving the transport line and
accelerator. The feasibility of an upgrade to increase the maximum proton energies by
incorporating a linac at CCC was explored in [166, 167] and measurements of the ex-
tracted beam and cyclotron were performed [168]. As there have been several changes
over the years, further work into the optical modelling and beam emittance was also
done by [128, 169]. However, these results were inconclusive and there has been little
attempt since to combine all findings and understanding of the beam optics for practical
use. Consequently, as there is no pre-existing optics beamline model for CCC, a com-
prehensive review of the facility was firstly needed for modelling of the beam dynamics.
All relevant documentation over the lifetime of the facility that was still in record
and accessible was reviewed (Appendix A). Historical information of the cyclotron and
beam properties (Appendices A.2-A.4) only originate from the period of time prior to
and surrounding the beamline conversion, thus only pertain to its initial operation for
neutron therapy. During the commissioning phase, studies were done in [110, 111] to
design a delivery system based upon considered specifications to generate a clinically
applicable beam. Since then, there has been an absence of functioning diagnostic sys-
tems upstream of the treatment room and as a result, the beam transport upstream
of the delivery system is not well understood. Despite this, the beam requirements for
treatment fall within defined ranges (Table 3.1); the operation of the accelerator and
beamline remain consistent as performance is maintained with routine checks.
In modern facilities, multiple beam instrumentation devices are commonly placed
along the transport line to provide measurements including the current, profile, emit-
tance, position, dose or energy losses [170]. These parameters are available either actively
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online or during downtime checks which can be used to examine the beam and to define
the beam behaviour. In the case of CCC this was not possible: it is difficult to accurately
model the treatment beam without knowing the characteristics and distribution of the
beam generated between the delivery system and the exit of the cyclotron. Nevertheless,
a retrospective study is a practical method to overcome this and model the beam optics
of an established proton therapy facility given the arrangement of the beamline, compo-
nents, cyclotron settings and magnetic parameters. This study has also been reported
with some modifications in [171].
4.2.1 Bunker Overview
Housed in the Clatterbridge Cancer Centre, Wirral in the North West of England, the
Douglas cyclotron and beamline was built and commissioned in 1984 initially for fast
neutron therapy trials. Further construction was required to accommodate a supple-
mentary treatment room for the proton therapy service [15, 111]. Parts of this early
beamline are still contained within the cyclotron bunker however are no longer in use,
along with several other components displayed in the layout below (Fig. 4.4). This in-
cludes flip screens (FS), stray beam detectors (SBD) and beam profile monitors (BPM)
which are shown in the layout but have been removed. The BPMs were last used more
than 10 years ago and wire scanners were no longer used as a much higher current was
needed to generate signals with sufficient resolution†.
Figure 4.4: Original layout of the complete CCC beamline. Within the vault, the
cyclotron produces the proton beam (red line) which passes through the transport line
comprising various components and magnets, to the treatment room area. Notable
beamline elements; quadrupoles (Q), dipoles (X), switching magnet (SWM) and beam
collimator (BC1). Full listing can be found in Appendix A.1.
†Personal communications, I Taylor, 2018.
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The Scanditronix MC-60 PF isochronous cyclotron (Fig. 4.5) generates a 62 MeV beam
of protons transported through nine quadrupoles arranged into three triplets, a switching
magnet and collimators before leaving the bunker and onto the passive delivery system
in the treatment room (Fig. 4.6). Adjustments were necessary to change the produced
beam from neutrons to protons, particularly to limit the extracted beam current from
50 µA to 30 nA and to therefore also decrease the resulting dose rate. This required
installation of another ion source power supply which restricted the arc current [111].
The affect of this change on the beam quality is not quantified however several observa-
tions are discussed in Chapter 3 which are thought to be strongly associated with the
cyclotron repurpose.
Figure 4.5: Scanditronix MC-60PF cyclotron. The first quadrupole triplet is partially
visible and located just after beam extraction upstream of a dipole which steers the
beam onward to the switching magnet.
The beam enters the treatment room through a beam pipe in the wall and traverses two
scattering foils before it leaves the vacuum pipe through a kapton window. Cross-wires
and an ionisation chamber in the box just upstream of the nozzle are used to monitor
the uniformity and performance of the beam.
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Figure 4.6: The treatment room beamline. The proton beam originates from the ac-
celerator bunker behind the wall and passes through the delivery system before exiting
through the brass nozzle and last collimator.
Functional parameters of the cyclotron and proton beam are listed in Table 4.1. These
are typical values considered for current practice and as noted, differ from those provided
by the manufacturer and as measured in past studies.
Table 4.1: Cyclotron and beam parameters.
Parameter Value
Ion type p+
Ion max kinetic energy 62 MeV
Beam current (treatment) 1-30 nA
Number of ions 3.12 × 1010
Energy spread 0.10 %
Accelerator Parameters
In order to generate an optical lattice of the facility, knowledge of fundamental beam
properties such as the Twiss parameters and the emittance at the source point or exit of
the cyclotron are necessary to define the input beam source for simulation codes. This
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information was either unknown, inconsistently documented or irretrievable. All relevant
historical documentation was extensively reviewed, salvaged and collated. Several values
of emittance were found mentioned and are listed in Table 4.2.
Table 4.2: Documented emittances.
εx [mm mrad] εy [mm mrad] Source/s
<15 <15 T. E. Saxton [172], Appendix A.4
4.2 6.6 J. Ahlbäck, >1986†
<2-3π <2-3π J. Clarke [168]
2 1.5 H. Owen, 1998†
As these are inconsistent, the more recent work done by [128] was further examined.
Similarly described in [169], a set of quadrupole variation scans (QVS) were done to
determine the transverse emittance and Twiss parameters at the entrance of the first
quadrupole. A set of Twiss parameters at the beginning of Q1 were obtained (Table
4.3) and these are assumed to be equivalent to the extraction point of the cyclotron.
This study encountered several difficulties; uncertainties associated with the beam tails
were reported however accommodations were made to appropriately analyse and model
the beam. Although these values did not agree specifically with those in Table 4.2, it
is recognised that the emittance would differ given the changes to the cyclotron and
facility over time (discussed previously in Section 3.4.6). As these are the most recently
reported values, were retained as input parameters for these beamline simulations.
Table 4.3: Reported Twiss parameters, dispersion and RMS (1-σ) emittances at the
cyclotron exit and nominal input parameters for this study [128].
Parameter Horizontal (i=x) Vertical (i=y)
Twiss Alpha (αi) 0.8600 0.2685
Twiss Beta (βi) 1.9897 1.0629
Dispersion (Di) 0 0
Transverse Emittance (εi) 5 mm mrad 1 mm mrad
†Reported in records of previous personal communication.
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4.2.2 Quadrupole Parametrisation
An accurate description of the beamline components are needed to model the beam
in any simulation code and specifically, it is necessary to define the parameters of the
magnetic elements which comprise the optical lattice.
Geometrical measurements were taken across the entire beamline (Table 4.4) for all
relevant components in both the demarcated bunker and treatment room areas. As the
beamline is permanently fixed in place and the beam pipe passes through a concrete
wall, measurements were also checked against original floor plans for accuracy [173].
The measured layout and determined lengths of the beamline components are shown in
Fig. 4.7. The process to define these quadrupole parameters is described in detail in the
following sections.
Figure 4.7: Beam transport line from the cyclotron to the treatment room. The origin
point for all treatment delivery simulation models is indicated (source plane) at the
start of the treatment room. Dimensions are provided in m but are not to scale.
For the magnets, defining the physical dimensions was more problematic as the quadrupoles
were grouped into triplets with their individual yokes and coils obscured from view (Fig.
4.8a). Schematics were only available from initial neutron therapy line designs and it is
not feasible to move or disassemble any elements. Therefore, dimensions were inferred
by checks against original manufacturer drawings and the geometry for the second and
third quadrupole were extrapolated from Q1. The SWM (Fig. 4.8b) has a deflection
angle of 5.5◦ which has only a slight influence on the beam optics.
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(a)
(b)
Figure 4.8: a) Close up of the second quadrupole triplet (Q2). Groups of bolts on
the upper half of the external enclosure indicate the locations of the coils and poles
belonging to each quadrupole. b) The switching magnet (SWM) coils are visible leading
onto an upstream pressure valve.
Fields
Magnetic fringe fields can also be modelled in the simulation code and this relates to
the difference between the physical and effective lengths. Fringe fields are the regions
96 Chapter 4. Clatterbridge Beam Dynamics
on the edges of a magnet where the field reduces to zero. For realistic simulations, field
maps or models can be implemented to account for the changes in the field.
Figure 4.9: Different regions and changes in the magnetic field across the physical and
effective lengths. The outline for a field approximation to model a dipole fringe field is
shown [174].
Due to the lack of information and accessibility, drift distances (exterior to the iron
core length) between the quadrupoles for all the triplets had to be estimated. As the
exterior magnet dimensions were known from physical measurements, this total length
(of a triplet) accommodates multiple drift spaces and effective lengths, which must be
compensated equally by each quad. A range of lengths were simulated and smaller gaps
were observed to cause blow ups in the optics further downstream, hence maximum
drift lengths of 0.13 m were designated for each triplet. For simplicity, fringe field effects
were discounted by equating the total effective lengths to physical lengths, as displayed
in Table 4.4. In the event that more precise information is determined in the future, the
optical lattice can be matched by modifying the relevant parameters.
It is also important to describe each quadrupole in terms of their magnetic strength
or field gradient. This presented complications, requiring that the limited information
provided by the manufacturer and any legacy control system data be converted into
relevant quantities.
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Accordingly, each quadrupole triplet had recommended operational parameters stated
for each magnet and these were scaled and optimised for practicality. As the field cov-
erage was approximated to the effective length of each quadrupole, a linear correlation
was assumed to calculate the normalised quadrupole gradients KI. This is based on
the listed field gradient and nominal current for each quadrupole, multiplied with the
programmed currents. This provides an estimate of each field gradient: the generated
field gradient G = I × KI , where I is the supplied current. The normal quadrupole
strength is determined by taking this field gradient over the beam rigidity (i.e. substi-
tute G for g in Eq. 4.2). Corresponding nominal values are also listed in Table 4.4. The
treatment line is indicated to begin 2.59 m downstream of Q3 and combined with the
beam transport line, amounts to the total beamline length from the exit of the cyclotron
to the treatment nozzle.
Table 4.4: Nominal parameters and lengths of beamline elements.
Element
Physical Effective Normal Quadrupole
Length [m] Length [m] Strength [m-2]
Q11 - 0.20 -11.93
Q12 - 0.20 7.35
Q13 0.97 0.20 -6.40
Q21 - 0.22 4.14
Q22 - 0.22 1.21
Q33 0.92 0.22 -4.14
Q31 - 0.22 5.89
Q32 - 0.22 -10.92
Q33 0.92 0.22 5.89
SWM 1.13 0.85 -
Transport line 16.15 - -
Treatment line 1.77 - -
Cyclotron to Nozzle 17.92 - -
Given all these considerations, two codes: Methodical Accelerator Design (MAD-X)
[43] and Beam Delivery Simulation (BDSIM) [44] were used to model the CCC beam
optics.
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4.3 Optical Modelling
4.3.1 MAD-X
MAD-X was originally developed and is currently maintained by CERN, used to de-
scribe alternating-gradient accelerators and transport lines. It performs beam dynamic
calculations of charged particle accelerators and is particularly useful for optics studies,
including design and optimisation. For this work, the CCC beamline was defined in
MAD-X using the optical components and lattice of the transport line combined with
nominal parameters (Tables 4.1, 4.3 and 4.4). By providing a description of the beam
source and a sequence of magnetic elements, it is possible to obtain the Twiss functions
which describe the beam envelope throughout the beamline. The tool performs beam
dynamic calculations to determine the beam ellipse at a point which can also be trans-
ported to various locations. As a result, the beam phase space can be determined at
any arbitrary position which allows the flexibility to match components and parameters
to generate outputs as necessary.
As mentioned in Section 4.2.2, the normal quadrupole coefficients listed in Table 4.4
were approximated and as such, a process of optimisation was necessary to obtain results
with minimal beam sizes and higher transmission. This was performed by applying a
range of factors to further scale the strengths of each quadrupole triplet and resulting
effects on the optical functions, transmission and calculated beam sizes along the trans-
port line were assessed. The values quoted in past work [169] were also examined. For
context, the resulting changes to the Twiss functions are also shown as additional plots
in Appendix B.16.
As the physical beam properties are primarily dependent on the extent and evolution
of the beam envelope, the Twiss functions were optimised to reduce erratic or large
fluctuations such that outputs within beamline constraints could be achieved. This
process is discussed later in Sections 4.3.3 and 4.4.3. Q1, Q2 and Q3 were finally scaled
by 0.3, 0.8 and 0.8 respectively, obtaining the optimised set of simulated Twiss functions
(Fig. 4.10). The code describing the optimised CCC optical lattice is included in
Appendix B.17.
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Figure 4.10: Twiss functions (Twiss beta βx, βy and dispersion Dx , Dy) for the nominal
case, across the entire beamline starting from the cyclotron exit to the nozzle. The
magnetic elements are displayed above the plot.
The green line shows an increase in dispersion in the negative direction (across the x
plane) beginning around the switching magnet but remains constant at 0 in the y plane
as the magnetic field generated by the dipole bends the particles in the beam only across
one plane. The switching magnet was originally responsible for diverting the beam to
the different beamlines but now just deflects the beam slightly, hence only has a small
dispersive effect.
The betatron functions βi are dependent on the fields produced by the quadrupoles
and describe the orientation and divergence of the beam. The beta functions converge
following passage through the first and second triplets, however the overall changes to
the optical functions show a clear increase from initial beam parameters. To examine
practical conditions, the Twiss functions are examined for the extent of their physical
implications, specifically to determine RMS transverse beam sizes.
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4.3.2 Transverse Beam Size
Knowledge of the divergence and size of the beam is essential when considering the
geometrical constraints of equipment. This includes the beam pipe and collimators;
also if integrating any instrumentation into the beamline either in the transport line or
further downstream. Therefore, beam sizes at several important locations were evaluated










where σi is the transverse RMS 1-sigma beam size and i denotes the horizontal (x) or
vertical (y) direction. This is determined by the Twiss beta βi, transverse emittance εi,
dispersion D i and the square of the relative RMS momentum spread
∆p
p . Furthermore,
as the beam is (slightly) relativistic, a correction was required to account for the spread











In this case, ∆EkEk is the kinetic energy spread of the Scanditronix cyclotron (Table 4.1)





The calculated transverse RMS sigma values are plotted against distances along the
beamline and displayed in Fig. 4.11. To examine the reliability of the nominal emittance
(red), two other emittance values were also used to calculate beam sizes as reported by
Clarke (blue) and the manufacturer - Ahlbäck (green), as listed in Table 4.2. A diagram
of the magnets has been overlaid for approximate comparison.
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Figure 4.11: RMS beam sigma values for x (solid line) and y (dashed line) for different
emittances. The nominal emittance (red line) is utilised for this study.
This plot illustrates the physical changes in the transverse beam sizes. As σi is largely
dependent on the optical Twiss functions, the plots follow the distribution of the beta
curves in Fig. 4.10. The lattice is designed such that the beam is delivered with qualities
to fulfil its operational purpose; for operation at CCC this mostly involves altering the
magnetic fields to transport a small and flat beam (uniform transverse distribution)
through the treatment nozzle. A smaller beam is desired to maximise transmission, to
avoid losses from interactions with the beam pipe wall or parts of components which
may obstruct the beam path. This was achieved by the geometrical arrangements of
quadrupoles into triplets and by the varying quadrupole field strengths or polarities,
resulting in stronger or weaker focusing in one, or the opposite plane.
4.3.3 Optimisation
Given the range of σi obtained by using these nominal parameters, in practice the upper
limits would not be possible as the beam would be too large for the beam pipes thus
resulting in large losses. Physical measurements of the vacuum beam pipes were made
however the outer diameters were not uniform and it is unclear if this is due to changes
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in the thickness of the pipe walls or if the inner dimensions also change. The minimum
inner radius was determined to be 30 mm and this was assumed for the simulations.
Furthermore, it is possible that other elements in the beamline may also affect the
transmission. It is also mentioned in [128] that BC1 (Fig. 4.4) is an actuated collimator
and when it was replaced with a scintillating screen to image the beam experimentally,
the appearance of a trailing tail in the horizontal plane was detected. It is thought that
BC1 was installed to remove the beam halo or tails [175] which skew the shape of the
beam asymmetrically, accounting for the larger horizontal emittance. The collimator
minimises the beam spread and dispersion of the beam envelope specifically as it enters
the switching dipole where the magnetic field results in the separation of particles,
horizontal beam growth and a magnified tail further downstream. BC1 is presumed to
mitigate radiation losses and improve the beam quality for treatment.
Given the uncertainties and to keep the lattice straightforward, smaller apertures or
collimators were not included. In reality, the beam should be less than the minimum
60 mm pipe diameter to be able to traverse the vacuum pipe at the beginning of the
treatment beamline (>16.15 m) with sufficient transmission. Ideally at this point the
beam size should be small enough as the pipe contains a first collimator (6 mm diameter).
At this stage the beam sigma has doubled in comparison to the start of the transport
line. Additional beam sizes, corresponding betatron values at significant locations and
potential positions for diagnostics (P1-P4) are listed in Table 4.5.
Table 4.5: Optimised lattice beam sizes and betatron values.
Marker Distance σx σy βx βy Dx Dy
Location [m] [mm] [mm] [m] [m] [m] [m]
Cyclotron exit 0 3.15 1.03 1.99 1.06 0.00 0.00
After SWM 6.09 15.13 3.99 45.81 15.91 -0.04 0.00
End of Q3 13.56 16.95 5.43 57.48 29.47 -0.03 0.00
Diagnostics P1 14.65 12.73 2.29 32.42 5.25 -0.02 0.00
Diagnostics P2 14.81 12.10 1.82 29.26 3.33 -0.01 0.00
Diagnostics P3 14.97 11.46 1.36 26.27 1.85 -0.01 0.00
Diagnostics P4 15.14 10.83 0.91 23.44 0.82 -0.01 0.00
Treatment line start 16.15 6.89 2.14 9.52 4.59 0.01 0.00
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Experimental measurements are necessary to benchmark this lattice as these values are
contingent on the reliability of information and the assumed parameters used in the
simulation. Moreover, as the quadrupole specifications cannot physically be checked
and have been approximated to their best degree, one approach is to modify the normal
quadrupole gradients to match actuality. This optimisation was performed in MAD-X
where the normal quadrupole strengths (Table 4.4) were scaled for all triplets and a
corresponding set of σi was generated. Fig. 4.12 illustrates the wide range of possible
beam sizes; minimum or maximum σi are denoted by either a marker or line to indicate
the boundaries at either extreme, anywhere along the transport line. Each marker or
line type represents a set of either σx (red) or σy (blue) values which have been generated
by applying a scaling factor to the nominal quad strengths. For clarity, only the sets
pertaining to the outer boundaries have been individually displayed and the remaining
series of σi pairs are contained within the shaded region. The beam sizes determined
for the nominal, optimised case is specified by the solid lines.
Figure 4.12: Ranges of possible transverse RMS beam sizes by varying the quadrupole
gradients. The non-solid lines and markers correspond to the sets with maximum
or minimum σx (red) and σy (blue) values. All other σi sets are contained within
the shaded regions and the optimised case is indicated by the solid lines. As distances
between 14.5-16.2 m are meaningful, there is smaller interpolation between these points.
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This plot indicates that varying the magnet settings results in a large range of beam
sizes. This is most significant at >12 m, where knowledge of the beam parameters is
most important. Experimental measurements are necessary to verify the precision of
this model and can be benchmarked by determining the emittance or transverse beam
profiles under standard or defined accelerator settings.
4.4 Model Verification
Active verification measurements are straightforward for modern facilities which already
have diagnostics devices [170, 176–178] installed in their transport lines. As such, two
approaches to verify the model experimentally were developed, as CCC would require
a system be designed and integrated into the beamline. In terms of both the physical
design and optics, locations P1-P4 were identified as the most ideal sites for system
integration for experimental measurements. These can be done using several different
methods, most suitably either pepper pot, quadrupole variation scans (QVS) or multi-
ple profile measurements [69, 165, 179]. As past difficulties were encountered using a
scintillating screen and camera to capture the beam, a more flexible and robust method
is needed. Therefore, a combination of multiple profile and QVS measurements with
a scanning fiber system [180] was pursued. It was aimed that measurements with this
system using multiple methods will yield the Twiss parameters, emittance and also allow
simultaneous characterisation of the quadrupoles.
4.4.1 Proposed Emittance Measurement Campaign
The 4PrOBεaM (4-Profiler Online Beam Emittance Measurement) [181, 182] is an effi-
cient system which measures the transverse RMS beam emittance by scanning a doped
silica fiber across the beam. The short acquisition time and compact size of the system
enables integration in medical beamlines, capable of providing fast and accurate mea-
surements of the beam size, shape and position. This allows the transverse emittance
to be studied as a function of both the accelerator and beam, across a wide range of
beam intensities. The technical specifications and concept of measurement is found in
the mentioned sources. The system comprises of 4 UniBEaM detectors (Fig. 4.13a)
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Figure 4.13: Single UniBEaM detector. The beam traverses horizontally through top
(open) pipe and fiber originates from bottom tubing. b) 4PrOBεaM detector system
installed at the Bern cyclotron [180].
To incorporate the system into the CCC beamline, several parameters needed to be
met, including: enough space (horizontally and vertically), suitable optics (visible beam
waist), positioned further downstream of the cyclotron, sufficient distance after a quadrupole
and preferably close to the start of the treatment line. Therefore, P1-P4 (Fig. 4.14a)
presented as the most suitable location and an experimental scheme was developed (Fig.
4.14 with equipment listed in C.6).




Figure 4.14: a) P1-P4 positions (red circle) along the beam pipe after the last
quadrupole triplet Q3. The left side of the photo leads onto the start of the treat-
ment room. b) Labelled diagram with dimensions of beamline and components.
c) Close up of bellow closest to Q3.
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Although temporary, the integration of any diagnostic devices requires destructive in-
terference with the beam pipe and components. For this system, beamtime over a few
days was required to allow for sufficient set-up, calibration and measurements. This pre-
sented significant difficulties as Clatterbridge operates a busy treatment schedule and
among other operational uncertainties, time and resource restrictions meant that this
experimental campaign was no longer feasible. Therefore, as an alternative approach to
this issue and moreover as a baseline check of the optics, a measurement of the trans-
verse beam profile at the beginning of the treatment line was performed with EBT3
GafchromicTM film.
4.4.2 Beam Profile Measurement
The start of the treatment line is indicated to begin at 16.15 m (Table 4.5), which is also
defined as the location of the beam source plane for particle tracking simulations. The
significance of this location is also associated with the close proximity to P1-P4, where
measurements performed here may also have additional uses secondary to the beam
optics by providing a direct determination of the beam profile. However, the closest
accessible location to non-destructively measure the beam is 36.3 cm downstream of
this point, where the beam exits the vacuum sealed scattering pipe (Fig. 4.15a) and
enters the treatment room. As such, EBT3 film was attached to the downstream face
of the kapton window and irradiated to obtain relevant information to resolve the beam
profile. A close up of the kapton window attached to the end of the scattering tube,
affixed film and obtained beam spot is shown in Fig. 4.15.
(a) (b)
108 Chapter 4. Clatterbridge Beam Dynamics
(c)
Figure 4.15: a) Scattering tube protruding from the wall separating the cyclotron
bunker. The beam exits the kapton window (orange hue) and enters into the treatment
room. b) Film setup. c) Beam spot on film after irradiation and self development.
The film was irradiated, calibrated and evaluated using the procedure described in Sec-
tion 3.4.2 to determine the transverse beam profile at the designated point (Fig. 4.15b).
Moreover, at this point the beam has passed through several components (two tungsten
scattering foils and a brass beam stopper, Fig. 3.3) which alter the shape and spread
of the beam. This is observed in Fig. 4.15c) by the distinctive void in the central area
of the beam spot, as intended by the delivery system design [110, 111]. Primarily due
to the presence of the brass stopper, the proton fluence here is substantially reduced
such that the beam distribution will be flat and uniform at isocentre (70 mm after the
end of the treatment nozzle). As the beam here has a modified shape and distribution,
the optics calculations alone are insufficient to determine the corresponding size of the
beam. Therefore, particle tracking simulations were necessary to reverse engineer the
expected input beam size at the designated start point of the treatment beamline.
GEANT4 Simulation
Simulations were performed using the GEANT4 beamline model described in Chapter
3.3, where outcomes of this beam dynamics study contribute to efforts to verify and
validate this and other related models of the Clatterbridge facility. As discussed, several
beam parameters must be inferred, thus the input particle source used for the simula-
tion (at the source plane) was defined from known beam quantities and those derived
from beam dynamics calculations (Tables 3.1, 4.5). A beam of 100 million primary pro-
tons was generated and tracked at the same position as the film. The particle fluence
Chapter 4. Clatterbridge Beam Dynamics 109
distribution was scored in the x and y directions and plotted against position in each
plane, representing corresponding beam profiles. These were compared to the transverse
profiles obtained from film measurements (Fig. 4.16).
(a)
(b)
Figure 4.16: Transverse beam distributions in the a) X and b) Y direction. Film
measurements (blue) are normalised to maximum doses obtained by conversion from
optical density by standard irradiation calibration protocol. Simulated profiles (red)
have been normalised to maximum doses for comparison.
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In order to directly compare the two methods, plots were normalised to maximum values.
As the film was also found to have a slight tilt in the positive x direction, an adapted
normalisation factor was applied to adjust for the non-uniformity. Furthermore, at this
location the dose is a relative value (correlated to ion chamber further downstream) and
the beam current would also be similarly approximated. As the fluence is dependent
on the beam current but directly proportional to dose, the simulated results were also
normalised to maximum dose and plotted according to position along the axis.
In Fig. 4.16, the profiles follow a similar distribution however the film plots have
a larger penumbra for both cases, with slight deviation in the central aperture regions.
This is partly attributed to the process of conversion from net OD, where higher un-
certainties were associated with smaller dose or net OD values. Furthermore, the expo-
nential nature of the calibration curve mean that at this lower end, marginal variations
in ODs may result in augmented doses. Additional scatter and interactions within the
multiple layers of the EBT3 gafchromic film contribute to the lower dose tails and dis-
agreement here also originates from differences with the scattering system geometry.
These simulations were run with the preliminary GEANT4 model and precise revisions
of the collimation geometry and specifications of the film were not yet implemented.
This was corrected in later work and better similarity was achieved, as reported in [171].
Good agreement between the simulation and experimental profiles is observed at the
highest regions of dose. While testing the model with different input source parameters,
it was also noted that the beam distribution remained mostly unchanged except for the
extent and elevation of the centre dip. However, as all factors influence the beam shape,
it was unclear which (beam size, angular spread etc.) had the most significant effect.
The differences between the two graphs are also evident of this, as the brass stopper has
the same radius and extrusion in either direction but there is less attenuation in y. Both
the beam size and emittance are smaller in y, indicating less spread, a slightly smaller
beam width and less reduction to the apex.
Nonetheless, the agreement between these distributions suggests the applicability of
the optical study derived parameters to simulate a physically similar beam. It is clear
that at this point the beam divergence and distribution are influenced by the input beam
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parameters. These results yield initial coherence with actual measurements which can
be further validated with experimental beam emittance and profile measurements.
4.4.3 BDSIM
The optical lattice was also defined in BDSIM to look at other aspects of the beamline
and for inclusion into a complete end-to-end model. Based on several codes, BDSIM
also utilises the GEANT4 toolkit to simulate the beam distribution, transport, particle
losses and has the capability of building detailed 3D geometries.
The lattice is defined in similar syntax to MAD-X; developers have provided several
python utilities to ease the conversion process, usage between different codes and also
to analyse results [183]. The necessary information describing the beam and lattice is
split into several .gmad text files where a single file is executed to run the simulation.
The main CCC lattice files are listed in Appendices B.18-B.19. Outputs from BDSIM
can also be visualised and analysed using the provided tools in ROOT and python.
For the scope of this study and specific applicability for the facility, BDSIM was used
to benchmark the MAD-X beta functions (Fig. 4.17) and analyse the beam transmission
(Fig. 4.18) for lattice optimisation. The beam distribution (Fig. 4.19) at the beginning
of the transport line was also visualised in the code.
Figure 4.17: Comparison of Beta function plots between MAD-X (solid line) and BD-
SIM (markers) in the x and y direction for 10,000 primaries.
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Although the optical functions are calculated differently, BDSIM was found to be con-
sistent with MAD-X as both codes are observed to agree well (Fig. 4.17). As discussed
before, BDSIM was also used to optimise the lattice by calculating the transmission.
The optimised transmission from the extraction point of the cyclotron to the end of the
treatment line is shown in Fig. 4.18.
Figure 4.18: Particle losses across the beamline for 10,000 simulated primaries.
Fig. 4.18 shows a transmission of 92% from the exit of the cyclotron to the end of the
treatment line. This suggests that minimum beam losses of 8% are expected with this
optical lattice arrangement and nominal parameters. Large numbers of particles are
lost after the SWM as the growth in dispersion here causes an increase in the beam
σx. Significant losses occur where there is high dispersion, as seen at points of entry to
Q2 and Q3. Once the beamline and quadrupoles have been characterised, it could be
possible to improve the actual transmission efficiency.
Low losses across the transport line are ideal because once the beam enters the
treatment line, transmission dramatically reduces to a few percent. This is caused by
beam traversal through multiple components in the delivery system or gantry to shape
and correct the beam as dependent on the needs for treatment. The scattering system
and shaping components collimate and modify the distribution to such an extent that
the beam delivered for treatment will remain consistently within specified constraints.
As a consequence, at this point the uncertainties associated with the optical model and
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its representation of the actual treatment beam and quality achieved at isocentre, has
a limited and unforeseen impact. Nonetheless, the resulting aim is to determine the
distribution and size of the beam as a basis for beam parameters at the start of this
treatment line.
End-to-End Model
BDSIM can be used to visualise and determine the beam size at any given point through-
out the beamline which is useful for beam characterisation (Fig. 4.19).
(a)
(b)
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(c)
Figure 4.19: a) Beam distribution at the exit of the cyclotron in the transverse plane.
Phase space ellipses in the b) x and c) y direction.
Figure 4.20: CCC transport line modelled in BDSIM displaying trajectories of protons
(blue) and secondary particles (green). Beam goes from left to right, through Q1 to
the SWM to Q2 and Q3.
The code has the capacity to import detailed geometry and as an additional capability
of the model, realistic Computer Aided Design (CAD) models of the treatment beamline
were imported (discussed later in Chapter 5.2.2) to achieve a complete end-to-end model
of the Clatterbridge beamline. The complete geometry was implemented as an individual
element in the components file. Several other aspects of the facility are able to be
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studied and the beam can be simulated anywhere from the extraction point of the
cyclotron all the way to the clinical nozzle (Fig. 4.21). This is an interesting concept
as complete models are uncommon; typically the accelerator and treatment line are
individually built as these areas of study do not overlap. BDSIM is a flexible code where
further developments for medical applications are anticipated. A potential avenue for
this would be to generate these beam distributions as an output file for incorporation
into simulations of the particle beam source for the treatment delivery line.
Figure 4.21: Complete end-to-end beamline model visualised in BDSIM with close up
of treatment line geometry. Beam originates from the right. The different components
are denoted: beam pipe (red), modulation box (blue), dosimetry box (green).
4.5 Summary
As a step toward the full characterisation of the Clatterbridge Cancer Centre proton
therapy beamline, a detailed overview of transverse beam optics has been described
in this chapter. Following the changes over the years, this chapter provides the first
comprehensive overview of the beam dynamics of the CCC facility.
Treatment requirements and present day conditions of the facility and transport
line provided constraints to define a model of the beamline simulated in both MAD-
X and BDSIM. All existing beamline information was reviewed and the quadrupole
parametrisation, simulated optical functions, RMS transverse beam sizes and transmis-
sion efficiency was investigated. The developed optical lattice can be modified to match
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arbitrary parameters but given discussed limitations, an optimised case was studied.
The resulting optimised quadrupole and beam parameters are summarised in Table 4.6.
Input beam parameters derived from optics calculations were used in GEANT4 sim-
ulations to generate beam profiles and these simulated beam distributions were checked
against EBT3 Gafchromic film measurements. Similarities suggest the applicability of
utilising parameters as determined from the developed optical lattice. It is expected
that the model can be improved further with experimental measurements. An addi-
tional end-to-end model of the beamline was developed in BDSIM and can also be used
for future studies.
Table 4.6: Summary table of optimised quadrupole settings and determined beam
parameters for the start of the treatment line.
Parameter Value
Quadrupoles Q11 3.58
















In previous chapters, different computational and experimental approaches were demon-
strated to model the facility in several simulation codes as accurately as possible. In
order to completely characterise the CCC facility, this chapter details a successive model
of the CCC treatment line resulting from the work discussed in Chapters 3 and 4.
As mentioned in Chapter 1, CCC is part of the quickly growing PBT community
in the United Kingdom and therefore it is highly valuable to have a publicly accessible,
comprehensive and validated simulation model of the facility. For this purpose, an im-
proved version was created using the Tool for Particle Simulation (TOPAS) [184] code
to extend the model for user ease, added capabilities and radiobiological applications.
This chapter describes a simulation of the CCC treatment line built in TOPAS and
the improvements and developments from the previous GEANT4 model. As this code
facilitates work into radiobiologically relevant quantities, studies into LET and further
applications were explored. Experimental measurements to benchmark the model with
a MiniPIX-Timepix detector are also detailed.
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5.1 Introduction to TOPAS
TOPAS is a Monte Carlo code extended from the GEANT4 toolkit and was developed
as a simulation platform specifically for research and clinical use in PBT. It was created
as a means to exploit the capabilities of GEANT4 without needing proficiency with
C++; to promote the ease of use of Monte Carlo simulations in medical physics research
and in the clinic. As Monte Carlo techniques are becoming more prevalent in clinical
environments, the tool enables users with ranging levels of experience and knowledge to
utilise the code. The CCC beamline was redeveloped in TOPAS to take advantage of
this, in addition to its other functions such as the TOPAS-nBIO extension [185]. This
allows simulation modelling at the biological scale: radiobiological effects from individual
and low energy interactions at the sub-cellular level, mechanistic DNA repair kinetics
and chemical responses with geometry of specialised cellular components. The code
also enables a platform for future biological work at the facility. At present, the TOPAS
model provides relevance for cell studies with the North West Cancer Research (NWCR)
centre and for further radiobiological and biophysical modelling with the Department of
Oncology, University of Oxford.
For the work covered within the scope of this thesis, the context of dose and im-
plications in treatment are considered through modelling of the LET. The significance
of this parameter is that it is a physical and measurable quantity of energy deposition
and can be related to radiobiological effects. The architecture and various functions
of the TOPAS code are described next, as relevant to the CCC model, however full
documentation of the code can be accessed from [186].
5.2 Simulation Environment
While the GEANT4 environment is governed by source code written in C++ to initialise
and specify parameters in user action classes, TOPAS operates much differently. TOPAS
still takes advantage of the extensive capabilities of GEANT4 such as incorporating its
libraries, materials and physics lists, however employs a more modular framework to
assemble and execute a simulation. This provides a more user friendly system while
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ensuring sufficient flexibility for advanced users who also have the option of hard coding
new classes or amending the TOPAS base classes, similar to GEANT4.
Instead of executing applications based on macro files, TOPAS uses a parameter sys-
tem to firstly check and prevent errors, seeking reliability and repeatability in avoidance
of dependency and other issues commonly encountered with GEANT4. Furthermore,
lines of code do not need to be in a particular sequence as TOPAS does not enforce
strict order dependence.
Parameter Control System
Parameter files must be written and read in plain text format and their functions are
specified given the following command structure:
1 Parameter_Type : Parameter_Name = Parameter_Value
The Parameter Type is the declared object type: string (s), integer (i), boolean (b), unit-
less double (u), dimensioned double (d) or a type of vector i.e. integer vector (iv). The
Parameter Name is a sequence of a prefix related to functionality (i.e. Ge: Geometry),
the object name and property:
1 Parameter_Name = Ge/Phantom/Material
The Parameter Value will be expressed according to object type and if appropriate,
must also be followed by the unit. Settings can also be specified with respect to other
parameters however acceptable boolean operations are limited (line 4). Some examples
of different parameter lines:
1 d:Ge/Phantom/HLX = 40. mm
2 b:Sc/DoseScorer/Active = "True"
3 sv:Ph/Default/Modules = 1 "g4em-standard_opt0"
4 d:Ge/RoomWall/HLX= Ge/DeliveryBLineBox/HLX - 0.5 mm
These prefixes are one instance where the predefined vocabulary and syntax provided
by TOPAS allows uncomplicated user specification. These enable different things to be
controlled with a single line command, including options controlling the physics (Ph),
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scoring (Sc) particle source (So), material (Ma) and graphics (Gr). This is not the full
list but are the most commonly used; several more prefixes are mentioned in this chapter
and their functionality will become apparent.
File Chain Structure
As more complicated applications require hundreds of parameter lines, it is logical to
split up the code into several parameter files. A file will inherit and execute all lines
from other files which are called by the following statement:
1 includeFile = anotherParameterFile.txt
It can be useful to also call another file from within the secondary parameter file where
it then becomes a parameter file chain. This allows the application to be organised and
managed as essentially separate modules: a supportive feature for collaborative work
or developing different aspects of a simulation model. Parameter file chains can span
horizontally as well as vertically, however the hierarchy structure must be considered
as the order is important in this case. Parameter lines higher up in the chain will take
precedence over the same commands further down. Moreover, to handle all the different
parameters, TOPAS does not allow settings belonging to the same object to be changed
in a separate chain. Two different files are not able to modify the same parameter.
Similarly, all components which are given the same geometry or the same scorer must
be contained in the same vertical chain.
Fundamentally, the main or default parameters should be defined in the initial file
and then everything else that utilises these conditions should be written into adjoin-
ing files. A mostly linear hierarchical structure was adopted for the CCC model with
interchangeable files for the scoring and this is illustrated in the diagram in Fig. 5.1.
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Figure 5.1: Parameter file chain. The initiating Run file is shown at the highest
position, through a single chain to the multiple parameter files, responsible for the
scoring.
Some of these have files been included in the Appendix (B.20-B.21) for reference and
several important parameter files are discussed in the following sections. The full source
code has been made available on [153]. Ongoing developments will be updated and
documented as it is hosted on the GitHub repository and can be accessed from [187].
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5.2.1 Particle Source
The particle source is defined in TOPAS by specifying various parameters of the beam
such as the particle type, energy, shape, size, distribution and angular spread. By
default, the beam is placed at the centre of the world volume. This ensures that the
particle source is positioned at the origin of each axis. In TOPAS, each generated
primary particle is termed as a history.
The CCC beam is defined in a parameter file (Appendix B.21) as a Gaussian beam
and as a second option, a more realistic beam is described by Twiss parameters (sum-
marised in Table 4.6). Both of these approaches correspond to the optical beam proper-
ties determined at the mentioned start of the treatment line ‘source plane’ in Chapter 4.
This is the point of overlap between the two models and for the rest of this chapter, will
be referred to the starting point of the simulation; all the following TOPAS parameters
will also be detailed as specifically implemented within the CCC model.
For clarity, a purple box was created to visualise the source plane and placed equiv-
alent to the particle source position (Fig. 5.2).
Figure 5.2: Particle beam origin at source plane. A beam of a small number of protons
(cyan) is shown traversing through the beginning of the vacuum tube and the first
scattering foil (gold), neutrons (yellow) are also visible.
The position of the source and the ‘PlaneAtBeamPosition’ box are both defined as
geometry components. Similar to GEANT4, geometries must be specified in relation
to their mother volume and overlaps must be avoided as they cause errors which often
break and stop the execution of the simulation.
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5.2.2 Geometry
In general, TOPAS geometry can be described in different ways: essentially the dimen-
sions and position must be specified with respect to the centre of their parent volume.
The component name is included in each line with the stated type (shape), parent vol-
ume and material. Translational and rotational X, Y, Z parameters are assigned for
positioning of the component within its mother in x, y and z. The orientation how-
ever will depend on the type of component and additional parameters may be required.
Furthermore, the size (length) of the component is defined as a half length in the 3
orthogonal axes. A box symbolising the ‘Room’ component: the CCC treatment room,
is defined with the following lines:
1 s:Ge/Room/Parent = "World"
2 s:Ge/Room/Type = "TsBox"
3 s:Ge/Room/Material = "Air"
4 d:Ge/Room/HLX = 4. m
5 d:Ge/Room/HLY = 2. m
6 d:Ge/Room/HLZ = 5. m
7 d:Ge/Room/TransX = 0. m
8 d:Ge/Room/TransY = 0. m
9 d:Ge/Room/TransZ = 0. m
In GEANT4 these properties also define the component geometry but require multiple
lines to construct the conceptual volume layers. Evidently, it is much easier to define
objects using the TOPAS parameter syntax.
A collection of predefined generic components also exists and users can implement
these individually or as a combination of components. Additionally, there is a TsCAD
import feature which enables the conversion of any geometry created using CAD soft-
ware into TOPAS geometry from Stereolithography binary (STL) or Polygon ASCII
format (PLY) format. In order to preserve precise details of the treatment line system,
the majority of the components were imported as STL files using this method. The
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remaining components needed to be individually user defined. They were unable to be
correctly imported and presented issues or difficulties due to the nature of their shapes.
STL files describe geometry only by their surfaces, a tessellation of triangular and
quadrangular faces which approximate the volume. Although other file formats (i.e.
GDML) may intrinsically include different properties such as materials or colour at-
tributes, TOPAS does not interpret this information.
Therefore, given some missing elements and discrepancies which were noticed in
the GEANT4 model (see Section 3.4.3), each component in the treatment line was
physically remeasured within ±0.5 mm precision. Photos and schematics from this
effort are extensively documented on the UCL website [173]. Following this, most of
the components were implemented as a CAD design in GDML and STEP format‡ (Fig.
5.3). This same model was also previously imported into BDSIM (see Section 4.4.3) but
in this case the entire treatment line could be imported into BDSIM as a single entity.
A GDML format was used and thus the material of each component could be preserved.
CAD Model
Figure 5.3: CAD rendering of the CCC treatment line with updated geometry following
the rechecking of physical measurements.
As TOPAS does not offer such capabilities, each component (with their elements grouped
by material) needed to be exported from the model as an individual STL file. This was
a rigorous task as each component could have been created with its own respective
axis within the world coordinate system, which is retained during export. TOPAS does
not automatically determine this origin point and therefore may randomly place the
‡Provided by O Mayenin, 2019.
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imported component either at the centre or the edge of the mother volume. As such,
this meant there were several coordinate systems at play and final adjustments required
additional rotation or translation using parameter lines. These were also checked against
a list of z positions determined for every single element as relative to the treatment line
coordinate system (Appendix C.7).
The CAD model (Fig. 5.3) was accessed using Autodesk Fusion 360 [188] and sev-
eral more amendments were made in order to successfully import the components. As
TOPAS does not allow overlaps, clearances were built between each adjacent surface
to provide a 0.05 mm tolerance between each component. Several other modifications
were also made to the original CAD design to improve the model and bring it closer to
reality. The first aluminium (scattering) tube was extended to exceed the kapton win-
dow. The tungsten cross-wires in the dosimetry box were positioned more accurately.
The dose monitors were reworked such that all of the pieces could be imported. Slightly
larger clearances were needed between pieces; similar parts were grouped (bolts, foils,
guard ring, PMMA exterior) and exported as separate STL files. These updates and all
corresponding dimensions are displayed in a complete schematic of the treatment line in
Appendix C.8.
CCC Treatment Beamline
The CCC treatment line is described in TOPAS realistically, as based on the exact ge-
ometrical measurements of each component. The entire delivery system is represented
in Fig. 5.4. This starts with the vacuum tube containing the double scattering foils,
through the modulation and dosimetry box and past the patient nozzle. All the simu-
lated components are shown in Appendices B.34-B.38.
(a)
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(b)
Figure 5.4: a) CCC treatment beamline model in TOPAS. b) Birds eye view with major
components labelled.
Time modulation features in TOPAS also enable a SOBP to be generated based on a
specified rotational rate, steps, repetition intervals and timeline. Additionally, schemat-
ics were obtained and used to model the components which were not able to be physically
measured (i.e. dose monitors). These can be found with numerous photos of every com-
ponent on [173].
5.2.3 Scoring
TOPAS scores particles using two main scoring classes: volume and surface scorers.
Several preset scoring types are provided and enable scoring for certain quantities; these
must be called upon as a Parameter Value. There are also other extended scorers avail-
able including an RBE scorer and it is also possible for users to write their own.
Quantities such as the dose, energy deposition, fluence, charge and LET can be
determined for different components and materials. There are more scoring options for
volumes and often the same information can be obtained (although may be output in a
different form) by using different scorers with the appropriate settings or filters.
To score the dose deposition and generate a BP, a 40 × 40 × 40 mm3 water phantom
was created (Appendix B.38) at isocentre. Scored quantities are contingent on the
geometry of the applicable component and the resolution is designated by the number
of bins in the respective axis (lines 10-12):
1 s:Ge/Phantom/Type = "TsBox"
2 s:Ge/Phantom/Parent = "DeliveryBLineBox"
3 s:Ge/Phantom/Material = "G4_WATER"
4 d:Ge/Phantom/HLX = 20.0 mm
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5 d:Ge/Phantom/HLY = 20.0 mm
6 d:Ge/Phantom/HLZ = 20.0 mm
7 d:Ge/Phantom/TransZ = 1863.4 mm
8 s:Ge/Phantom/Color = "lightblue"
9 s:Ge/Phantom/DrawingStyle = "Wireframe"
10 i:Ge/Phantom/XBins = 1
11 i:Ge/Phantom/YBins = 1
12 i:Ge/Phantom/ZBins = 400
A volume scorer was used to obtain the dose accumulated in each 0.1 mm slice of the
water cube:
1 s:Sc/DoseInPhantom/Quantity = "DoseToMedium"
2 s:Sc/DoseInPhantom/Component = "Phantom"
3 s:Sc/DoseInPhantom/OutputFile = "Data/DoseInPhantom"
4 s:Sc/DoseInPhantom/OutputType = "csv"
5 b:Sc/DoseInPhantom/OutputToConsole = "False"
6 s:Sc/DoseInPhantom/IfOutputFileAlreadyExists = "Overwrite"
7 s:Sc/DoseInPhantom/Visualize = "TRUE"
The LET could be determined using the prebuilt ‘ProtonLET ’ scorer, weighted by either
the average dose or track (line 3). TOPAS implements the approach developed by [189];
the energy deposition from both primary, secondary protons and electrons are taken
over each step.
1 s:Sc/LETScorer/Quantity = "ProtonLET"
2 s:Sc/LETScorer/Component = "Phantom"
3 s:Sc/LETScorer/WeightBy = "Dose"
4 d:Sc/LETScorer/MaxScoredLET = 100 MeV/mm/(g/cm3)
5 d:Sc/LETScorer/UseFluenceWeightedBelowDensity = 0. g/cm3
6 b:Sc/LETScorer/OutputToConsole = "False"
7 s:Sc/LETScorer/OutputFile = "Data/LET"
8 s:Sc/LETScorer/OutputType = "csv"
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9 s:Sc/LETScorer/IfOutputFileAlreadyExists = "Overwrite"
10 b:Sc/LETScorer/PreCalculateStoppingPowerRatios = "True"
Surface scorers were useful to quickly check that the simulation and scoring was function-
ing correctly. As such, these were assigned at key locations in each section as checkpoints
throughout the beamline. Quantities could be scored according to transmission (in any
direction) through a single surface and also as a phase space file. The phase space output
provides detailed information about particles at that exact plane, scoring for multiple
quantities including the position (in x, y, z ), divergence, energy, time and particle ID.
The other scoring and parameter files can be accessed from [187].
5.2.4 Physics Settings
The default physics processes in TOPAS correspond to a physics list used in an earlier
version of GEANT4 which has been validated for proton therapy research at MGH.
Although it is possible to create a whole new physics list, TOPAS provides two gen-
eral methods of customisation: reference and modular lists. The first option applies a
complete, preset GEANT4 list and the latter allows users to select different modules to
construct a list.
Parameter lines are used to specify the type of physics processes chosen and to
define cuts for different particles, energy thresholds and geometric ranges. As previously
discussed (see Chapter 3), the step size can be a consequential factor in tracking particles.
TOPAS tries to account for this automatically so that it doesn’t need to be initiated by
the user but can be changed if necessary.
A second set of QA Bragg peak measurements‡ were used to benchmark the model.
As this model implements the final revised geometry, several parameters were adjusted
to match the obtained BP with actual data. The lack of definitive and verified input
beam parameters (input energy, energy spread etc.) permitted this flexibility.
In order to match the simulated BP with the CCC BP, the most significant param-
eters are related to the beam energy. The energy spread mostly affects the shape of the
‡Provided by A Kacperek, 2019.
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peak however also influences the depth of the BP and the steepness of the fall-off. There-
fore, a balance between all these characteristics is necessary. A range of input settings
were tested to modify the BP to replicate the CCC BP curve. Moreover, physics models
which most appropriately represent the data best must also be selected. The type of
physics lists and cuts also have a further impact on the BP, particularly in the build
up region: the dose here is mostly contributed by nuclear interactions and secondaries.
The differences between some chosen physics lists and options are shown with simulated
BPs in Fig. 5.5. In addition, the impact of these differences were assessed by scoring
LETd (Appendix B.39) however, limited variation was observed.
Figure 5.5: Pristine BPs simulated using different physics options against CCC data.
After numerous iterations of these adaptations, the best match was achieved with the
following beam settings (Appendix B.21):
1 d:So/BeamSource/BeamEnergy = 62.2 MeV
2 u:So/BeamSource/BeamEnergySpread = 0.53
3 sv:Ph/Default/Modules = 2 "g4em-standard_opt3" "g4h-phy_QGSP_BIC_HP"
4 d:Ph/Default/CutForElectron = 0.01 mm
5 d:Ph/Default/CutForProton = 0.01 mm
6 d:Ph/Default/CutForGamma = 0.1 mm
7 d:Ph/Default/CutForPositron = 0.1 mm
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Notably, the complexity of the chosen physics lists and the size of the cuts have varying
computational demands. All the simulations were tested and executed on a single, quad
core computer. As a consequence, a compromise between the combination of these
settings were necessary: the number of modules and cuts were limited to those shown
(lines 3-7).
5.3 Results
Simulations were run using TOPAS 3.2.p1 with a beam of 10 million protons and scored
across the length of the water phantom to obtain a proton depth dose profile and corre-
sponding LETd values. The nozzle collimator and cap were removed in order to attain
a pristine BP (Fig. 5.6). A phase space scorer was placed after the nozzle to determine
the number of particles and the total transmission was found to be ∼5%.
Figure 5.6: TOPAS visualisation of dose deposition in the phantom. Only protons
(cyan) and neutrons (yellow) are visible.
5.3.1 Simulated CCC Dose Profile
The dose deposition was normalised to the maximum dose as the beam parameters for
the QA measurement were not clear. The simulated BP and LETd is compared against
the measured CCC BP in Fig. 5.7.
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Figure 5.7: Simulated CCC BP and LETd in water.
The maximum dose is observed at a depth of 30.59 mm for CCC and 30.50 mm with
TOPAS. There is a slight margin of difference here as the CCC data was measured in
graduations of 0.175 mm in depth. The entrance region agrees well however an under
dose at the base of the BP is observed. Instead, the additional dose is displaced to
the edge of the fall-off region where the simulated data is not as steep. These are
both influenced by the shape of the peak, indicating minor differences in the energy
characteristics of the input beam.
5.3.2 Transverse Beam Profiles
As discussed in Section 3.4, the distributions of the beam in transverse plane can illus-
trate the accuracy of the simulation model. Multiple pieces of EBT3 film were defined
in the model (Fig. 5.8) with an area large enough to reproduce the majority of the beam
distribution. The dose deposition was scored in 0.1 mm slices across the transverse x
plane within a 28 µm sensitive (lucite) layer. Given the previously mentioned uncer-
tainties with the beam current and computational limitations, 10 million primaries were
simulated and normalised to the maximum dose for each film.
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Figure 5.8: Eight pieces of EBT3 film (red) simulated in TOPAS to obtain transverse
beam profiles in x.
The same film comparisons as Section 3.4.3 were made to examine the transverse beam
distributions in the x plane at the eight locations (Fig. 3.16). Additional scaling and
correction factors were applied to correct for the asymmetries and non-uniformities seen
with the film. Comparative plots are included in Appendix B.24 and similarly, quan-
titative differences between the film and simulated beam profile FWHMs are shown in
Table 5.1.
Table 5.1: Film and TOPAS simulated FWHM comparisons.
# Film [mm] Simulation [mm] Difference [mm] Difference [%]
1 12.05 10.40 -1.65 -13.66
2 14.05 14.20 0.15 1.03
3 22.86 23.20 0.34 1.49
6 29.73 30.80 1.07 3.61
4 37.42 40.80 3.38 9.02
8 43.49 53.20 9.71 22.34
5 51.45 63.60 12.15 23.62
7 43.45 38.20 -5.25 -12.09
The transverse profiles obtained with TOPAS have an improved agreement over GEANT4
and this is seen in the first 4 plots (Appendices B.24a-B.24d). The later positions have
noisier data points (limited statistical number of particles) as the beam transmission
decreases and as a result, each plot shows the simulated hits with a fitted curve to il-
lustrate the general trend. Inconsistencies between the distributions are visible starting
from film 4 (Appendix B.24e). From this location onward, the deviations between the
simulated and film profiles start to propagate. At the next position (Appendix B.24f),
the simulation still shows a dip in the central axis even after traversing through both
the multi-layered dose monitors. The effect of this results in further scatter particularly
along the higher dose regions and continues onto isocentre.
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In contrast, this does not show up on the film, which has a rounded profile and
is ∼22 mm smaller than the simulated FWHM. After passing through the tungsten
cross-wires, a notch in the centre is present in the film which is inconsequential in the
simulation. The beam then passes through the 43 mm collimator where it appears to
converge at isocentre (Appendix B.24h). These deviations indicate that: inaccuracies
in the simulation become magnified further downstream; the film measurements are
susceptible to beamline variations and experimental conditions; dissimilarities with the
beam distributions after the integration zone are related to the model.
The observed agreement at the beginning of the treatment line suggests that the
input beam source parameters are applicable to a certain extent. However, this changes
dramatically after the integration zone. As discussed in Section 3.3.4, variations in the
parameters which describe the source will impact the beam distributions downstream;
these are potentially magnified with the propagation distance as the beam is free to move
through the air uninterrupted until it passes through the dose monitors. After this, the
simulations register minimal effect and profiles still show the central dip from the beam
stopper. On the other hand, the film shows a rounded profile with maximum dose
centrally and a much smaller FWHM. This suggests that in reality, the dose monitors
actually do have a more significant effect on the beam which hasn’t been sufficiently
modelled in the simulation. The differences in the shape at these downstream locations
may also allude to differences in the geometry of the beamline at this point; the dosimetry
box was enclosed and therefore access was physically restricted. Moreover, the dose
monitors themselves are also difficult to model as they were developed at CCC and
contain multiple layers and components.
A uniform and flat beam profile is expected at the isocentre however this was not
obtained with the film or simulations: the slight decrease in the centre indicates that
the quality on the day was not ideal. Uncertainties with this batch of film and analysis
have been previously detailed in Section 3.4.3. Aberrations can be augmented especially
at the points of high dose and the sensitivity of the film is exhibited after the cross-
wires (Appendix B.24g). Additionally, at this point the large spread means the beam
undergoes considerable collimation before it exits the nozzle and consequently, is still
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converging at the isocentre. Some of these discrepancies may decrease with higher statis-
tics by simulating much larger numbers of primaries and certainly also with verification
measurements (see Section 4.4.1).
Nevertheless, it is inferred that these identified issues do not have any considerable
significance on the resulting dose distribution: it is offset by the low beam transmission
and prevalence of particles at the central axis. It is also very much dependent on the
measured and on the day performance. However, in practice these beam deviations
would be negated by clinical requirements and QA practices. As the simulation model
has been matched to the CCC dose profile, simulated LET quantities achieved with the
model were further examined.
5.4 Linear Energy Transfer
The LET is macroscopic quantity and is similar to the stopping power (Eqns. 2.1 and
2.2) however instead of the mean energy loss, it describes the energy deposited (dE ) by





LET is synonymous with the restricted linear electronic stopping power as the energy
deposited by the incident particle may produce secondary scattered electrons; these form
individual tracks and carry sufficient energy for subsequent ionisations to occur further
from the primary path. The restriction in this case refers to an omission of energy
contributions from liberated electrons which have a greater initial kinetic energy than a
specified threshold (i.e. 100 eV) [49]. This limits it to the local energy absorbed within
the medium and is defined in terms of the energy rather than as a range cut-off.
LET is often used to describe the radiation quality of different RT modalities. It
is a function of particle type where charged and heavier particles possess higher val-
ues resulting in a better possibility of inducing detrimental effects at a cellular level.
Qualitative radiobiological differences in track structure and the lethality of lesions have
been shown as related to the repair, fractionation, dose-rate and chemical modifiability
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[190]. As dose is delivered primarily by the interaction of primary particles with elec-
trons, a larger LET arises from a greater number of interaction events across the same
path length. The increase in direct ionisation events and the concentration of interaction
sites translates to significant damage to the cell nucleus: the enhanced relative biological
effect seen in CPT.
In general, cell damage occurs due to direct or indirect action by single (SSB) or
double strand breaks (DSB) within the double helical DNA structure. Single radiation
tracks may induce SSBs which occur sparsely and can be easily repaired. In contrast,
DSBs have a much lower possibility of repair due to the increased complexity, cluster-
ing and prevalence of errors during the repair process. The pattern and occurrence of
these events is dependent on the LET: higher LET has been demonstrated experimen-
tally to correlate to greater cell damage as the dense ionisations clusters are distributed
inhomogeneously, causing multiple breaks which are more difficult to repair [21, 190].
For CPT and as also shown in Fig. 5.7, the LET remains relatively constant along
the path of the particle towards the end of its range before increasing rapidly to a
maximum and extending past the terminal end of the BP fall-off. The higher LET
values associated with particle beams represent the radiobiological impact of the BP
and possibility to achieve better treatment outcomes with PBT. However, LET is a
quantity indicative of the track structure and the physical energy deposition: there are
many complexities in defining a casual relationship with the biology and RBE effects
[20, 191]. These are not discussed in this thesis however there are extensive studies
which model the radiobiological effects for clinical applications of LET [192–196].
As such, several definitions of LET exist in order to adequately calculate and score
the quantity either analytically or with MC methods [189, 197–202]. In practice, a
particle beam is not monoenergetic and therefore the LET is averaged for the weighted
dose contributions of individual particles. This is the dose-averaged LET (LETd) and
can include contributions from both primary and secondary particles. LETd is widely
considered as an indicator of biological effects and has been examined for use in TPS
[203]. As the LETd can be obtained by MC simulations with TOPAS, it also provides a
meaningful link to the radiobiological work performed at the CCC beamline.
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5.4.1 LET Studies and Radiobiological Applications
As mentioned in Chapter 3, the CCC beamline has been simulated several times. In
[204], a BP and SOBP was simulated under standard conditions at 6 positions to de-
termine the LET and examine the RBE dependency as relevant for radiobiological cell
studies (Table 5.2).
Table 5.2: LET values for studies performed in [204].
Positions Depth [mm] LET [keV/µm]
P1 1.69 1.11 ± 0.03
P2 28.21 4.02 ± 0.16
P3 29.28 7.0 ± 0.9
P4 29.76 11.9 ± 1.5
P5 30.24 18.0 ± 1.4
P6 30.72 22.6 ± 1.2
The scope of this work preceded what is currently being investigated with the beamline
by the NWCR group [205–208] and similarly, one objective of the TOPAS model is to
determine the LETd for relevance in these studies. For comparison, the LETd obtained
with the TOPAS model and differences with the previous study are listed in Table 5.3.
The uncertainty values are calculated based on interpolated deviations in depths.
Table 5.3: TOPAS simulated LETd at corresponding experimental study depths.
Depth [mm] LETd [keV/µm] Difference [keV/µm] (%)
1.70 2.34 ± 0.01 -1.23 (-111.82)
28.20 4.30 ± 0.01 -0.28 (-6.96)
29.30 6.14 ± 0.07 0.86 (12.29)
29.80 8.99 ± 0.28 2.91 (24.45)
30.20 12.13 ± 0.29 5.87 (32.61)
30.70 15.71 ± 0.12 6.89 (30.49)
The earlier work by [204] utilised a GEANT4 model which was based on the Hadronther-
apy example [209] and adapted for the CCC beamline. The model was checked against
ionisation and film measurements; the only major modification involved implementing
the CCC modulation wheel specifications. The simulations were run with an input pro-
ton beam energy of 62 MeV and 0.3 MeV sigma. LET values were scored within a water
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phantom using a standard approach (energy deposited in each step as a ratio of the step
length) to determine the dose-weighted LET in each voxel†. This quantity is equivalent
to the LETd however values here are referred to as LET.
As this was essentially a different model with generic geometry and different beam
parameters, it is reasonable that the obtained LET values would differ. On face value
there is good similarity with the study’s simulated LET and BP curve: LET values are
within expected ranges (maximum at 25 keV/µm). However, at the small increments
where the LET increases quickly (P3-P6 ≈ 29.30-30.70 mm), the deviation is clear as
the positioning of the BP differs. It is also noted that TOPAS scores the LET using a
more rigorous method: this would also result in differences to the achieved LET curve.
In Fig. 5.7 the BP falls off sharply and the dose is shown to drop back to 0 keV/µm
at approximately 33.20 mm. After this point the LET (red markers) are inferred to be
spurious due to low statistics but are included for completeness. Physically, negligible
energy transfer would occur past this point and these points are thought to be a by-
product of the simulation: presumably these would diminish if simulations were run
with larger numbers of primaries.
Experiments to measure the LET spectra were pursued to provide an empirical value
of the physical energy deposition as the TOPAS model can also determine the antici-
pated and corresponding LET values under the experimental conditions. However, these
do not provide any information about the induced biological or chemical responses re-
sulting in the measured biological outcomes or endpoints. In compliment, the NWCR
group investigates the impact of proton irradiation under different LET conditions, as-
sessing the DNA damage and repair mechanisms of different cell lines. Furthermore, by
analysing the energy spectra and deposition, it is possible to establish relevance in this
direction. This also facilitates further collaborative work to model DSB induction and
damage as biological factors for application in treatment planning [210].
However, it is fundamentally difficult to measure the LET due to several performance
requirements which exceed typical capabilities of commonly used methods of detection.
†Personal communications, S McMahon, 2018.
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In particular, the position, charge and distribution of tracks deposited by individual par-
ticles must be able to be recorded rapidly and resolved with very high spatial resolution.
Given the previous experiments with Medipix3 (see Section 3.4.4), the MiniPIX-Timepix
imaging system‡ was identified as a suitable device for measurements.
5.5 Experimental Measurements
5.5.1 The MiniPIX-Timepix Detector
The Timepix chip [211] was developed at CERN, proceeding from developments made
by the Medipix Collaboration. Among other capabilities, the chip has a time-over-
threshold (TOT) feature which allows individual events to be counted independently in
each pixel according to their arrival times. The capacity of Timepix to measure LET
has been demonstrated in different radiation environments [212–217] and techniques for
application in ion beam therapy have been explored [218–221]. As such, this technology
was utilised for measurements at the CCC clinical proton beamline to determine the
LET and relevant quantities applicable for simulation studies and radiobiological work.
The MiniPIX-Timepix detector is a compact, hybrid semiconductor pixel detector
which has a Timepix chip with a 300 µm thick silicon sensor, 55 µm pixels and a 14 ×
14 mm2 active area (Fig. 5.9). This encompasses a 256 × 256 pixel array with 65,536
independent channels and readout via USB at up to 45 frames per second (FPS). An
approximately 1 mm aluminium slider covers the chip sensitive window [45].
Figure 5.9: a) Labelled illustration and b) photo of the Timepix chip. c) Miniaturised
MiniPIX-Timepix detector system [45].
‡Provided by collaborator Advacam s.r.o, Czech Republic.
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5.5.2 Detector Setup
In order to securely support and rotate the detector, a 3D printed case was designed
and built for attachment to a remotely controlled, motorised rotating stand (Fig. 5.10).
Figure 5.10: The MiniPIX-Timepix detector casing (blue), the centre of the chip is
positioned at the the origin of the rotational axis. The stand is affixed to a metal plate
and was clamped into position to the upper fixtures of the treatment chair.
At CCC, typical treatment beam settings achieve flux rates of up to 1010 protons/s how-
ever MiniPIX operates optimally within a range in the orders of 103-104 protons/s/cm2
and an upper limit of ∼106 protons/s/cm2. As several beam current related challenges
were encountered during the Medipix3 measurements (see Chapter 3), the beam current
needed to be heavily reduced to prevent damage to the sensor. As it was uncertain if
this could be done reliably with the cyclotron, preliminary simulations were necessary
to gauge an alternative approach.
As seen previously, the lowest approximate beam current achieved at CCC was 0.012
nA, corresponding to ∼7.5 × 107 protons/s. The beam current (event/s) detected by
Medipix3 was used to calculate the fluence specifically for the MiniPIX sensor area at
each current (Table 5.4).
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Table 5.4: Estimated proton fluence rates for MiniPIX at CCC
Current [nA] Fluence [Protons/s/cm2]
0.012 3.82 × 107
0.052 1.66 × 108
0.350 1.11 × 109
0.690 2.20 × 109
1.350 4.30 × 109
1.970 6.27 × 109
Therefore a reduction by an order of at least 103 protons/s is necessary. As simula-
tion results were demonstrated to trend linearly based on the number of primaries (see
Chapter 3), various conditions were simulated with up to 200,000 initial protons. Some
common solutions include using a target, filter or mesh placed between the beam and
sensor. In this case, secondaries produced with the high intensity beam are detected.
An alternative method is to directly reduce the flux by decreasing the beam transmis-
sion and hence the number of protons which reach the detector. This could be done by
restricting the passage of the beam with small apertured collimators and metal (high
Z material) shielding to limit the particle transmission. The different methods were
simulated at an arbitrary distance of 30 cm after the nozzle, based on equipment which
could be sourced for the experiment given short notice. The lead disc was found to be
most effective and the calculated decreases to the beam fluence are listed below in Table
5.5.
Table 5.5: Relative reductions in beam transmission using different filters. The trans-








None 1.58 × 106 92.98 7.02
Cu foil 1.26 × 106 80.15 19.85
(0.1 mm thick)
Steel grid 1.06 × 106 67.31 32.69
(0.4 mm diameter wires)
Steel grid 9.28 × 105 58.81 41.19
(1 mm diameter wires)
Pb disc 1.57 × 105 9.93 90.07
(2 mm thick, 250 µm pinhole)
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In addition, multiple solid water absorbers of varying thicknesses were implemented in
the simulation to determine the expected proton BP depths necessary to shift the peak
relative to the sensor location. This identified the approximate range of PMMA block
thicknesses needed to be able to measure along the BP. As the objective was to examine
the LET spectra, the LETd was also scored along the full range as an indication of
predicted measurements.
5.5.3 Beam Measurements
The MiniPIX system was placed roughly 16 cm from the patient collimator and firstly
aligned perpendicular to the propagation direction of the beam. The first few runs (# 0-
2) were performed using a 1 mm diameter nozzle brass collimator and a 2 mm thick sheet
of lead with a 200 µm diameter pinhole placed in front of the detector (Appendix B.40).
Adjustments were then made with the accelerator to reduce the flux by several orders
of magnitude to within the acceptable operational range (∼103-104) and to stabilise the
beam. Following this, the collimator was retained and the detector was rotated at an
angle of 45◦ to the beam. Data was firstly taken over different acquisition times to
select the appropriate settings before the different PMMA blocks were inserted directly
upstream of the sensor (Fig. 5.11).
Figure 5.11: The MiniPIX-Timepix system angled at 45◦ with a 24.4 mm PMMA block
to shift the pristine BP onto the sensor.
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Having a tilted plane with an incidence angle of >45◦ has been demonstrated [45] to
increase the track acceptance. Therefore, measurements were also performed with the
detector angled at 60◦ in the perpendicular plane. Additional measurements to acquire
levels of background radiation were also taken (B1-B4). Statistical data and a description
of each run for both angles is provided in Tables 5.6 and 5.7.













0 Yes 0 59.66 2623 550.30
118.68 4922 252.50
197.95 4915 656.00
1 Yes 24.40 99.80 79 86.74
2 Yes 20.10 58.44 147 167.40
3 No 24.40 58.44 2609 505.90
58.44 3445 581.10
4 No 25.48 58.44 2270 460.30
60.81 1682 433.20
5 No 26.40 58.44 179 203.90
6 No 25.87 58.44 569 288.70
58.44 569 294.30
7 No 20.10 68.07 7277 909.30
8 No 10.00 131.35 9440 693.90
B1 No 131.25 63 59.26
B2 No 95.26 48 56.60











0 25.48 39.70 86 126.40
58.44 344 259.20
90.28 294 201.10
1 24.40 58.44 5325 763.10
2 10.00 58.44 21610 1341.00
B3 43.56 21 55.46
B4 254.58 130 52.24
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Measurements were recorded in real time using the Advacam PIXET [222] software. An
initial digitisation test showed 0 dead pixels and a recommended bias of 30 V was applied
with a frame acquisition time of 10 ms. A visual check is sufficient to ensure that the
chosen frame rate is suitable (single tracks appear): if this is too short, the particles are
not able to deposit sufficient charge and the detector will register incomplete tracks. The
bias threshold is arbitrary as it correlates to some detector specific factor responsible for
converting the charge to energy; this is a non-linear relationship and is accounted for in
the acquisition software. Data was taken for similar total acquisition times for each run,
mainly to acquire adequate statistics. Cluster files reported global frame times every
∼30 ms: this consists of the 10 ms open shutter time with the remaining as dead time
for readout (closed shutter), approximating a data capture rate of 33 FPS.
During the 45◦ runs, online visuals of the hits and cluster statistics indicated the
most significant depths. It is difficult to substantiate this from only the cluster statistics
(Tables 5.6 and 5.7) as these quantities do not distinguish the different particle types:
a larger cluster rate at the fall-off may indicate more secondaries present rather than
primary protons. However, there is a clear overall decrease in numbers of clusters with
depth and the highest cluster rate is achieved at 24.40 mm which is approximately at
the BP. Sudden stringent time limitations meant fewer measurements were possible for
the second set of runs and therefore the 60◦ runs focused on three different depths for
comparison. Similar trends in the cluster rates for both angled cases can also be seen.
Given these observations, the following was deduced for the different PMMA blocks:
– 10.00 mm: Entrance region
– 20.10 mm: Build-up region
– 24.40 mm: At BP
– 25.48 mm: Just after BP
– 25.87 mm: Beginning of fall-off
– 26.40 mm: Distal fall off
5.5.4 Results
Log files were processed with Advacam proprietary tools to generate different metrics
(i.e. energy deposited, track sizes, angle etc.) for the distributions of recorded events
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for each run and stored as cluster lists. The program also enabled hits to be visualised
as integrated over all frames (Fig. 5.12a) or for a specific frame (Fig. 5.12b). These
events are recorded as the charge deposited from individual particles produce hits across
multiple pixels and this recruitment of several pixels are termed as ‘clusters’. The
software applies pattern recognition and clustering algorithms to resolve pixel clusters
based on morphology, spectral and other parameters [220]. Different in-built tools allow
further online or offline processing. The numbers and rate of clusters obtained from the
post measurement analysis for each run are also presented in Tables 5.6 and 5.7.
(a) (b)
Figure 5.12: Run 3 repeat, 24.40 mm at 45◦ a) Track visualisation of all accumulated
events. The hits accumulate in the bottom right corner as the sensor was not centred
with respect to the beam axis. b) Two clusters in a single frame are displayed showing
pixel position and normalised charge.
The detector can image single radiation tracks in high resolution with 100% collection
efficiency from the size of the pixel (55 µm) to the sensor thickness (300 µm), given the tilt
angle. This position and directional tracking capability combined with the timing and
the energy detection for each pixel, enables wide ranging measurements to characterise
the beam and radiation field. Given this information, the program can determine particle
specific properties including the type, energy loss, LET (0.1 to >100 keV/µm), track
mapping and also beam related properties (profile, flux, dose rates etc.). How this is
incorporated and analysed by the software is detailed in [45]. For our purposes only the
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properties related to the LET spectra were considered: energy loss, elevation angle and
3D path length. Resulting graphs generated by the Pixet proprietary software‡ show
the main cluster properties. The cluster height shows the distribution of the highest
energies deposited per pixel, the volume is the deposited energy summed for all pixels
in a cluster and the area indicates the number of pixels recruited. For example, plots




Figure 5.13: Cluster distributions at 10.00 mm for 45◦ (left) and 60◦ (right). a, b)
Largest deposited energy per pixel. c, d) Energy summed over a cluster. e, f) Cluster
area. Note the different axis scales.
Plots for the 24.40 mm case are shown in Fig. 5.14. Similar scaling differences for
each cluster property can be seen consistently at both depths and between the different
angled cases. In general, a larger sensitive area is exposed as the change by 15◦ increases
the effective depth of the sensor and probability of detecting longer tracks.
‡Data and graphs were provided by C Oancea, 2019.




Figure 5.14: Cluster distributions at 24.40 mm for 45◦ (left) and 60◦ (right). a, b)
Largest deposited energy per pixel. c, d) Energy summed over a cluster. e, f) Cluster
area.
Due to the greater statistics of clusters depositing larger amounts of charge, the depth at
this position is estimated to correspond to just before the BP. Higher energy levels with
a much bigger range of energy per cluster and a multi-peaked distribution of cluster
sizes is observed. In particular for the 60◦ case (Fig. 5.14f), the double peaks at 20
and 40 pixels indicate that the detector has recorded multiple particles resulting in an
overlapping of tracks and an artificial increase in the cluster sizes. A peak at the lower
end of the spectrum is also evident. This is due to the presence of the aluminium
slider which was kept closed as a protective measure initially however remained shut
for the remainder of the measurements. Deeper cluster analysis would require technical
manipulation of the software and is outside the scope of this thesis. Nonetheless, the
LET could be determined using Eq. 5.1 by evaluating the cluster lists and taking the
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cluster volume (energy deposition, dE ) and cluster size (track length, dl) distributions.
As the tracks can be recorded in any orientation, the path length was calculated given the
directional angle of the incident track and the measured projected length (Fig. 5.15).
The measured energy and calculated LET spectra at each depth for both angles are
included in Appendices B.42-B.45 for reference.
Figure 5.15: Sketch illustrating the particle track parameters and recruitment of pixels.
These metrics are used for cluster and morphological identification to resolve different
particle properties [220].
Simulation Results
The geometry of the silicon sensor (with aluminium slider) along with the blocks of
PMMA were built in the TOPAS model described earlier in the chapter, to simulate
the exact experimental conditions for direct comparison with measured results. As
only a small number of particles ultimately reach the sensor due to low transmission, a
phase space scorer was implemented after the nozzle. This resulted in an output file of
∼1 million histories, showing a Gaussian beam with mean energy and spread of 60.04
MeV and 0.48 MeV, respectively. A large number of histories are needed for adequate
statistics to replicate the experiment. As the phase space information sufficiently defines
each proton, was subsequently used as the particle source to reduce the computational
demand. All simulations were performed on a system consisting of 23 CPUs at the
University of Oxford. The achieved LET values and related quantities‡ are presented
‡Additional analysis and simulation results were provided by M Brooke.
148 Chapter 5. TOPAS Model
here however specific details and further application of these for radiobiological modelling
can be found in [210]. As only the LET was considered for this work, the empirical
LET spectra was resolved from the provided cluster lists and compared directly with
simulations.
The ProtonLET scorer was used to obtain the LETd in bins of 28 × 28 × 784 (in x,
y and z ) to represent the silicon sensor. These were chosen as smaller bins demand an
increased computational load. As cluster sizes did not exceed ∼40 pixels, these would
correspond to an approximate resolution of a single cluster per bin, therefore providing
suitable statistics for comparison. For the measured energy spectra, the detected ener-
gies required further processing from the cluster volumes. The kinetic energies of each
simulated particle were used to interpolate stopping powers and were multiplied by the
median measured track lengths to determine the energy deposition within the sensor.
The simulated energy spectra are compared with empirical data and this is also included
for reference in Appendix B.46.
As the aluminium slider introduced another attenuating layer in addition to the
various PMMA blocks used, the water equivalent thickness (WET) was determined as a
more precise indicator of the depths. The angular rotation of the detector also resulted in
a change to the WET which provided additional depth measurements: all corresponding
values are listed in Table 5.8. The cases where particles have undergone almost complete
energy loss and are absorbed by the material have a designated WET of ∞.







45 10.00 1.4 14.42
45 20.10 1.4 26.00
45 24.40 1.4 30.87
45 25.48 1.4 31.96
45 25.87 1.4 ∞
45 26.40 1.4 ∞
60 10.00 2.0 15.64
60 24.40 2.0 32.00
60 25.87 2.0 ∞
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Therefore, the irradiations covered a wide range of depths to examine the LETd, partic-
ularly around the BP region. As both the simulated and empirical results (Appendices
B.44-B.45) demonstrate a spectrum of LET values at each depth, a median or average
metric representative of the distribution was determined. The mode, most probable
value (MPV), a Landau distribution or other fits were chosen according to which suited
the data best in order to obtain a singular LET value. These are discussed in more
detail in [210] however the applicable MPVs were provided and are presented below in
Fig. 5.16. The simulated dose deposition and the LETd are also plotted for reference;
these were scored in a smaller water phantom of 35 × 35 × 35 mm3. Only the error bars
for the phantom case are included which indicate the variance as reported by TOPAS
and the spread of values across the LET spectra are shown in Appendix B.41.
Figure 5.16: Measured and simulated dose averaged LET at the corresponding WET,
with the CCC dose profile across a 35 mm depth.
For all cases, the linear energy transfer is maintained below approximately 3 keV/µm
before showing a clear upward trend from the BP build-up region to the distal fall-off.
This is expected as the increases in the density of ionisation and nuclear interactions
cause the protons to slow dramatically; the transfer of energies to secondary particles
result in high deposition events in short ranges as demonstrated by the steep rise at the
BP. An LET of ∼12 keV/µm is obtained at the BP. This extends past the peak where
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the fluence rapidly reduces as protons deposit the majority of their energy downstream,
achieving maximum LET values between 13.5-18.2 keV/µm. Larger errors are observed
at the fall-off due to statistical fluctuations and the departure of primaries which generate
electrons or other secondary particles: these are scattered with a wide range of energies
and path lengths. After this point all particles have undergone complete energy loss
resulting in no further LET.
The plot shows good agreement for the simulated LETd cases, particularly at depths
before the build-up region. However, as the number of interaction events increase,
the LET becomes more difficult to model and the deviation between the data sets is
clear. At the BP, the simulated and measured MiniPIX LET values are greater than
for the reference phantom, except at 32 mm where they are partly contained within the
uncertainty range. The distribution of measurements (Appendices B.42-B.43) are also
observed to be skewed to lower energies in comparison to simulations (Appendix B.46),
hence corresponding to smaller empirical LET values. However, it is also noted that at
this terminal end, the number of simulated particles and recorded MiniPIX events were
likely to have been statistically insufficient.
In contrast, in the plateau region before the BP, the empirical data has tended
to overestimate the LET. This is largely attributed to the presence of the aluminium
slider, complexities with the analysis and retrieving reliable information from the pro-
vided cluster files. For example, overlapping events recorded by the detector produced
multiple peaks in the cluster distributions for runs with PMMA larger than 24.40 mm.
This results in an increase in the range of track lengths and also the variance in the de-
posited energy per cluster, therefore a greater spread in the energy deposition (Appendix
B.46). Further evaluation was necessary to determine the measured energies however
an approach to filter the artificial peaks were not pursued. If ideal measurements were
attained with the experiment, it is expected that they would agree more closely with the
simulated case. It is also thought that the empirical LET values may correspond bet-
ter if the energy depositions were calculated using the same approach as the simulated
LETd i.e. dose averaged.
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Furthermore, the simulated MiniPIX LET is expected to differ from the water phan-
tom LETd as the experimental setup is inherently different to the reference case. This
is due to the presence of the aluminium slider, differences between the physical prop-
erties of the absorbing medium and the geometry of the scorers. The bin (voxel) sizes
effectively moderate the track lengths and the ProtonLET method averages the energy
deposition across this length to overcome this.
In general, the ranging distributions for the different cluster metrics obtained with
these measurements were not ideal. It is also unclear if limitations with preparation
and beam calibration had a significant effect on device performance: it is expected
that the distributions would approach better consistency given increased exposure and
counts. The protective aluminium slider also introduced several additional consider-
ations however was implemented in TOPAS to accurately simulate the experimental
conditions. The runs at a 60◦ tilt also provided additional measurement depths and
slight differences between the cases occur at the depths corresponding to the BP and
fall-off. Nevertheless, the measured LET values are shown to be within expected ranges
and correlate well with the simulated data.
5.6 Summary
An improved model of the CCC treatment beamline was redeveloped entirely in TOPAS
to provide a more accessible simulation platform for future users of the facility and also
to facilitate further applications for radiobiological modelling. The model builds off
progress made with GEANT4 described in Chapter 3 and utilises beam information de-
termined by optical modelling in Chapter 4. CAD imports into TOPAS enable highly
realistic geometries to be built, representing the actual CCC treatment delivery com-
ponents. Transverse beam profiles were generated and compared to film measurements,
showing an improvement from the previous model. Differences observed are largely due
to the beam quality during the film irradiations and potential effects from disparities
in modelling components within the dose monitors and dosimetry box. Nevertheless,
the dose profile was matched to CCC to simulate the LETd, providing a parameter for
correlation with radiobiological applications.
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Experiments were performed with a MiniPIX-Timepix detector to determine the
LET at different depths along the BP, using PMMA blocks of various thicknesses. De-
tector measurements yielded distributions of cluster properties, where the energy spectra
and track lengths were evaluated to calculate the LET. The experimental conditions were
implemented in the TOPAS model and simulated quantities were compared to detec-
tor measurements. General agreement was shown, supporting the validity of the model.
These results establish the possibility of utilising the MiniPIX detector and CCC TOPAS
model to determine quantities to resolve the linear energy transfer. The outcomes of





The LHCb VELO detector modules were developed into an online beam monitoring
system for application in ion beam therapy beamlines. The standalone system was
originally adapted for implementation into the CCC facility; beam characterisation and
simulation studies were discussed in Chapter 3. In order to investigate the technical
capabilities of the detectors and optimise the system for clinical environments, experi-
mental measurements are necessary.
Following recent upgrades to the hardware and software, tests were performed at the
University of Birmingham (UoB) which demonstrated for the first time, the functionality
of the monitoring system in a medical proton beamline. This chapter overviews the
UoB facility, system developments and the experimental campaign. Similar to work
in previous chapters, beam measurements were performed and results were compared
to EBT3 film and simulation modelling done in GEANT4. The benefits of the VELO
system and further opportunities for development are also discussed.
153
154 Chapter 6. VELO Measurements
6.1 University of Birmingham Beamline
UoB operates a proton beamline which is mostly used for radioisotope production for
medical applications but also supports testing of equipment for various research and
commercial purposes. The facility operates a Scanditronix MC40 medical cyclotron, ca-
pable of producing a range of particle species at currents from tens of fA to µA at high
fluence rates, ideal for testing of electronics and sensors. The facility has been running
since 2004; the beam has been characterised and there are several dosimetry and diag-
nostics systems in place [223]. A switching magnet downstream of the cyclotron allows
the beam to be extracted and transported to multiple rooms. For our measurements,
the detector system was positioned in the main ‘Medical and Nuclear Physics (UOB)’
room adjacent to the cyclotron vault (Fig. 6.1).
Figure 6.1: Layout of the University of Birmingham facility. Multiple particle species
are generated with the MC40 cyclotron and transported across multiple beamlines [223].
6.2 Experimental Method
The entire VELO system was brought to UoB and measurements were performed over
the course of 5 days (Fig. 6.2). Set-up and preparations were done in the first two
days with running beamtime over the remaining 3 days. Further technical details of
the measurements are described in [129] however a summary of the overall experiment
is outlined. The objectives of the campaign were primarily: to test the response of
the detectors in a proton environment, verify the changes to the synchronised readout
scheme and acquire data for different beam currents and sizes.
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Figure 6.2: Beam monitor positioned after the main beamline nozzle with sensor mod-
ules perpendicular to beam propagation direction. The beam originates from the cy-
clotron vault behind the wall, transported through the switching magnet. Downstream,
a faraday cup is aligned to the capture the beam passing between the detector modules.
Details and specifications of the VELO monitor have been previously described in Section
2.3.3 but for relevance to the experiment, key attributes are mentioned. The VELO mod-
ules are counting detectors and similar to Medipix3, provide an instantaneous recording
of hits by individual particles. An ionisation chamber within the beamline was connected
to an electrometer to cross-correlate absolute charge measurements with the monitor.
The recent system improvements mainly enable data collection processes to be adjusted
for the parameters of different facilities: the Keysight 8110A pulse generator was added
as an injected external trigger and the readout software was also updated to enable
simultaneous acquisition of data. As the RF frequency of clinical accelerators differ
from the LHC bunch crossing frequency, this allows VELO to trigger and collect data
in synchronisation with proton bunches at any RF.
To firstly optimise the proton bunches with the data acquisition and readout timing,
several ‘phase scan’ runs were performed at the start of each day. Added delays between
0-40 ns were set with the pulse generator and the total accumulated hits for both modules
were recorded. The delay time with the highest number of hits was implemented with the
trigger for all the measurements (i.e. 22.5 s and 7.5 s). As encountered at CCC, beam
losses due to RF dropouts also occurred and phase scans were repeated to resynchronise
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the system. In addition, a phase scan was unable to be performed for the first day
as it was discovered that the cyclotron RF frequency (22 MHz) exceeded the upper
acceptable limit for the pulse generator. Therefore, the external trigger could not be
used to synchronise the data acquisition. As such, the beam energy was decreased from
28 MeV to 18 MeV for the remaining days as the corresponding 18.21 MHz RF frequency
is below the 20 MHz scope threshold.
Measurements were taken at varying beam currents, sizes and sensor positions. The
VELO modules were translated longitudinally in the z -axis and laterally in the x -axis.
The size of the beam was modified by using interchangeable collimators with different
diameters, placed on the end of the beam nozzle. The diameters were chosen to restrict
the beam distribution such that it would pass straight through the aperture between
both sensors without interference. Experimental parameters for days 2 and 3 are listed in
Table 6.1; beam currents are later converted to absolute beam intensity measurements.
A larger range is listed for day 3 as the holder which physically supported the scattering
foil in the beam transport line, melted after the last set of measurements on day 2. This
resulted in significant changes to the beam quality as the beam had to be enlarged to
practical sizes by the optics. The adjustments to the magnets resulted in a distorted,
non-Gaussian beam for day 3. The ion chamber was moved and placed downstream, in
front of the modules (Fig. 6.3).
Table 6.1: Measurement conditions with 18 MeV protons.
Parameter Day 2 Day 3
Collimator diameter [mm] 7, 10, 15 7, 10, 15
Beam current [nA] 0.5, 1, 2, 3, 4, 5, 6 1.75, 3.5, 7, 10.5, 14, 17.5, 21
Sensor position in x [mm] 0, 4, 8 0, 4, 8
Sensor position in z [cm] 0 6, 12
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Figure 6.3: Facing outward from the nozzle, the beam passes through an ion chamber
before the detector modules.
6.2.1 Film Measurements
In order to correlate the hits recorded by the detector modules, the divergence and
distribution of the beam must be well known. This was performed using two comparative
methods: film and simulations. 5 pieces of film were placed on the downstream face of the
ion chamber (Fig. 6.3) and were simultaneously irradiated to determine the transverse
beam profiles (Fig. 6.4).
Figure 6.4: Irradiated film from day 3, from left to right: 7 mm, 10 mm, 15 mm and 10
mm at z = 6, 12 cm. Beam spots are non-Gaussian due to the removal of the scattering
foil.
A calibration set was provided afterwards and a calibration curve was generated (Ap-
pendix. B.25). Large error bars are noted due to the large variations in pixel intensities.
Slight changes were also applied to accommodate differences with the film and scanner
properties in the Matlab script (Appendix C.1). Nevertheless, given the standard anal-
ysis procedure described in Section 3.4.2, transverse beam profiles were determined for
158 Chapter 6. VELO Measurements
each film. The FWHM and area coverage was also determined and these are all included
in Appendices B.26-B.30.
The non-uniformity of the beam distributions proved difficult to analyse as taking
the ROI across the central third was not equivalent for each beam spot. A smearing
effect can be seen (Fig. 6.4) and this reduction in the beam quality appears as a jagged
edge on the top of the dose distributions (Appendices B.26-B.30). A Gaussian curve has
been fitted to each plot and the area underneath calculated for each half. These also
indicate the proportion of the rotation of the beam ellipse in the perpendicular plane
and the FWHM provides an indication of the beam width. The beam does diverge, as
shown by the differences between the evaluated FWHM and the collimator diameter: it
is clear that greater distances along the propagation direction result in a larger beam
width. For our applications, the halo is defined as anything peripheral to the distance
between the two opposing modules, assigned as 16 mm. The calculated area allows for
evaluation of the integral dose, which can be further correlated to density maps of the
transverse profile. For now, measurements along the radial axis are only considered and
compared later to the R-sensor hits.
Due to the irregularities and non-uniformities, it is difficult to accurately evaluate
the beam profiles for this case. Further analysis and better beam modelling would
be needed in order to correlate these distributions with measurements. Given this,
additional irradiations were performed later on by collaborators once the scattering foil
could be used again. Film measurements were repeated to reproduce a standard beam
with the same 7, 10 and 15 mm collimator sizes as day 2 (Fig. 6.5).
Figure 6.5: Irradiated film for day 2 measurements with varying collimators from left
to right: 15 mm, 10 mm and 7 mm.
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Additional plots of the profiles, FWHM and dose coverage were determined (Appendices
B.31-B.33). These beam profiles are more homogenous. As it is dependent on the beam
quality and conditions on the day, there are clear improvements from the previous (day
3) batch of film. Additionally, these have a smaller penumbra on both sides and the low
dose tails are not present. Non-uniformities appear again at the peaks, also caused by the
uncertainties in the calibration and OD conversion: the lower doses are minimised and
the higher doses are augmented by the calibration fit. Nevertheless, the most significant
regions are along each side of the beam profiles and comparisons to the hits recorded by
the detector are reported later.
6.2.2 GEANT4 Simulation
In order to benchmark both the EBT3 film beam profiles and the hits measured by
the detector, the beam was simulated using a validated model of the transport line‡
with realistic beam parameters in GEANT4 (Fig. 6.6). Parts of the source code were
amended and adapted for the requirements of this study and simulations were executed
on the same computer (as in Chapter 5).
Figure 6.6: UoB beamline simulation model visualised in GEANT4. The input beam
is defined upstream of the switching magnet (yellow) showing protons (blue), electrons
(red) and film (green square).
‡Developed and provided by Tony Price, 2019.
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EBT3 film was already defined in the model (27 µm sensitive layer sandwiched between
a 130 µm back and front layer) and was positioned at the same experimental z location
as the film, 168 mm after the nozzle. Hits were tracked within this sensitive (absorber)
layer and phase space information (particle ID, position and momentum in x, y, z,
kinetic energy or deposited energy) was recorded as ntuples, filling a ‘tree’ written as
a root file. This process is handled by the analysisManager within the SteppingAction
and RunAction classes. To score in the same way for a plane representing the VELO
sensors, the absorber needed to be redefined to fill a tree if the step points of particles
were checked as having entered the ‘VELO ’ (sensitive detector) volume. The VELO
geometry was created in the DetectorConstruction class as a 20 × 20 cm2 square of 300
µm thick silicon (Fig. 6.7a). It was placed at the same z position as the monitors in UoB
(208 mm after the nozzle) and a switch of the absorber from film to VELO was executed
in the run macro file. The collimator (inner) diameter size could also be changed in the
macro (Fig. 6.7b).
(a) (b)
Figure 6.7: a) Redefined absorber volume to score hits in a silicon plane for VELO
(red). b) Film absorber placed after the nozzle (orange) which contains the collimator
(silver), adjustable for inner diameter.
The root output files contained distributions of hits in the transverse plane and by radial
distance. Therefore, beam density maps and radial plots could be obtained for each film
for different collimator sizes and positions. Simulations were also run with increasing
numbers of initial primary protons, to examine changes in the divergence and numbers
of hits for the different beam currents. Strong linearity between the number of input
protons and hits indicate that only a linear scaling factor is necessary to account for
varying beam intensities. A density map can be obtained and scaled for the applied
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beam current, providing relevant quantities for correlation between the halo region and
beam core. This halo dose correlation relationship, experimental methods and analysis
are further detailed in [129]; the main findings of this experimental campaign are dis-
cussed as relevant for this chapter. The viability of this correlation was examined by
benchmarking the hits along the radial axis obtained with the R-sensors, against beam
distributions achieved by simulations and film. To mitigate the experimental uncer-
tainties, measurements from day 2 with the reproduced film irradiations (Fig. 6.5) are
considered and compared with simulated results.
6.3 Results
Experimental data was collected across a range of beam currents to test the response of
all four sensors to the 18 MeV proton beam. With the phase scan delays implemented,
the electrometer outputs were recorded against total numbers of hits in each sensor.
Strong linearity was observed: the total absolute charge increased linearly with the
proton beam current for all collimator sizes. Higher uncertainties were seen for the
smaller collimators as lesser hits were recorded.
The VELO modules register hits as an Analogue-to-Digital Converter (ADC) signal
which correspond to the generation of electron hole pairs in the silicon, depending on
the amount of energy deposited. As such, it should be possible to resolve information
about each interaction by the resulting ADC count. However, a significant observation
was realised from these tests: the majority of hits registered as a maximum ADC value.
Any hits above a maximum threshold (127 ADC counts) saturate the modules and it was
found that single protons exceeded this limit, even at the most minimal beam settings.
Consequently, as the threshold is so low, any hit regardless of energy, particle type or
interaction is counted.
Furthermore, as the beam does not diverge much after the nozzle, the beam sizes for
the 7, 10 and 15 mm collimators were expected to be smaller than the (16 mm) sensor
aperture (Appendices B.31-B.33). Therefore, the beam would completely pass between
the two sensors with reasonable clearance. Even so, the detector was observed to be able
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to sufficiently detect interactions and counts across the modules. Therefore, indirect
measurements without interference to the beam are possible due to the sensitivity of the
detector modules; the beam current can be resolved by considering the number of hits
as a function of distance along the radial axis. Accordingly, the beam distributions in
the transverse plane were obtained with simulations and measurements using the VELO
detectors‡ and EBT3 film. For comparison, each data set was normalised to maximum
output values and plotted on the same axes for the three collimator sizes (Fig. 6.8).
(a)
(b)
‡VELO data was provided by R Schnuerer.
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(c)
Figure 6.8: Transverse beam distributions measured by the VELO R-sensors, film and
simulations for the a) 7 mm b) 10 mm and c) 15 mm cases. The geometrical extent
of the >8 mm halo region (vertical black line) and collimator diameter (dashed orange
line) is shown.
The film profiles indicate the expected size of the beam and it is clear that only a small
proportion of the beam (tails) is detected by the sensors. This is also evident in the
more conformal spread of R1 and R2 hits for the 15 mm collimator case due to the larger
acquisition of hits and detected signal. The non-uniform hit distribution and higher R2
outputs compared to R1 for all cases also suggest that the modules were misaligned
in the perpendicular plane. Nonetheless, the simulated film profile match well with
measurements, apart from the low tail regions; these differences are more pronounced
with the larger beams. As mentioned, the film has a very sharp distribution with no
penumbra, indicating that exposure at low levels has been lost somewhere along the
dose conversion process.
The simulated hits from the VELO absorber (VELO Sim) also follow the film profiles
closely but there is slight divergence from traversing the 40 mm distance to the sensors
which results in some additional scatter at the tails. These are most significant for
correlation of the halo region of the beam, with respect to the total dose distribution:
the halo is designated as the hits outside the 8 mm R1 and R2 boundaries. Therefore,
these simulations give the expected beam profile at the same plane as the VELO sensors
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and by taking the halo region, can provide a prediction of the distribution of hits which
will be detected. Accordingly, the simulated hits belonging to the halo (VELO Halo)
as shown in Fig. 6.8, are normalised to the R1 and R2 boundary output value and
similarities between the distributions are observed. Again, the overall agreement is best
for the larger 15 mm collimator as more hits are registered.
Although fair initial coherence is seen, it is evident that a better dataset is needed
for precise correlation. The misalignment results in the simulated points being skewed
slightly (in the positive radial direction) and also extend past the R1 hits. This is
effectively an absence of 25% of meaningful halo measurements. Furthermore, the data is
noisy and this is due to several mentioned uncertainties. Better results can be obtained
with longer acquisition times to record more hits as well as with larger numbers of
simulated primaries. As both the film and VELO absorber geometries are very thin, low
numbers of particles are tracked even when using an input beam of 100 million protons.
Additionally, the small misalignment (∼2 mm) of the modules are shown to result in
large differences, around ∼50% of the output signal between the R1 and R2 sensors.
Positioning errors are amplified as the sensors contain numerous micron sized strips.
6.4 Discussion
These measurements demonstrate for the first time, the proof of concept of the VELO
beam monitor in a medical proton beamline, since undergoing several upgrades to adapt
the system for application outside of CCC. These studies contribute to ongoing work
on the monitoring system; it offers many benefits however further developments are
necessary for clinical use.
The system offers a real possibility to enhance the measurements currently offered
by commonly used particle therapy beam diagnostics instruments. The novel design of
the sensors, among other beneficial properties associated with its initial use in the LHC
(i.e. radiation hard, build, data acquisition streams etc.) provides many unique and
competitive advantages. The beam can be measured using non-invasive methods with
negligible interference and if required, the modules can also be translated laterally. The
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sensors themselves are in reality so sensitive such that measurements can still be taken
without being in close proximity however there must be a compromise with the detection
resolution. This can be compensated to some extent with simulations, although this
necessitates that the facility must be well characterised: simulations must be able to
reproducibly model the beam across the full range of treatment parameters. As such, a
scattered beam is the more ideal candidate and given the present state and capabilities
of the system, several limitations are anticipated with scanning systems (i.e. beam
movement, varying spot sizes, shapes and intensities etc.).
Furthermore, as the beam monitor directly detects only the halo region which must be
correlated, the system may be considered as providing relative measurements: another
instrument or method is required to measure the total beam distribution. This was
done with film, simulations and a Faraday cup which are common approaches and can
be easily performed in a clinical environment. However, a caveat with these are the
uncertainties, which scale to large differences at the level of the detectors. Using other
methods are advised, such as benchmarking measurements with another profile monitor
or also ionisation chambers. As discussed in Section 3.4.4, the Medipix3 detector offers
absolute measurements of the beam current and profile and is also suitable for this
purpose.
Additionally, since first tests many years ago at the CCC beamline, the system is now
able to be implemented in other facilities. The entire system is actually very extensive
(numerous components, cabling, equipment and computing power etc.) and requires
substantial arrangements for set-up and transport. To exist in the clinical environment
and workflow, the system, software and operating processes would need to be streamlined
and simplified. An avenue for development in this area would be a framework which
connects the functions of the detector and data acquisition with the operation of the
accelerator. An added bonus would be incorporating these with simulation or treatment
planning software. Related resources for simulations involving pixel detectors (Allpix2
[224]) exist; expanding from this to integrate with VELO measurements would be a
significant development. Even so, just building a graphical user interface to manage
detector operations would also be valuable.
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With the detector itself, further technical improvements may offer additional fea-
tures. It was observed that the fine signal thresholding resulted in saturation; adjust-
ments to this could provide more detailed information about each hit, such as the particle
type and energy deposition. Additional software upgrades could also synchronise the
channels for the different sensor geometries (R and ϕ) more effectively and utilise the
position sensitive capabilities.
6.5 Summary
The LHCb VELO detector modules have been adapted into a standalone beam moni-
tor and first tests were successfully performed at the UoB 35 MeV medical beamline.
Measurements of the beam halo were recorded and compared to transverse beam dis-
tributions determined with Monte Carlo simulation studies and EBT3 film analysis.
Multiple methods were performed to examine the feasibility of the sensors for this ap-
plication and to benchmark detector hits along the radial axis. The detected signal
from the halo can be resolved from simulations for correlation of the halo and scaled for
different beam settings.
Several challenges were encountered during the measurement campaign resulting in
several uncertainties and relatively noisy data. Despite this, initial coherence between
simulated and measured data was achieved. Furthermore, several valuable detector
attributes were identified from these tests, indicating the capabilities of the system for
clinical applications as well as avenues for further improvements. These measurements





This thesis described several methods to characterise and model a particle beam for novel
beam diagnostics development. Namely, the VELO beam halo monitor was adapted
into a standalone system and optimised for implementation into the CCC ocular proton
therapy beamline. As the detector provides beam information based on non-destructive
measurements of the halo, a comprehensive overview of the cyclotron, beam transport
and treatment delivery system at the facility was performed. Clatterbridge is a pioneer-
ing PBT centre which supports a wide range of research and offers a unique environment
for experimental work. It follows that in order to fully exploit the beamline, the propaga-
tion and behaviour of the beam must be well understood. Therefore, simulation studies
and experimental measurements were required to precisely model and completely char-
acterise the facility. Several computational tools were developed to accurately reproduce
the current state of the facility and physical properties of the beam. This work could
also be carried out at similar facilities to study aspects which are necessary for beamline
upgrades, optimisation and for the integration of diagnostics.
Firstly, a simulation study was performed using a recent GEANT4 model of the
CCC treatment line to investigate the beam propagation and impact of the sensors when
positioned in the integration zone. The projected transverse beam profiles were attained,
indicating an insignificant effect on the beam performance (0.04 MeV, 0.06% energy
loss) thus supporting the feasibility of minimally invasive measurements. Following the
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discovery of new facility information and implementation in the model, considerable
improvements were made to the code. However, an assessment of the historical input
beam parameters revealed a dependency of the results on the defined distribution of the
particle source (increases in FWHM up to 2.4 mm and 3.2 mm at the integration zone
start and isocentre, respectively). CCC does not maintain any beam diagnostics in the
beam transport line and as a result, several approaches were pursued to verify these
details: measurements of the transverse beam distribution with film and the Medipix3
silicon detector and also an extensive beam dynamics study.
Irradiations were performed with EBT3 Gafchromic film placed throughout the de-
livery system and analysed using scripts developed in Matlab to automate the conversion
of pixel intensity values to OD and generate plots of the transverse dose distributions.
Several uncertainties resulted in quantified differences to simulation results, also influ-
enced by beam quality on the day. As such, additional simultaneous measurements were
performed with the Medipix3 detector and these showed good agreement with film, par-
ticularly at the lateral edges of the transverse beam profiles. A calibration set performed
on the day also had smaller deviation, indicating better beam performance. Moreover,
this became the first test using the Medipix3 technology in a clinical proton beam envi-
ronment. Despite further concerns related to the beam parameters and facility, a linear
response and achieved results demonstrated the capability of the detector to provide an
absolute representation of the spatial spread of the beam. In addition, several other
observations were noted which suggest its possible application in identifying accelerator
related issues.
The numerous uncertainties associated with the beam and facility proved challeng-
ing. Direct measurements enabled the simulated results to be matched by varying the
input source however the beam study established that this would involve testing count-
less parameters. Therefore, a complete review of the facility was carried out to develop
an optical lattice to model and determine the linear beam optics upstream of the treat-
ment room. Based on historically documented information and physical measurements,
the quadrupole parameters and beamline was described in models developed in MAD-X
and BDSIM. The sensitivity of these parameters and their effects on the resulting beam
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sizes were shown, hence an optimised nominal case was determined. This was chosen to
constrain the lattice to generate a realistic beam distribution which would be represen-
tative of present day conditions. Simulations were compared with film profiles in place
of the proposed emittance measurements: similar agreement suggest the applicability of
input parameters (σx,y = 6.89, 2.14 mm, βx,y = 9.52, 4.59 m and Dx,y = 0.01, 0.00 m)
determined from the optical study.
Given the breadth of this work and the recognised complexity to fully utilise informa-
tion across the multiple codes, a completely new CCC simulation model was developed
in TOPAS. Although the GEANT4 model itself is a useful tool to study the beamline,
the complicated processes, analysis, user interface, as well as discontinuation in user sup-
port and development limit its future use. The TOPAS model incorporates everything
known about the facility, updated geometry and beam parameters. Results showed an
overall improved agreement to the film profiles and the capability to easily score physical
quantities such as the LET, enabled correlation for radiobiological applications. Exper-
iments were performed to benchmark the simulation using another silicon detector, the
MiniPIX-Timepix. The LET was resolved by evaluating the measured energy deposi-
tions and track lengths, showing an expected increasing trend which correlated well with
simulations. Empirical LET values of ∼12 keV/µm at the BP and a maximal value of
15.5 keV/µm at the BP fall-off were obtained, falling within expected ranges.
All these tools allow simulations of the CCC beam and the methods presented in this
thesis also support the investigation and development of new technologies as diagnostics
systems for PBT and potentially, advanced CPT techniques. However, as access to CCC
was limited given the extensive setup of the VELO system, experiments were conducted
at the UoB proton beamline. These were the first proof of concept measurements with
the upgraded system and using the same approaches, were compared with simulations
and film. These demonstrated good agreement, particularly for the halo region at higher
signal output counts (15 mm collimator case). Several experimental uncertainties and
the envisioned clinical capabilities of the monitor were discussed: the positive outcomes
indicate the possibilities of the adapted LHCb VELO detectors as a novel beam halo
monitoring system for medical proton beamlines.
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7.2 Outlook
Beam diagnostics tools are essential components in the PBT workflow which ensure the
safe and correct delivery of the beam to provide high quality treatments. The instru-
ments explored in this work show promising capabilities however several areas were iden-
tified where further work is necessary to optimise their application in particle therapy.
There are also various aspects of development which could improve the computational
models presented in this thesis.
The VELO system is highly sensitive and can offer completely non-interceptive rela-
tive measurements which could provide the dose online, converted from the signal read-
out using several benchmarking methods. The potential of the system was demonstrated
with the proof of concept measurements achieved at UoB; feasibility in a clinical environ-
ment was also previously explored with its integration into the CCC treatment beamline.
Recent developments offer additional functionalities such as the external triggering sys-
tem, enabling synchronisation of the readout and data acquisition with different beam
structures: this provides the possibility of adapting the monitor for different facilities.
These tests however identified several improvements which could be pursued to enhance
the system toward clinical implementation. In general, a reduction of the physical size of
the setup, removing the charge threshold and simplifying the processing and operational
software would be highly advantageous. Moreover, the VELO detectors have intrinsic
capabilities which could also be better utilised, this includes exploiting the combined
dual geometry of the modules to access position sensitive information and the sensor hit
maps during active operation, rather than only offline during post-processing.
As both CCC and UoB present similar environments (proton beams generated by
comparable cyclotrons but at different energies and frequencies), it would also be benefi-
cial to test the system with different accelerator types and delivery methods, to explore
the capabilities of the system for wider applications and advanced technologies. In
addition to the pulsed structure and intensity variations with a beam produced by a
synchrotron, experimental measurements at a facility with active PBS delivery would
also offer insight into system performance under different conditions.
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Furthermore, due to the non-interceptive nature of the monitors, different approaches
are necessary for correlation of the halo to the total beam distribution and then to dose.
This requires relevant beam properties to be derived or measured in a way which is
accurate, reproducible and which can also be scaled for different beam settings. Typically
this involves several instruments including a FC, ion chambers or EBT3 film. However,
complimentary devices such as the Medipix3 detector enable direct measurements of the
beam and can be easily compared with film however both need to be performed with
high precision. Measurements obtained at CCC showed the advanced capabilities of the
Medipix3 chip and pixel technology within a PBT environment: the remarkable time
resolution alongside overall agreement with the film measurements.
Limitations with the film are due to uncertainties surrounding the analysis and con-
version process, as indicated by the error bars in the calibration curves and the irregu-
larity of the attained beam profiles. A way to mitigate this would be to proceed with a
more robust process: strictly monitoring the film protocol to maintain uniformity with
the film irradiation, development, scanning and analysis; or to attain profiles using well
established or commercial methods. For example, using commercial software and hard-
ware to determine the beam profiles from the irradiated film or by direct measurements
using commonly used ion chambers for QA or dosimetry. However, it is important to
note that with conventional ICs, interception in the beam path reduces the beam quality,
has deficiencies with performance and also requires individual and regular calibration
and multiple factors to convert the charge generated in gas. A better possibility could be
to perform simultaneous measurements with the VELO system and the Medipix3 detec-
tor for comparison with simulations. Nonetheless, generating a correlation database of
halo measurements from the predicted beam distribution using MC simulations is only
applicable if the beam is well characterised.
The computational models of the beam transport and treatment line were opti-
mised and matched as based on available information but would benefit highly from
further measurements. The tools used however are highly flexible: the optical lattice
and delivery system model can be further adjusted to accommodate findings from future
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measurements. For the BTL, carrying out the proposed emittance measurement cam-
paign would be worthwhile in order to determine the emittance, transverse beam sizes
and quadrupole parameters. Other approaches to verify the beam profiles at the desig-
nated positions between the last quadrupole triplet and the treatment line or arguably,
at anywhere along the beamline, contributes additional parameters useful for matching.
Alternatively, characterising the quadrupoles by measuring and modelling the fields also
provides a more realistic representation of the lattice components. In addition, it is
noted that machine learning techniques could be applied to optimise the beam dynam-
ics to determine the optical parameters based on the best achievable quadrupole and
dipole field settings. This could similarly be done with a database of beam distributions
to parameterise the halo and determine an analytical correlation factor.
For the treatment line, verifying the physical components where there were notice-
able deviations between the simulated and film profiles would be valuable to progress
the model to approach a more realistic, physical representation of the clinical beam.
Additional measurements of the dose deposition (pristine BP and SOBP) and trans-
verse beam profiles with film or other methods, would also assist with model validation.
Enhancements can also be made to the TOPAS model source code to improve the compu-
tational efficiency and better implement time modulation features to generate a SOBP.
As complex geometries can be imported into TOPAS, the VELO detector itself could
also be built into the model, offering the ability to score within the actual physical di-
mensions of the sensor modules and generate hit maps congruent with measured data.
For added capabilities, developing radiobiological scorers allows detailed simulations in
the cellular and sub-cellular scale, increasing the utility and scope of the model to bio-
logical applications. This can all be done in the future as the models are made available
for public use.
Finally, developing a system to connect these computational tools with the opera-
tion of the beam diagnostics and accelerator control system would be highly useful. The
combination of all this work details the basis for a framework to integrate realistic sim-
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Figure A.1: Full listed schematic of entire CCC beamline.
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Machine Name: Scanditronix MC-60 PF
Date: 6/6/01 8:55:36 AM
Institution: Douglas Cyclotron Unit, Clatterbridge Centre
for Oncology
Address Bebington, Wirral UK
In Charge of Cyclotron: A Kacperek
Telephone: ++44 (0)151 334 6366
Fax: ++44 (0)151 334 2845




Designed By: Scandidtronix SA
Construction Dates: 1983-84
First Beam Date: 1985
CHARACTERISTIC BEAMS
ions / energy(MeV/N)/current(pps)/power(w)
p 62 50 uamps
transmision efficiency(source to extract beam)
typical: 70% - best: 85%
tranverse emmitance
emmitance definition: not known
vertical: <15π mm mrad
horizontal: <15π mm mrad
longitudinal: < 0.1 % energy(∆) E/E)%xdeg RF
USES
basic research: % therapy: 80%
development: 5% isotope production: 10%
other: 5% maintenance: %
beam tuning: % Total Time: 700h/year
TECHNICAL DATA
a)magnet: type: simple yoke
Kb: MeV/A Kf: MeV/A
average field (min/max): 1.77 ave. T
number of magnet sectors: 3




injection radius: 0 m
extraction radius: m
hill gap: m valley gap: m
trim coils
-number: 6x2
-current(max): 260 amp total A-turns
harmonic coils







weight - iron: 120t coils: t
power
main coils (total): 110 kW
trim coils (total max): 5 kW





number of dees: 2
number of cavities: 2
dee angular width: 80degrees
voltage
at injection: nakV(peak to ground, max)
at extraction: nakV(peak to ground, max)






c)ion source: PIG 300 mA
external injection:
components:











pumps: 2 x 4000 l/sec oil diff pumps with baffles
achieved vacuum: < 10-5Pa
REFERENCES
BONNETT DE, KACPEREK A, SHEEN MA, GOODALL
R and SAXTON TE 1993 The 62 MeV proton beam for the
treatment of ocular melanoma at Clatterbridge. British Journal
of Radiology 66, 907-914.
EXPERIMENTAL FACILITIES
I treatment room; 4 available beam lines for irradiation;
COMMENTS
Figure A.4: Cyclotron documentation.
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Figure A.5: Bunker schematic.
Appendix B
Additional results and simulation source code.
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184 Appendices
B.1 CCC GEANT4 Simulation Results
(a)
(b)
Figure B.1: a) CCC dose and b) lateral beam profile at isocentre (z = 1829) as simulated
in GEANT4 with 10M primaries scored within 400 bins of a 40 × 40 × 40 mm3 cube
of water.
Appendices 185
Figure B.2: Characterisation plots at isocentre using default beam parameters.
Figure B.3: Characterisation plots at isocentre using default beam parameters with
implemented updates to the scattering foil and dose monitor geometries.
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Figure B.4: Characterisation plots at isocentre with a silicon disc at z = 736 mm.
Figure B.5: Characterisation plots, the beam has just exited the kapton window into
air.
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Figure B.6: Characterisation plots, the beam is near the start of the integration zone
in the removable aluminium pipe.
Figure B.7: Characterisation plots, the beam is in the middle of the integration zone.
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Figure B.8: Characterisation plots, the beam is in the air gap between the dose monitors
having just traversed the first ion chamber.
Figure B.9: Characterisation plots, the beam has just passed the cross-wires.
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Figure B.10: CCC dose profiles simulated (red) at 30.50 mm and measured (blue) at
30.80 mm.
Table B.1: Proton ranges (in water) calculated from stopping powers on [225].










Figure B.11: Simulated beam profiles in x, at each corresponding film in order of
position along beamline: 1, 2, 3, 6, 4, 8, 5 and 7.
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B.2 GEANT4 Code
1 // M Hentz, 2016
2 // Edited J Yap, 2018
3
4 #ifndef SteppingAction_h















20 virtual void UserSteppingAction(const G4Step*);
21
22 inline void InitialiseFiles();
23
24 // used to set tracking options in macro file
25 void SetTracking(G4String trackingString)
26 {
27 // track at all positions defined in trackingPosFiller below
28 if (trackingString == "All")
29 {
30 isTracked = true;
31 trackSingle = false;
32
33 // For default "All"
34 //std::vector<int> trackingPosFiller(38);
35 std::vector<int> trackingPosFiller(9);
36 //trackingPosFiller = { 0, 45, 79, 81, 100, 150, 200, 250, 299, 300, 307,
37 350, 400, 449, 471, 629, 676, 700, 750, 800, 850, 900, 950, 1000, 1050,
38 1099, 1121, 1129, 1141, 1149, 1265, 1535, 1577, 1671, 1759, 1800,
39 1839, 1881 };
40
41 //for beamsize
42 trackingPosFiller = { 0, 357, 471, 676, 756, 1099, 1265, 1759, 1829 };
43
44 //for absorber
45 //trackingPosFiller = { 0, 1759, 1815, 1827, 1829, 1839, 1850 };
46 //trackingPosFiller = { 0, 1759, 1800, 1827, 1829, 1839 };
47
48 //for no dose monitors
49 //trackingPosFiller = {0, 1000, 1141, 1265, 1829, 1839};
50
51 //for general data set of 15
52 //trackingPosFiller = { 0, 81, 307, 357, 471, 676, 750, 1099, 1195, 1265,
53 1577, 1759, 1829, 1871, 1875 };
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54
55 //for integ zone of 16
56 //trackingPosFiller = { 676, 706, 736, 766, 796, 826, 856, 886, 916, 946,
57 976, 1006, 1036, 1066, 1096, 1829};
58
59 //for si disc
60 //trackingPosFiller = { 676, 706, 736, 766, 796, 826, 856, 886, 916, 946,
61 976, 1006, 1036, 1066, 1096, 1829};
62
63 trackingPosVec = trackingPosFiller;
64 }
65 // no tracking
66 else if (trackingString == "None")
67 { isTracked = false; }
68 // track at single position given in the macro
69 else
70 {
71 isTracked = true;
72 trackSingle = true;
73
74 trackerPos = std::stoi(trackingString);
75
76 std::vector<int> trackingPosFiller(1);
77 trackingPosFiller = { trackerPos };
78











4 // Sensitive detector over parameterised volumes
5 // - Same as /all command except over the distances specified below
6 // 40x40x40mm cube after isocentre = 1829. Centred at 1849
7 // J Yap 23/8/18
8 //----------------------------------------------------------------------------
9
10 if( fDetChoice == "detectorvolume" ){
11
12 // Container - L1
13 // fdetectorvolPosition wtr room ie centred at fdetectorvolPosition=1860
14
15 G4double containerPositionZnew = -fRoomSizeZ/2 + fdetectorvolPosition;
16 //G4double containerLengthNew = 2100*CLHEP::mm - containerPositionZnew;
17 //take width as fcontainerlength is from proton.mac
18 G4double containerLengthNew = fRoomSizeZ/4;
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19 G4Box* sParallelContainer = new G4Box( "parallel_container", width/2, width/2,
20 containerLengthNew/2 );
21 G4LogicalVolume* lParallelContainer = new G4LogicalVolume( sParallelContainer,
22 0, "parallel_container" );
23
24 // New position of parallel container - L2
25 new G4PVPlacement( 0, G4ThreeVector(0., 0., containerPositionZnew),
26 lParallelContainer, "parallel_container", lGhostWorld, false, 0 );
27
28 //-----------------------------------------------------------------------------
29 // Detector for parametrised volumes - L3
30 // Position relative to room: z = -4200 + fdetectorvolPosition/2
31 //-----------------------------------------------------------------------------
32
33 // Container solid and logical volume to be replicated
34 G4VSolid* sParallelDet = new G4Box( "parallel_detector", fContainerLength/2,
35 fContainerLength/2, thickness/2 );
36 G4LogicalVolume* lParallelDet = new G4LogicalVolume( sParallelDet, 0,
37 "parallel_detector" );
38
39 // Construct fNoOfCopies parametrised volumes along the z axis
40 ParallelWorldParam* parametrisation2 = new ParallelWorldParam( fContainerLength,
41 fDetSpacing );
42 new G4PVParameterised( "parallel_detector", lParallelDet, lParallelContainer,
43 kZAxis, fNoOfCopies, parametrisation2 );
44
45 // Define sensitive detector on parametrised volumes
46 PhaseSpaceSD* sd = new PhaseSpaceSD( "/sd/phaseSpace" );
47 SDman->AddNewDetector( sd );
48 lParallelDet->SetSensitiveDetector( sd );
49





55 /*// starting position of first parameterised slice
56 G4double detectorvolPositionFirstPos = -950.*CLHEP::mm + (fdetectorvolPosition -
57 fContainerLength/2 + fDetSpacing/2);
58
59 // Define solid and logical volume to be replicated dimensions/2
60 G4VSolid* sParallelDetVol = new G4Box( "parallel_detectorvol", fContainerLength/2,
61 fContainerLength/2, thickness/2 );
62 G4LogicalVolume* lParallelDetVol = new G4LogicalVolume( sParallelDetVol, 0,
63 "parallel_detectorvol" );
64
65 // Construct fNoOfCopies parametrised volumes along the z axis
66 ParallelWorldParam* parametrisation2 = new ParallelWorldParam( fNoOfCopies,
67 detectorvolPositionFirstPos, fContainerLength, fDetSpacing );
68 new G4PVParameterised("parallel_detectorvol", lParallelDetVol, lParallelContainer,
69 kZAxis, fNoOfCopies, parametrisation2);
70
71 // Define sensitive detector on parametrised volumes
72 PhaseSpaceSD* sd = new PhaseSpaceSD( "/sd/phaseSpace" );
73 SDman->AddNewDetector( sd );





78 // Sensitive detector on single volume
79 // - Defines sensitive detector on a volume chosen in the macro using the
80 // /parallel/detector command.
81 // JY 30/01/19
82 // MH defined containervol as 1900mm for this option, for the others JY defined it
83 // as 2400mm (fRoomSizeZ/4) such that it is consistent with the treatment beamline z
84 //------------------------------------------------------------------------------------
85
86 if( fDetChoice != "all" && fDetChoice != "detectorvolume" ){
87 G4String sdVolName = "sd_" + fDetChoice;
88
89 G4Box* sParallelContainer = new G4Box( "parallel_container", width/2, width/2,
90 fContainerLength/2 );
91 G4LogicalVolume* lParallelContainer = new G4LogicalVolume( sParallelContainer, 0,
92 "parallel_container" );
93
94 new G4PVPlacement( 0, G4ThreeVector(0., 0., containerPositionZ), lParallelContainer,
95 "parallel_container", lGhostWorld, false, 0 );
96
97 // Define map of component positions of face closest to the source, ie the face
98 // hit first by the proton beam. This allows retrieving the position by the
99 component’s name.
100 // JY - Component position = -1900/2 + (position in z)
101 std::map< G4String, G4ThreeVector > componentPosition;
102 componentPosition["scatterfoil1"] = G4ThreeVector(0., 0., -869.*CLHEP::mm); //81
103 componentPosition["tube1"] = G4ThreeVector(0., 0., -593.*CLHEP::mm);
104 componentPosition["nozzle"] = G4ThreeVector(0., 0., 750.*CLHEP::mm);
105 componentPosition["outside"] = G4ThreeVector(0., 0., 818.*CLHEP::mm);
106 // 1768 mm ie 1cm after nozzle
107 // JY - Add sensitive detector to water phantom at BP position
108 componentPosition["phantom"] = G4ThreeVector(0., 0., 910.*CLHEP::mm);
109 //1860 mm
110 //add variable component dependent on location z, change z coord here before running
111 componentPosition["film1"] = G4ThreeVector(0., 0., -593.*CLHEP::mm);
112 componentPosition["film1new"] = G4ThreeVector(0., 0., -570.*CLHEP::mm);
113 componentPosition["film2"] = G4ThreeVector(0., 0., -501.*CLHEP::mm);
114 componentPosition["film_integzone"] = G4ThreeVector(0., 0., -274.*CLHEP::mm);
115 componentPosition["film6"] = G4ThreeVector(0., 0., -104.*CLHEP::mm);
116 componentPosition["film4"] = G4ThreeVector(0., 0., 59.*CLHEP::mm);
117 componentPosition["film8"] = G4ThreeVector(0., 0., 496.*CLHEP::mm);
118 componentPosition["film5"] = G4ThreeVector(0., 0., 721.*CLHEP::mm);
119 componentPosition["film7"] = G4ThreeVector(0., 0., 921.*CLHEP::mm);
120
121 // Define volume for sensitive detector
122 G4VSolid* sDetector = new G4Box( sdVolName, width/2, width/2, thickness/2 );
123 //14.*CLHEP::um);//JY//;
124 G4LogicalVolume* lDetector = new G4LogicalVolume( sDetector, 0, sdVolName );
125
126 // Shift position of detector so faces of detector and component volume coincide
127 G4ThreeVector detPosition = componentPosition.at(fDetChoice) + G4ThreeVector(0.,
128 0., 0.5*CLHEP::nm);
129 new G4PVPlacement(0, detPosition, lDetector, sdVolName, lParallelContainer,
130 0, 0, 0);
131
132 // Define sensitive detector on volume
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133 PhaseSpaceSD* sd = new PhaseSpaceSD( "/sd/phaseSpace/" + fDetChoice );
134 SDman->AddNewDetector( sd );
135 lDetector->SetSensitiveDetector( sd );
136
137 ...}
Figure B.13: ParallelWorldConstruction.cc adapted from M Hentz, 2018.
1 // M Hentz, 2016




















22 using namespace std;
23
24 RunAction::RunAction( DetectorConstruction* det, PhysicsList* phys,






















46 void RunAction::BeginOfRunAction( const G4Run* aRun )
47 {
48 G4cout << "### Run " << aRun->GetRunID() << " start." << G4endl;
49
50 // JYAP updated 2018
51 //create messenger link
52 MaxLayer = fDetector ->GetLayerNumber();
53 //MaxLayer = fContainerLength ->GetContainerLength();
54 //MaxLayer = fDetDistance ->GetDetDistance();
55
56 //create edep file
57 // Dump
58 psfile.open( "data/edep.txt", ofstream::app );
59
60 // Set precision of variables to be dumped
61 psfile
62 << setiosflags( ios::fixed)
63 << setprecision(8);
64
65 G4String header = "eDep [MeV]";





2 ## This macro file is used to run Geant4 simulations in batch mode. ##
3 ## ##
4 ## - Several settings are preset. ##
5 ## - Comment/uncomment add/remove lines as required. ##
6 ## - Parallel simulations can be run, where "parallel" is taken to mean ##
7 ## several simulations running concurrently. If doing so, the "parallel" ##
8 ## version of the command to execute the gps.mac macro, /control/execute, ##
9 ## the command to set the seeds, /random/setSeeds, and the command to run ##
10 ## the simulation, /run/beamOn, should be uncommented. ##
11 ## (Don’t forget to comment the normal commands.) ##
12 ## ##
13 ## Author: 07/03/2018, M. Hentz ##
















29 # Primary generator settings
30 #-------------------------------------------------------------------------------
31 # Choose how to generate primary particles and set required settings.
32 #
33 # 1) The macro gps.mac uses /gps/ commands to set desired energy
34 # distribution, mean energy, std dev, gun position, beam width,
35 # angular distribution.
36 #
37 # 2) Particles can be generated from a phase space file. The input
38 # should contain the following values separated by commas:
39 #
40 # parentID, particleName, x, y, z, mom_x, mom_y, mom_z, ke
41 #
42 # The positions (x, y, z) should be given in mm and the kinetic
43 # energy (ke) should be given in MeV. The format of the input
44 # file can be modified in FileReader.cc.
45 #
46 # Note: parentID is redundant and is in fact ignored but it is
47 # simplest to include it anyway as this allows an output
48 # file from one simulation to be used as the input of
49 # another.
50 #
51 # The path to the file used as an input is set with:




56 ## Use macro to set properties of primaries
57 #/control/execute gps.mac
58
59 # Parallel version
60 /control/execute ../../gps.mac
61











73 # Detector settings
74 #-------------------------------------------------------------------------------
75 # Choose where to record particles and set required settings.
76 #
77 # 1) ’all’: record along the beamline at every position at intervals
78 # and overall distance specified below.
79 #
80 # Set detector spacing and distance recorded below using:
81 # - /parallel/detector/spacing
82 # - /parallel/detector/distance
83 #
84 # Also pass the parameters to the run action so output files
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85 # are written correctly:
86 # - /user/run/detector/spacing
87 # - /user/run/detector/distance
88 #
89 # Set the size of the vector of hits saved in the run action with:
90 # - /user/run/buffer
91 #
92 # Once the vector reaches this size, hits are dumped to output.
93 # The ideal value for this will depend on the application. Making
94 # it too small results in large overhead from opening and closing
95 # files too often. Making it too large leads to too much memory
96 # being used. Both cases slow down the simulation considerably,
97 # so play around before submitting large runs and choose wisely!
98 #
99 # 1.a) ’detectorvolume’: record all but in detectorvolume
100 # - Useful for BP simulations
101 # Select detectorvolume to record particles
102 # - /parallel/detector detectorvolume
103 # Uncomment and specify options for:
104 # - /parallel/detector/position
105 # - /parallel/detector/spacing
106 # - /parallel/detector/distance
107 # - /user/run/detector/spacing
108 # - /user/run/detector/distance
109 # Set the size of the vector of hits saved in the run action with:
110 # - /user/run/buffer
111 # Set detector geometry and options under:
112 # - /cb_sim/det/
113 #
114 # 2) <component>: record at the specified components.
115 #
116 # Currently available keywords: - scatterfoil1 (at 81 mm)
117 # - tube1 (at 357 mm)
118 # - nozzle (at 1700 mm)
119 # - outside (at 1768 mm)
120 #
121 # Component-position pairs can be added to the component map
122 # in ParallelWorldConstruction. The dump function in the run
123 # action needs to know if only one position is being recorded
124 # so switch on "single" mode and tell it where particles are
125 # recorded using:
126 # - /user/run/dump/single true




131 ## Choose where particles are recorded
132 #/parallel/detector all

















149 ## If using ’all’
150 #/parallel/detector/spacing 25 mm
151 #/parallel/detector/distance 1900 mm
152
153 ## If using ’detectorvolume’ uncomment all here
154 /parallel/detector/position 379 mm
155 /parallel/detector/spacing 27 um #JY#0.1 mm # slice size, default is 25 mm
156 /parallel/detector/distance 27 um #JY#40 mm # length of detector, for BP 40 mm
157 /user/run/detector/spacing 27 #JY#0.1
158 /user/run/detector/distance 27 #JY#40 # same as detector distance
159




164 # Set buffer size
165 /user/run/buffer 5000 #JY#
166














181 # Stepping action settings
182 #-------------------------------------------------------------------------------
183 # Choose where to kill particles if required. This can be useful if
184 # only a given section of the beamline needs to be simulated.
185 #
186 # To be safe and not accidentally interfere with the ongoing
187 # simulation, this should ideally be done after the particles have
188 # been recorded.
189 #













202 # Set physics process
203 #-------------------------------------------------------------------------------
204 # Choose physics list and set range cuts.
205 #
206 # Cuts should be set such that they are no bigger than 10% of slice thickness.
207 #-------------------------------------------------------------------------------
208






215 ## Production thresholds
216 /cb_sim/phys/setCuts 0.1 mm
217 #/cb_sim/phys/setGCut 1 um
218 #/cb_sim/phys/setECut 1 um
219 #/cb_sim/phys/setPCut 1 um
220
221 #-------------------------------------------------------------------------------
222 # Set detector geometry
223 #-------------------------------------------------------------------------------
224 /cb_sim/det/setMaterial PMMA #JY#Water
225 /cb_sim/det/setPosition 0 0 -3820 mm #JY# wrt room ie -4200-(detectorvolume position)
226 /cb_sim/det/setSizeXY 40 mm
227 /cb_sim/det/setSizeZ 27 um #JY#40 mm
228 /cb_sim/det/setSliceSizeXY 40 mm
229 /cb_sim/det/sliceNumber 1 #JY#400
230 #number of layers for edep calc needs to be less than det distance
231
232 #-------------------------------------------------------------------------------










243 # Set seeds for randon number generators
244 #-------------------------------------------------------------------------------
245 # If running simulations "in parallel", the variables seed1 and seed2 are set by
246 # the submission script cb_parallel.sh.
247 # Make sure to uncomment the corresponding line.
248 #-------------------------------------------------------------------------------
249 #/random/setSeeds 1 100
250
251 # Parallel version
252 /random/setSeeds ${seed1} ${seed2}
253
254 #-------------------------------------------------------------------------------
255 # Step limit
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256 #-------------------------------------------------------------------------------
257 # Step limit shouls be set such that it is no bigger than 5% of slice thickness
258 #-------------------------------------------------------------------------------
259 /cb_sim/stepMax 0.1 mm #JY#
260
261 #-------------------------------------------------------------------------------
262 # Print to console
263 #-------------------------------------------------------------------------------





269 # Run simulation
270 #-------------------------------------------------------------------------------
271 # Choose how many primaries should be simulated.
272 #
273 # If running simulations "in parallel", the variable nevents is set by
274 # cb_parallel.sh. Make sure to uncomment the corresponding line. Check the
275 # number of events matches the number of lines in the input file. If that is












Figure B.16: Iterations of the CCC beamline lattice in MAD-X showing progressive
changes to the Twiss functions following the discovery of facility information: emittance




3 // Clatterbridge Cancer Centre 62 MeV eye proton therapy beamline //
4 // //
5 // J Yap, July 2019 //
6 ////////////////////////////////////////////////////////////////////
7
8 // V2 developed using lattice info from OK
9 // V3 improved upon by verifying all lattice information
10 //uncertainty approx +/-10cm (differences between physical & schematics)
11 //experimental measurements providing twiss parameters to follow
12 // V4 replaced all lengths of quads with approximated effective lengths
13 // V6 scaled gradient coefficients
14 // V7 updated measurements
15 // V8 optimised quads, final measurements
16
17 // Limited access.. can’t check: Polarities
18 // Physically double checked: Quad currents & Distances to diagnostics positions
19 // Things to consider: Fringe fields
20
21 Title, "Clatterbridge Beamline";
22 Beam, particle=proton,
23 energy:=1.00027, !all in GeV
24
25 //HO emittance 1998
26 !EX=2E-6/pi, EY=1.5E-6/pi, SIGE= 0.0001;
27 //TC emmitance 2012
28 EX=5E-6/pi, EY=1E-6/pi, SIGE= 0.0001;
29 //Documentation emittance - upper end HO paper
30 !EX=15E-6, EY=15E-6, SIGE= 0.0001; unrealistically large





36 gamma:=e0/m0; !for momentum spread correction








45 o: DRIFT, L= 0.77 ;
46 Q11: QUADRUPOLE, L= 0.2, K1=-11.93294936*MAT1;
47 o11: DRIFT, L= 0.13 ;
48 Q12: QUADRUPOLE, L= 0.2, K1=7.348256623*MAT1;
49 o12: DRIFT, L= 0.13 ;
50 Q13: QUADRUPOLE, L= 0.2, K1=-6.397589241*MAT1;
51
52 o2: DRIFT, L= 1.73 ;
53 D: RBEND, L= 0.85, ANGLE=-0.095993109;
54 o20: DRIFT, L= 1.88;
55
56 Q21: QUADRUPOLE, L= 0.22, K1=4.137794811*MAT2;
57 o21: DRIFT, L= 0.13;
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58 Q22: QUADRUPOLE, L= 0.22, K1=1.207583305*MAT2;
59 o22: DRIFT, L= 0.13;
60 Q23: QUADRUPOLE, L= 0.22, K1=-4.13779481*MAT2;
61
62 o3: DRIFT, L= 5.63/10;
63 Q31: QUADRUPOLE, L= 0.22, K1=5.894578456*MAT3;
64 o31: DRIFT, L= 0.13;
65 Q32: QUADRUPOLE, L= 0.22, K1=-10.92415638*MAT3;
66 o32: DRIFT, L= 0.13;
67 Q33: QUADRUPOLE, L= 0.22, K1=5.894578456*MAT3;
68
69 // total distance to source plane 2.59m //
70 //pipe is 109cm from end of Q3 ie relevant beam sizes for diagnostics
71 o4: DRIFT, L=1.085; //distance from Q3 to beginning of pipe
72 //beginning of pipe / instrumentation location
73 oDiag: DRIFT, L=0.6/11; //first 60cm of pipe (probeam is 54cm)
74 o5: DRIFT, L=0.6/10; //end of pipe
75 o6: DRIFT, L=0.308/5; //bellow and cross to source plane, 30.8cm
76 mS: MARKER; //at source plane, ~2.5mm before Sf1
77
78 //first collimator 6mm diameter before scattering foil
79 oSf1: DRIFT, L= 0.05;
80 mSf1: MARKER; //at collimator
81 oend: DRIFT, L= 1.72; //to end of nozzle
82
83 MACHINE: LINE=(o,Q11, o11, Q12, o12, Q13, o2, D, o20, Q21, o21, Q22,
84 o22, Q23, o3,o3,o3,o3,o3,o3,o3,o3,o3,o3,




89 mS, oSf1, msf1, oend);
90
91 setplot, xsize=30, ysize=18;
92 setplot, lwidth=6, !line thickness
93 lscale=1.8, !axis graduation font size
94 ascale=1.5, !function label size












107 select, flag=twiss, clear;
108 //for normal twiss table uncomment the following,







115 //OK inputs at entrance of Q1 = initial
116 TWISS,betx= 1.9897, alfx= 0.86,
117 bety= 1.0629, alfy= 0.2685,
118 dx=0, dpx=0, dy=0, dpy=0, file=twiss.tfs;
119






Figure B.17: Optical lattice defined in MAD-X. Quadrupole parameters have been
scaled and optimised.
1 ! Wed, 22 May 2019 09:55:20 +0000
2 ! pybdsim.Builder Lattice
3 ! COMPONENT DEFINITION
4
5 O: drift, l=0.77;
6 Q11: quadrupole, k1=-3.579884808, l=0.2;
7 O11: drift, l=0.13;
8 Q12: quadrupole, k1=2.204476987, l=0.2;
9 O12: drift, l=0.13;
10 Q13: quadrupole, k1=-1.9192767725, l=0.2;
11 O2: drift, l=1.73;
12 D: rbend, angle=-0.095993109, l=0.850000000031;
13 O20: drift, l=1.88;
14 Q21: quadrupole, k1=3.31023584864, l=0.22;
15 O21: drift, l=0.13;
16 Q22: quadrupole, k1=0.966066644091, l=0.22;
17 O22: drift, l=0.13;
18 Q23: quadrupole, k1=-3.31023584818, l=0.22;
19 O3: drift, l=0.563;
20 Q31: quadrupole, k1=4.71566276364, l=0.22;
21 O31: drift, l=0.13;
22 Q32: quadrupole, k1=-8.73932510455, l=0.22;
23 O32: drift, l=0.13;
24 Q33: quadrupole, k1=4.71566276364, l=0.22;
25 O4: drift, l=1.085;
26 ODIAG: drift, l=0.05454545455;
27 O5: drift, l=0.06;
28 O6: drift, l=0.0616;
29 OSF1: drift, l=0.05;
30 OEND: drift, l=1.72;
31 theendoftheline: marker;
Figure B.18: Optical components equivalent to the optimised MAD-X lattice, defined
in BDSIM.
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1 ! Wed, 22 May 2019 09:55:20 +0000
2 ! pybdsim.Builder




















Figure B.19: BDSIM beam definition file.
1 ##################################
2 ## Run file ##
3 ## Written by J Yap 2019 ##
4 ##################################
5
6 #-- Turn off quickly --#
7 i:So/BeamSource/NumberOfHistoriesInRun = 100000
8 b:Gr/MyViewer/Active = "False"
9 i:Ts/TrackingVerbosity = 0
10 i:Ts/EventVerbosity = 0
11 i:Ts/MaxInterruptedHistories = 1000
12
13 #=====================================================================#
14 # Parameter file chain
15 #=====================================================================#
16 includeFile = Materials.txt
17
18 # Run > Materials > BeamSource > Geometry > Visualiser > Scoring
19 > ParallelScoring >/> FilmScoring
Figure B.20: Run.txt parameter file.
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1 ##################################
2 ## Input beam ##
3 ## Written by J Yap 2019 ##
4 ##################################
5
6 includeFile = Geometry/Geometry.txt
7
8 #b:Sc/Beam/Active = "False"
9 b:Sc/BeamSourceTwiss/Active = "False"
10
11 s:So/BeamSource/Type = "Beam"
12 s:So/BeamSource/Component = "BeamPosition"
13 s:So/BeamSource/BeamParticle = "proton"
14 d:So/BeamSource/BeamEnergy = 62.2 MeV
15 u:So/BeamSource/BeamEnergySpread = 0.53
16 s:So/BeamSource/BeamPositionDistribution = "Gaussian"
17 s:So/BeamSource/BeamPositionCutoffShape = "Ellipse"
18 d:So/BeamSource/BeamPositionCutoffX = 6.89 mm #4.0 mm
19 d:So/BeamSource/BeamPositionCutoffY = 2.14 mm #4.5 mm
20 d:So/BeamSource/BeamPositionSpreadX = 0.6 mm
21 d:So/BeamSource/BeamPositionSpreadY = 0.2 mm
22 s:So/BeamSource/BeamAngularDistribution = "Gaussian"
23 d:So/BeamSource/BeamAngularCutoffX = 2.3 mrad
24 d:So/BeamSource/BeamAngularCutoffY = 1.2 mrad
25 d:So/BeamSource/BeamAngularSpreadX = 0.002 mrad #2.3 mrad
26 d:So/BeamSource/BeamAngularSpreadY = 0.001 mrad #1.2 mrad
27
28 ## TWISS ##
29 s:So/BeamSourceTwiss/Distribution = "twiss_gaussian"
30 u:So/BeamSourceTwiss/AlphaX = 5.29402
31 d:So/BeamSourceTwiss/BetaX = 48.73517 m
32 d:So/BeamSourceTwiss/EmittanceX = 0.00005 mm # we don’t multiply pi intrinsically.
33 u:So/BeamSourceTwiss/AlphaY = -6.14021
34 d:So/BeamSourceTwiss/BetaY = 13.48019 m
35 d:So/BeamSourceTwiss/EmittanceY = 0.00001 mm
36 u:So/BeamSourceTwiss/ParticleFractionX = 0.683 ## 1 sigma RMS
37 u:So/BeamSourceTwiss/ParticleFractionY = 0.683
38
39 sv:Ph/Default/Modules = 1 "g4em-standard_opt0"
40 #sv:Ph/Default/Modules = 2 "g4em-standard_opt3"
41 "g4h-phy_QGSP_BIC_HP" #"g4em-standard_opt0"
42 ##s:Ph/Default/Type = "QGSP_BIC_HP" #"QGSP_BERT_HP" #"QGSP_BIC_EMY"
43 #d:Ph/Default/CutForAllParticles = 0.05 mm
44 d:Ph/Default/CutForElectron = 0.01 mm
45 d:Ph/Default/CutForProton = 0.01 mm
46 d:Ph/Default/CutForGamma = 0.1 mm
47 d:Ph/Default/CutForPositron = 0.1 mm
48 #b:Ph/ListProcesses = "True"
Figure B.21: BeamSource.txt.
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B.4 Film and Image Analysis
Figure B.22: Calibration curve obtained for Medipix3 measurements.
Figure B.23: Images generated from a run with Medipix3 in the integration zone.








Figure B.24: TOPAS simulated beam profiles in the x plane, at each corresponding
film in order of position along beamline a) 1. b) 2. c) 3. d) 6. e) 4. f) 8. g) 5. h) 7.
Figure B.25: Calibration curve for red channel obtained for UoB film measurements.
Appendices 211
Figure B.26: Film profile with 7 mm collimator.
Figure B.27: Film profile with 10 mm collimator.
Figure B.28: Film profile with 15 mm collimator.
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Figure B.29: Film profile with 10 mm collimator at 6 cm distance in z.
Figure B.30: Film profile with 10 mm collimator at 12 cm distance in z.
Figure B.31: Film profile with 7 mm collimator.
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Figure B.32: Film profile with 10 mm collimator.
Figure B.33: Film profile with 15 mm collimator.
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B.5 TOPAS and MiniPIX Study
Scattering Tube
Figure B.34: Beam passes from left to right into this vacuum filled aluminium tube
housing the double scattering system: first collimator (yellow), tungsten scattering
foils (gold), brass stopper (orange) and kapton window (cyan).
Modulation Box
Figure B.35: A rotating modulation wheel to produces a SOBP. This is positioned at




Figure B.36: Second aluminium box containing the diagnostics devices: 2 dose monitors
(pink) and wire profile monitor where horizontal and vertical tungsten wires are held




Figure B.37: Dose monitors: PMMA outer layers (magenta), mylar foils (green), alu-
minium foils (white), guard rings (orange) and steel bolts (blue). b) Opposing view.
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Treatment Nozzle
Figure B.38: Treatment nozzle with brass cap, patient collimator (dark blue) and
arbitrary phantom for scoring (light blue).
Figure B.39: LETd scored across a pristine BP using different physics lists.
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Figure B.40: MiniPIX detector setup with lead sheet for beam calibration.
Figure B.41: Boxplots of simulated and measured LET at all depths for 45◦ and 60◦.
At greater depths the plots are shaded, corresponding to runs with a designated ∞
WET. Reproduced with permission from [210].
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Figure B.42: Measured energy spectra at all depths for 45◦.
Figure B.43: Measured energy spectra for 60◦.
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Figure B.44: Empirical LET spectra at all depths for 45◦.
Figure B.45: Empirical LET spectra for 60◦.
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Figure B.46: Comparisons of simulated and measured energies at all depths for 45◦ and
60◦, reproduced with permission from [210].
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Protocol for plotting calibration curves and beam profiles 
from film with MATLAB & ImageJ 












1. Scan film with the following: 
 .tif format 
 16 bits per pixel 
 150 pixels per inch 
 
2.  Rename all .tif files to their respective irradiated doses (ie  4Gy -> 4.tif) 
 
Creating ROIs for each film spot 
 
3. Open ImageJ, drag and drop all .tif files onto toolbar 
a) Select region of interest (click on the oval tool and draw a circle – hold 
shift while dragging to maintain/scale diameter for an even circle) 
b) Choose appropriate ROI size for beam spot coverage, this selects area of 
interest for the Red channel (scroll bar is at left third) 
i.e. Click Edit-> Selection-> Specify, Width = 250, Height = 250, 
tick for Oval 
 c) Press ‘ctrl’ + ‘m’ or Analyze -> Measure 
  Creates a table of results (Label, Area, Mean, Min, Max) 
 
Save pixel data in each ROI for each film  
d) Click on next .tif image and press 'ctrl' + 'shift' + 'E' to paste ROI 
It should be the same circle, same dimensions and position 
If needed, drag ROI to necessary position 
 e) Again, press ‘ctrl’ + ‘m’ or Analyze -> Measure 
  Generates a table of results for each film 
f) Move ROI onto film background to get a control measurement (0 Gy) 
 g) Save file as red.txt  
Move scroll bar on image to middle (green channel) and repeat d) & e), save as green.txt 
Do the same for the blue channel (scroll bar to right) and save as blue.txt 
 
  
- Make sure all .txt files are in this same 
directory 
 red.txt   






4. Open MATLAB and open all .m files in editor 
a) To generate a plot of the calibration curve, run 
CalibrationODtoDose_CCC.m 
This script reads data from all colour.txt files and generates 
a plot with: 
NetOD against Dose calibration curves for each 
channel with error bars 
  ‘Fit’ line fitted to the red channel  
 
- To see the fit equation, enter ‘f’ into command window 
- The type of fit can be changed in line 57 
- To hide the fit, comment out lines 133-135  
- To hide from legend table, 156 and uncomment line 157 
- For high resolution image uncomment line 164 
- To change the plot title, edit line 145 
- To view individual channel curves, uncomment lines 70-71 in CalibrationBlue/Green_CCC.m 
- The plot is saved automatically in the directory as date_CalibrationCurve.png 
- Calculation of OD, conversion to dose and errors are calculated using procedures found in literature [1–3] 
 
  
Beam profile plots 
 
Creating ROIs for relevant film spot 
 
5. Open ImageJ, drag and drop the .tif file onto toolbar 
a) Select region of interest (click on the rectangle tool and draw a 
rectangle on the image 
b) Choose appropriate ROI size for beam spot coverage,  
i.e. Click Edit-> Selection-> Specify, Width = 580, Height = 120 
- Ideally the ROI should be larger (better statistics) but also be able to 
maintain consistency when analysing different beam spot shapes 
- Only needs to be done for the Red channel 
 c) Press ‘ctrl’ + ‘k’ or Analyze -> Plot Profile 
  Creates a plot of the grey values by position 
 d) Press 'Save...' and rename file, saving data as a .txt file  
 
- You can use 'ctrl' + 'shift' + 'E' to paste ROI from before 
  
Generating the profile plot 
 
- If you have not run the calibration script this session, uncomment line 12 
- After running it once, you can comment the line again to speed up the analysis 
- This takes the fitted equation from the calibration fits and uses the fit to calculate the doses by pixel 
 
6. Make sure line 7 corresponds to the relevant .txt file  
a) Run PlotProfileofScannedFilmWithOD_CCC.m 
   Generates a plot with: 
  Pixel position in mm 
  Dose at each position 
  FWHM of the plotted profile 
- The FWHM is calculated by 2 methods: 
1. Finds x position of the maximum point and doubles it  
(default option, works better for symmetrical plots) 
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 2. Fits a Gaussian to the plot (works better for double peaks) 
- To use option 2, you need to uncomment line 57 
- You can preview how the Gaussian fit compares to the plot by 
displaying it by uncommenting line 86 
 
- To change the graph title, edit line 69 
- For high resolution image uncomment line 98 
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This protocol and all scripts were written by Jacinta Yap to demonstrate methods used for analysis of film 
irradiations performed at the Clattterbridge Cancer Centre, UK.  Any work carried out was for the purposes of 














Figure C.1: Protocol documentation for dose conversion specifically for film measure-
ments and analysis done at Clatterbridge. Script uses Matlab and ImageJ to generate
calibration curves for each RGB channel, converting grey pixel values to OD to dose
and the pixel size and (scanner) dots per inch to lengths in mm. Automates plotting
of beam profiles for dose (Gy) against position (mm).
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1 %% MATLAB script to plot optical density calibration curved from scanned film %%
2 % This is for Red channel, will also automatically call the scripts for the
3 blue & green
4
5 % Written by J Yap, Apr 2019 (yapjacinta@gmail.com)
6
7 %% Load file - red channel
8 filename = ’red’;
9 fileID = string(filename)+’.txt’;
10
11 file = fopen(fileID,’rt’);
12 data = textscan(file,’%d %s %f %10f %f %f’,’HeaderLines’,1); %skip header line
13 fclose(file);
14
15 %% Definitions %%
16 format long g
17 A = data{3};
18 Area = A(1);
19 ZeroVal = 65535; % grey value from scanner (white pixel)
20
21 DoseCol = data{2};
22 d = split(DoseCol,’.’);
23 DoseVals = d(:,1);
24
25 MeanVals = data{4};
26 MinVals = data{5};




31 d1=double(string(DoseVals)); % convert to numbers
32 DoseData = [d1, MeanVals];
33 index = find(DoseData==0);
34 Rcontrol = DoseData(index,2);
35
36 %% Optical density %%
37
38 OD = -log10((Rcontrol-ZeroVal)./(MeanVals-ZeroVal));
39 doseRed = sort(d1);
40 Red = sort(OD);
41 calibData = [doseRed,Red];
42





48 %% Interpolate between points for smooth curves %%
49
50 f1 = fit(Red,doseRed,’smoothingspline’);
51 f2 = fit(Green,doseGreen,’linear’);
52 f3 = fit(Blue,doseBlue,’linear’);
53





58 f=fit(x1,y1,’exp2’); %type of fit ’exp1’
59
60 coeff = coeffvalues(f);
61
62 fita = coeff(1);
63 fitb = coeff(2);
64 fitc = coeff(3); %comment out for exp1
65 fitd = coeff(4); %comment out for exp1
66
67 %% Error bars
68
69 Diffred = [d1,MeanVals,MinVals,MaxVals];
70 Diffred = sortrows(Diffred,1);
71 controlred = Diffred(1,:);
72



























100 set(gcf, ’Units’, ’Normalized’, ’OuterPosition’, [0.2, 0.2, 0.4, 0.6]);















































147 title(’Optical Density Calibration’, ’FontSize’,14); % graph title,










158 lgd.Title.String = ’Channel’;
159 lgd.Location=’northwest’;
160 legend([pr pg pb pf]);
161 %legend([pr pg pb]);
162
163 %% Save as picture
164
165 savefilename = string(date)+’_CalibrationCurve.png’;
166 saveas(gcf,savefilename);
167 print(gcf,savefilename,’-dpng’,’-r600’) %high resolution
Figure C.2: CalibrationODtoDose CCC.m
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1 %% MATLAB script to plot optical density calibration curved from scanned film %%
2
3 % Generates data for the blue channel
4 % Note: You don’t need to open or run this script, it is called from the
5 Calibration.m script
6 % Checks: Make sure it is in the same directory as Calibration.m
7 % Written by J Yap, Apr 2019 (yapjacinta@gmail.com)
8
9 %% Load file - blue channel
10 file = fopen(’blue.txt’,’rt’);
11 datab = textscan(file,’%d %s %f %10f %f %f’,’HeaderLines’,1); %skip header line
12 fclose(file);
13
14 %% Definitions %%
15 format long g
16 B = datab{3};
17 ZeroVal = 65535; % grey value from scanner (white pixel)
18
19 DoseColb = datab{2};
20 db = split(DoseColb,’.’);
21 DoseValsb = db(:,1);
22
23 MeanValsb = datab{4};
24 MinValsb = datab{5};




29 d1b=double(string(DoseValsb)); % convert to numbers
30 DoseDatab = [d1b, MeanValsb];
31 indexb = find(DoseDatab==0);
32 Bcontrol = DoseDatab(indexb,2);
33
34 %% Error bars
35
36 Diffblue = [d1b,MeanValsb,MinValsb,MaxValsb];
37 Diffblue = sortrows(Diffblue,1);



























64 %% Optical density %%
65
66 ODblue = -log10((Bcontrol-ZeroVal)./(MeanValsb-ZeroVal));
67 doseBlue = sort(d1b);
68 Blue = sort(ODblue);






Figure C.3: CalibrationBlue CCC.m
1 %% MATLAB script to plot optical density calibration curved from scanned film %%
2
3 % Generates data for the green channel
4 % Note: You don’t need to open or run this script, it is called from the
5 Calibration.m script
6 % Checks: Make sure it is in the same directory as Calibration.m
7 % Written by J Yap, Apr 2019 (yapjacinta@gmail.com)
8
9 %% Load file - green channel
10 file = fopen(’green.txt’,’rt’);
11 datag = textscan(file,’%d %s %f %10f %f %f’,’HeaderLines’,1); %skip header line
12 fclose(file);
13
14 alsg = dg(:,1);
15
16 MeanValsg = datag{4};
17 MinValsg = datag{5};




22 d1g=double(string(DoseValsg)); % convert to numbers
23 DoseDatag = [d1g, MeanValsg];
24 indexg = find(DoseDatag==0);
25 Gcontrol = DoseDatag(indexg,2);
26
27 %% Error bars
28
29 Diffgreen = [d1g,MeanValsg,MinValsg,MaxValsg];
30 Diffgreen = sortrows(Diffgreen,1);



























57 %% Optical density %%
58
59 ODgreen = -log10((Gcontrol-ZeroVal)./(MeanValsg-ZeroVal));
60 doseGreen = sort(d1g);
61 Green = sort(ODgreen);






Figure C.4: CalibrationGreen CCC.m
1 %% MATLAB script to convert scanned film to profile plots %%
2 % Please see accompanying PDF for protocol to run these scripts
3
4 % Written by J Yap, Apr 2019 (yapjacinta@gmail.com)
5
6 %% Load file - Enter name of file here without .txt
7 filenamecal = ’F3’;
8
9 % Just need to run this calibration script once for the first film, comment it out




14 % Only change any of the following if there is a double peak & you need to
15 % fit a gaussian for the FWHM calculation
16
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17 %% Read file %%
18 file = string(filenamecal)+’.txt’;
19 disptext = [’You are plotting ’ char(file)];
20 disp(disptext)





26 posXinch = filmdata(:,1);
27 posXcm = posXinch*25.4; %convert pixel position to cm
28
29 %convert pixel values to dose
30 pixelVals = filmdata(:,2);
31 converttoOD = -log10((Rcontrol-ZeroVal)./(pixelVals-ZeroVal));
32 ODtoDose = (fita*exp(fitb.*converttoOD))+(fitc*exp(fitd.*converttoOD));
33
34 %symmetrical plotting
35 centre = max(posXcm)/2;
36 %invert plot
37 %minPixelval = min(converttoOD);
38 %position (x column for plotting)
39 position = posXcm - centre;
40 %converted dose (y column)
41 pixel = ODtoDose;
42










53 % Calc FWHM by fitting a gaussian, if using this method uncomment the 4th line
54 f = fit(position,pixel,’gauss1’);




59 %% Graph positioning
60 figure
61 hold on
62 set(gcf, ’Units’, ’Normalized’, ’OuterPosition’, [0.2, 0.2, 0.5, 0.6]);
63 arrangement = [0.27 0.12 0.7 0.8]; % [left bottom width height]
64 subplot(’Position’,arrangement);
65
66 %% Plot graph
67 a=plot(position,pixel,’LineWidth’,1.2, ’Color’,[0,0,1]);
68 name = [filenamecal ’ Profile’];
69 title(name, ’FontSize’,14); % graph title, change here if needed
70 grid on
71
72 set(gca, ’GridLineStyle’,’--’, ’GridColor’,’[0.3 0.3 0.3]’)
73
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78 set(get(gca,’ylabel’),’rotation’,0); %rotate y title horizontally
79 set(yl,’Units’,’normalized’);
80 shift=0.15; %shift ylabel left
81 set(yl,’Position’,get(yl,’position’)-[shift 0 0]) %position ylabel
82 buffery=1.1*(max(pixel)); %increase y graph
83 ylim([0,buffery]);
84
85 %Uncomment to see fitted double gaussian
86 %plot(f,position,pixel); legend(’FontSize’,12,’Location’,’northwest’);
87
88 %% FWHM box
89 annotate= [’FWHM= ’ char(string(fwhms)) ’mm’];
90 annotation(’textbox’,[0.75 0.75 0.2 0.15],’String’,{annotate},’FitBoxToText’,
91 ’on’, ’FontSize’,10, ’LineWidth’,1, ’BackgroundColor’,[1 1 1]);
92 disp(annotate)
93




98 %print(gcf,’saveasnameHR.png’,’-dpng’,’-r600’) %high resolution
Figure C.5: PlotProfileofScannedFilmWithOD CCC.m
Emittance Measurement Scheme
Figure C.6: Sketch of relevant components and dimensions for integration of the
4PrOBεaM system into the beamline (between Q3 and treatment room) for emittance
measurements.
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C.1 CCC Component Specifications
Figure C.7: List of each treatment line component and corresponding positions in z


































































































































Figure C.8: Drawing of the CCC treatment line with all dimensions listed.
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[82] M. Durante, E. BräUer-Krisch, and M. Hill, “Faster and safer? FLASH ultra-high
dose rate in radiotherapy,” British Journal of Radiology, vol. 91, no. 1082, pp. 6–9,
2018.
[83] M. Lempart, B. Blad, G. Adrian, S. Bäck, T. Knöös, C. Ceberg, and K. Peters-
son, “Modifying a clinical linear accelerator for delivery of ultra-high dose rate
irradiation,” Radiotherapy and Oncology, no. 139, pp. 40–45, 2019.
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[176] R. Dölling, “Profile, Current, and Halo Monitors of the PROSCAN Beam Lines,”
in Beam Instrumentation Workshop, vol. 732, (Knoxville), pp. 244–252, AIP Con-
ference Proceedings, 2004.
[177] M. Schwickert and A. Peters, “Diagnostic instrumentation for medical accelerator
facilities,” 8th European Workshop on Beam Diagnostics and Instrumentation for
Particle Accelerators, DIPAC 2007, pp. 381–385, 2007.
[178] J. M. Schippers, J. Duppich, G. Goitein, M. Jermann, A. Lomax, E. Pedroni,
H. Reist, B. Timmermann, et al., “The use of protons in cancer therapy at PSI
and related instrumentation,” Journal of Physics: Conference Series, vol. 41, no. 1,
pp. 61–71, 2006.
[179] S. H. Park, S. H. Lee, and Y. S. Kim, “Emittance Measurement for Beamline
Extension at the PET Cyclotron,” Science and Technology of Nuclear Installations,
vol. 2016, pp. 1–4, mar 2016.
[180] K. Nesteruk, M. Auger, S. Braccini, T. Carzaniga, A. Ereditato, and P. Scampoli,
“A system for online beam emittance measurements and proton beam characteri-
zation,” Journal of Instrumentation, vol. 13, jan 2018.
[181] K. Nesteruk, A New System for Online Measurement of the Beam Emittance of
Particle Accelerators for Research and medical Applications. PhD thesis, Univer-
sity of Bern, 2017.
[182] M. Auger, S. Braccini, T. S. Carzaniga, A. Ereditato, K. P. Nesteruk, and P. Scam-
poli, “A detector based on silica fibers for ion beam monitoring in a wide current
range,” Journal of Instrumentation, vol. 11, no. 03, p. P03027, 2016.
258 Bibliography
[183] L. Nevay, S. Boogert, A. Abramov, J. Albrecht, S. Alden, H. G. Morales, S. Gibson,
H. Pikhartova, et al., “BDSIM documentation,”. URL: http://www.pp.rhul.ac.
uk/bdsim/manual/introduction.html.
[184] J. Perl, J. Shin, J. Schümann, B. Faddegon, and H. Paganetti, “TOPAS: An
innovative proton Monte Carlo platform for research and clinical applications,”
Medical Physics, vol. 39, no. 11, pp. 6818–6837, 2012.
[185] J. Schuemann, A. L. McNamara, J. Ramos-Méndez, J. Perl, K. D. Held, H. Pa-
ganetti, S. Incerti, and B. Faddegon, “TOPAS-nBio: An Extension to the TOPAS
Simulation Toolkit for Cellular and Sub-cellular Radiobiology,” Radiation Re-
search, vol. 191, no. 2, p. 125, 2019.
[186] J. Perl, J. Shin, J. Schuemann, J. R. Mendez, D. Hall, A. Biegun, and F. Guan,
“TOPAS documentation,”. URL: https://topas.readthedocs.io/en/latest/
index.html.
[187] J. Yap, “TOPAS model of the 60 MeV Ocular Proton Therapy Beamline at the
Clatterbridge Cancer Centre (CCC), Wirral, United Kingdom,”. URL: https:
//github.com/jacyap/ClatterbridgeTreatmentLine.
[188] Autodesk, “Fusion 360,”.
[189] D. A. Granville and G. O. Sawakuchi, “Comparison of linear energy transfer scor-
ing techniques in Monte Carlo simulations of proton beams,” Physics in Medicine
and Biology, vol. 60, no. 14, pp. N283–N291, 2015.
[190] D. T. Goodhead, “Energy deposition stochastics and track structure: What about
the target?,” Radiation Protection Dosimetry, vol. 122, no. 1-4, pp. 3–15, 2006.
[191] H. Nikjoo, S. Uehara, and D. Emfietzoglou, Interaction of Radiation with Matter.
Boca Raton, Florida, USA: CRC Press, 2012.
[192] M. C. Frese, J. J. Wilkens, P. E. Huber, A. D. Jensen, U. Oelfke, and Z. Taheri-
Kadkhoda, “Application of constant vs. variable relative biological effectiveness in
treatment planning of intensity-modulated proton therapy,” International Journal
of Radiation Oncology Biology Physics, vol. 79, no. 1, pp. 80–88, 2011.
[193] R. A. Britten, V. Nazaryan, L. K. Davis, S. B. Klein, D. Nichiporov, M. S. Men-
donca, M. Wolanski, X. Nie, et al., “Variations in the RBE for cell killing along
the depth-dose profile of a modulated proton therapy beam.,” Radiation Research,
vol. 179, no. 1, pp. 21–8, 2013.
[194] M. Fager, I. Toma-Dasu, M. Kirk, D. Dolney, E. S. Diffenderfer, N. Vapiwala,
and A. Carabe, “Linear energy transfer painting with proton therapy: A means
of reducing radiation doses with equivalent clinical effectiveness,” International
Journal of Radiation Oncology Biology Physics, vol. 91, no. 5, pp. 1057–1064,
2015.
[195] J. J. Wilkens and U. Oelfke, “Optimization of radiobiological effects in intensity
modulated proton therapy.,” Medical physics, vol. 32, no. 2, pp. 455–465, 2005.
[196] H. Paganetti, E. Blakely, A. Carabe-Fernandez, D. J. Carlson, I. J. Das, L. Dong,
D. Grosshans, K. D. Held, et al., “Report of the AAPM TG-256 on the relative
biological effectiveness of proton beams in radiation therapy,” Medical Physics,
vol. 46, no. 3, pp. e53–e78, 2019.
Bibliography 259
[197] J. J. Wilkens and U. Oelfke, “A phenomenological model for the relative biologi-
cal effectiveness in therapeutic proton beams.,” Physics in medicine and biology,
vol. 49, no. 13, pp. 2811–2825, 2004.
[198] J. J. Wilkens and U. Oelfke, “Analytical linear energy transfer calculations for
proton therapy.,” Medical physics, vol. 30, no. 5, pp. 806–815, 2003.
[199] F. Romano, G. a. P. Cirrone, G. Cuttone, F. D. Rosa, S. E. Mazzaglia, I. Petrovic,
a. R. Fira, and A. Varisano, “A Monte Carlo study for the calculation of the
average linear energy transfer (LET) distributions for a clinical proton beam line
and a radiobiological carbon ion beam line,” Physics in Medicine and Biology,
vol. 59, no. 12, pp. 2863–2882, 2014.
[200] M. A. Cortés-Giraldo and A. Carabe, “A critical study of different Monte Carlo
scoring methods of dose average linear-energy-transfer maps calculated in vox-
elized geometries irradiated with clinical proton beams.,” Physics in medicine and
biology, vol. 60, no. 7, pp. 2645–69, 2015.
[201] C. Grassberger and H. Paganetti, “Elevated LET components in clinical proton
beams,” Physics in Medicine and Biology, vol. 56, pp. 6677–6691, 2011.
[202] F. Guan, C. Peeler, L. Bronk, C. Geng, R. Taleei, S. Randeniya, S. Ge, D. Mirkovic,
et al., “Analysis of the track-and dose-averaged LET and LET spectra in proton
therapy using the geant4 Monte Carlo code,” vol. 42, no. November, pp. 1–34,
2015.
[203] A. C.-F. A. Bertolet, M. Cortés-Giraldo, “On the concepts of dose-mean lineal
energy, unrestricted and restricted dose-averaged LET in proton therapy,” Physics
in Medicine & Biology, pp. 1–46, 2020.
[204] P. Chaudhary, T. I. Marshall, F. M. Perozziello, L. Manti, F. J. Currell, F. Hanton,
S. J. McMahon, J. N. Kavanagh, et al., “Relative biological effectiveness variation
along monoenergetic and modulated Bragg peaks of a 62-MeV therapeutic proton
beam: A preclinical assessment,” International Journal of Radiation Oncology
Biology Physics, vol. 90, no. 1, pp. 27–35, 2014.
[205] C. M. Nickson, P. Moori, R. J. Carter, C. P. Rubbi, and J. L. Parsons, “Misregu-
lation of DNA damage repair pathways in HPV-positive head and neck squamous
cell carcinoma contributes to cellular radiosensitivity,” Oncotarget, vol. 8, no. 18,
pp. 29963–29975, 2017.
[206] R. J. Carter, C. M. Nickson, J. M. Thompson, A. Kacperek, M. A. Hill, and J. L.
Parsons, “Characterisation of Deubiquitylating Enzymes in the Cellular Response
to High-LET Ionizing Radiation and Complex DNA Damage,” International Jour-
nal of Radiation Oncology Biology Physics, vol. 104, no. 3, pp. 656–665, 2019.
[207] R. J. Carter, C. M. Nickson, J. M. Thompson, A. Kacperek, M. A. Hill, and
J. L. Parsons, “Complex DNA damage induced by high-LET α-particles and pro-
tons triggers a specific cellular DNA damage response,” International Journal of
Radiation Oncology*Biology*Physics, vol. 100, no. 3, pp. 776–784, 2017.
[208] E. T. Vitti and J. L. Parsons, “The radiobiological effects of proton beam therapy:
Impact on DNA damage and repair,” Cancers, vol. 11, no. 7, pp. 1–15, 2019.
260 Bibliography
[209] G. A. P. Cirrone, G. Cuttone, F. Di Rosa, S. E. Mazzaglia, F. Romano, A. Attili,
F. Bourhaleb, G. Russo, et al., “Hadrontherapy: An open source, Geant4-based
application for proton-ion therapy studies,” IEEE Nuclear Science Symposium
Conference Record, no. I, pp. 4186–4189, 2009.
[210] M. Brooke, Incorporating biological factors in radiation therapy treatment plan-
ning. PhD thesis, University of Oxford, 2020.
[211] X. Llopart, R. Ballabriga, M. Campbell, L. Tlustos, and W. Wong, “Timepix, a 65k
programmable pixel readout chip for arrival time, energy and/or photon counting
measurements,” Nuclear Instruments and Methods in Physics Research, Section A:
Accelerators, Spectrometers, Detectors and Associated Equipment, vol. 581, no. 1-2
SPEC. ISS., pp. 485–494, 2007.
[212] S. Hoang, L. Pinsky, R. Vilalta, and J. Jakubek, “LET estimation of heavy ion
particles based on a timepix-based Si detector,” Journal of Physics: Conference
Series, vol. 396, 2012.
[213] L. Opalka, C. Granja, B. Hartmann, J. Jakubek, O. Jaekel, M. Martisikova,
S. Pospisil, and J. Solc, “3D measurement of the radiation distribution in a water
phantom in a hadron therapy beam,” Journal of Instrumentation, vol. 7, no. 1,
2012.
[214] L. Opalka, C. Granja, B. Hartmann, J. Jakubek, O. Jaekel, M. Martisikova,
S. Pospisil, and J. Solc, “Linear energy transfer and track pattern recognition
of secondary radiation generated in hadron therapy beam in a PMMA target,”
Journal of Instrumentation, vol. 8, no. 2, 2013.
[215] J. Jakubek, C. Granja, B. Hartmann, O. Jaekel, M. Martisikova, L. Opalka, and
S. Pospisil, “Selective detection of secondary particles and neutrons produced in
ion beam therapy with 3D sensitive voxel detector,” Journal of Instrumentation,
vol. 6, no. 12, 2011.
[216] M. Jakubek, J. Jakubek, J. Zemlicka, M. Platkevic, V. Havranek, and V. Semian,
“3D imaging of radiation damage in silicon sensor and spatial mapping of charge
collection efficiency,” Journal of Instrumentation, vol. 8, no. 3, 2013.
[217] N. Stoffle and L. Pinsky, “Identification of stopping ions in a silicon Timepix de-
tector,” Nuclear Instruments and Methods in Physics Research, Section A: Accel-
erators, Spectrometers, Detectors and Associated Equipment, vol. 880, no. October
2017, pp. 35–39, 2018.
[218] M. Martǐśıková, B. M. Hesse, O. Nairz, and O. Jäkel, “Test of an amorphous sil-
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